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Abstract  
Background: The relationship between blood pressure (BP) and early-life factors 
such as birth weight, life-course factors such as obesity, and genetic variants among 
Africans are unknown. This PhD aimed to systematically review literature on the 
relationship between birth weight and BP among young Africans and to use data from 
the Entebbe Mother and Baby Study (EMaBS), a Ugandan birth cohort, to investigate 
the impact of early-life, life-course and genetic factors on adolescents’ BP. 
Methods: Four databases were systematically searched for relevant publications. In 
the EMaBS, data were collected prenatally from pregnant women and prospectively 
from the resulting offspring, with BP measured in adolescence. Linear regression was 
used to relate birth weight, early-growth and other characteristics to BP. Genetic 
analyses were conducted to investigate genetic variants associated with adolescents’ 
BP. 
Results: The systematic review showed that among the few published studies from 
Africa, the relationship between birth weight and BP varied by participants’ age. 
Findings from the EMaBS indicated strong evidence of association between postnatal 
weight gain and later BP, with fast-growing low birth weight individuals particularly 
affected. Maternal factors positively associated with higher adolescent BP were 
gestational body mass index (BMI) and higher education status. Adolescent factors 
positively associated with higher BP were age, waist circumference, BMI, family 
history of hypertension and current Trichuris infection. Previous malaria infection in 
childhood and higher vegetable or fruit consumption were associated with lower BP 
in adolescence. No genetic variant reached genome-wide significance for association 
with BP. Thirty-three of 330 variants previously identified as associated with BP were 
replicated in this study, but none were significant after accounting for multiple testing. 
Conclusions: Postnatal weight gain rather than birth weight is associated with later 
BP, with fast-growing low birth weight individuals at particular risk. Larger studies 
are required to characterise BP genetics in African adolescents. 
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Chapter 1: Background 
1.1 Introduction 
This chapter provides background regarding the epidemiology of blood pressure (BP) and 
presents the hypothesis and the rationale for undertaking this PhD project. For the purpose 
of this chapter, high BP and hypertension are used interchangeably. High BP was defined 
as mean systolic BP ³140 mmHg and/or diastolic BP ³90 mmHg in the adults (age ³18 
years) on one or more separate occasions or mean systolic and/or diastolic BP ³95th 
percentile for sex, age and height based on readings taken on one or more separate 
occasions for children and adolescents (age 0-18 years). Pre-hypertension was defined as 
mean systolic BP between 120-139 mmHg and or diastolic BP between 80-89 mmHg in 
adults or mean systolic BP and/or diastolic BP ³90th percentile but <95th percentile for 
sex, age, and height based on readings taken on one or more separate occasions in children 
and adolescents. 
1.2 Blood pressure burden 
Globally, high BP affects over a billion adults and contributes to over 10 million deaths 
annually [1-3]. In 2015, nearly 211 million disability-adjusted life-years (DALYs) were 
lost due to high BP [4]. High BP was the leading cause of global mortality and morbidity 
in 2013 [5]. The burden of high BP varies with geographical region and ethnicity, being 
highest in populations of African ancestries but lowest in Caucasians [6]. Approximately, 
75% of the individuals with high BP are in low income countries (LICs) [7]. High BP is 
estimated to affect over 46% of adults above 25 years of age in Africa, compared to 35-
40% in the same age group elsewhere in the world [8]. 
Diagnosis of cardiovascular diseases (CVDs) is uncommon before middle age. Yet 
important determinants, such as atherosclerosis and high BP, begin early in life [9]. 
Cardiovascular and metabolic changes begin long before clinical manifestation of disease 
[10]; left ventricular hypertrophy (LVH) occurs in more than a third of children with high 
BP [11] and fatty streaks were observed at autopsy of 15- to 19-year-old adolescents [12] 
and in aortas of premature fetuses [13]. 
The prevalence of CVDs determinants (including high BP, dyslipidaemia, diabetes 
mellitus and obesity) is high and rising in much of Sub-Saharan Africa (SSA) [14]. After 
allowing for differences in the age distribution of the populations, CVDs and related 
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determinants are affecting individuals at younger ages in SSA than in more affluent 
countries [15]. Once uncommon on the African continent, the burden of hypertension has 
grown continuously over the past decades. Despite a drop in the prevalence of high BP 
in high income countries (HICs) over the past four decades, LICs in SSA and Asia have 
seen an increase in the prevalence of high BP in the same period [16]. Earlier studies from 
Africa reported no or low burden of hypertension [17-19]. However, more recent studies 
from the continent summarised in systematic reviews have shown a high burden of 
hypertension in adults [20] and in young Africans [21]. The growing burden of high BP 
in Africa has been attributed to a transition from active to more sedentary lifestyles and a 
rise in unhealthy dietary practices (characterised by over consumption of saturated and 
trans fats) on the continent over the past decades [14, 16, 22-24]. 
Globally, the burden of hypertension has increased in children and adolescents. Between 
1988 and 1999, prevalence of pre-hypertension and hypertension increased by 2% and 
1% respectively, among American children [25]. In the early 2000s, the prevalence of 
hypertension doubled among South African adolescents [23]. In the United States of 
America (USA), the incidence rate of hypertension in adolescents was estimated at 7% 
per year [26]. Prevalence of high BP among young Africans varies between 1% and 25% 
[21, 27]. For example, it was estimated at 4% in Nigeria [28] and 4% in Uganda [29] 
based on readings on three different occasions and estimated at 8% in the Gambia [30], 
10% in Seychelles [31], 17% in Uganda [29] and 21% in South Africa [32], based on the 
mean of 2 or 3 BP readings taken on the same occasion. 
High BP is most commonly “essential hypertension” (no identifiable cause). Globally, 
essential hypertension affects 40-70% of children with hypertension [33, 34]. Essential 
hypertension is associated with obesity and family history of hypertension or CVDs [11]. 
Secondary hypertension (underlying cause present) is more common in children than 
adults and estimated to affect 30-60% of children with hypertension [33, 34]. 
Although high BP is less common in children than in adults, most adulthood hypertension 
initiates in childhood [35, 36]. A large proportion of those with childhood hypertension 
sustain the condition into adolescence [37, 38]. A study among 3,273 young black South 
Africans showed that children (mean age of 7.6 years at enrolment) maintained high BP 
into adolescence; after six years of follow-up, 36% of those with high BP remained 
hypertensive while 80% of the normotensives remained normotensive [38]. Among 1,927 
Finnish participants between 3 and 18 years of age in 1980, observation of two or more 
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abnormal BP measurements was a good predictor of hypertension in these participants 21 
to 31 years later [39]. 
Hypertension is a strong predictor of cardiovascular mortality in patients with end stage 
renal disease [40]; progression of chronic kidney disease [41]; and stroke in adults [42]. 
High BP in children is associated with CVDs markers such as LVH, atherosclerosis, 
intima media thickness, diastolic dysfunction and adulthood hypertension [11, 26, 43-
46]. 
1.3 Diagnosis and treatment 
1.3.1 Diagnosis 
There is evidence that most hypertension is undetected and under treated. Globally, over 
75% of hypertension in children and adolescents is estimated to be undiagnosed [47-49]. 
In HICs, only 13% to 26% of hypertension among children is properly diagnosed [33, 
34]. Between November 2010 and October 2011, in a study of 29,000 children in the 
USA, identified as having three raised BP measurements at outpatient visits, only 215 
(<1%) had been previously diagnosed as having high BP [49]. The burden of undiagnosed 
or inaccurately classified BP is undocumented among young Africans and could be higher 
than among children and adolescents from HICs. 
Several challenges to hypertension diagnosis in children and adolescents exist. Blood 
pressure check-up (a vital medical examination) is routinely performed among adults but 
rarely in children or adolescents [47], despite the international recommendations to 
annually measure children’s and adolescents’ BP starting at three years of age in healthy 
individuals, and at every health care encounter if they are obese, or have renal disease, 
history of aortic arch obstruction or coarctation, or diabetes [11]. Unlike in adults for 
whom cut-offs for normal BP are clearly defined, in children and adolescents normal and 
abnormal BP values vary depending on sex, age, and height. This makes classification of 
BP in the young more challenging and cumbersome. 
In addition, a cuff size appropriate for the child’s arm (bladder length covering at least 
80% of the mid-upper arm circumference (MUAC) but not more than 100% and bladder 
width covering at least 40% of the MUAC) is required for accurate measurement of BP 
[11]. Larger-than-appropriate cuff sizes give falsely low BP readings, a cuff that is too 
small for a child’s arm will give a falsely high reading [50]. 
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Blood pressure varies over time; thus, it is important to document raised BP from multiple 
readings for accurate diagnosis of high BP [11, 38, 51]. Following repeated BP 
measurements among 1,725 American adolescents (13 to 18 years), BP reduced to normal 
levels in 6% of those initially classified as having pre-hypertension (based on a single 
measurement) but increased to hypertensive levels in 3% of these initially classified as 
pre-hypertensive [51]. Pre-hypertensive children are at risk of developing hypertension 
later in life [52]. 
Hypertension in children is often asymptomatic and frequently missed by clinicians. 
Undiagnosed or untreated childhood hypertension is associated with serious health 
consequences, including organ damage (to organs such as the kidneys and heart) in 
childhood [11, 53, 54] and increased risk of hypertension [54], CVDs, stroke, and kidney 
disease in adulthood [42, 55]. Severe high BP is associated with increased risk of 
hypertensive encephalopathy, cerebrovascular accidents, myocardial infarction and 
congestive cardiac failure [53, 56]. Yet, treatment of BP reduces the risk for 
cardiovascular events [11] and could reverse and prevent the long-term sequelae to organ 
damage [48, 51, 53]. Therefore, identifying children and adolescents who already have, 
or who are at risk of developing, high BP is vital for the control and prevention of later 
cardiovascular events. 
1.3.2 Treatment 
Lifestyle modification (non-pharmacological) therapy is the first line treatment for 
primary hypertension in children [57, 58]. This consists of regular physical exercise, a 
diet restricted in salt (sodium) but rich in fresh fruits and vegetables, and reduction in 
weight for those who are overweight or obese [58, 59]. In addition to preventing the 
development of hypertension, regular physical exercise lowers BP levels among adults, 
with and without hypertension [60]. Moderate to vigorous physical exercise lasting 40 
minutes for 3 to 5 days a week reduced systolic BP by 6-10 mmHg among 25 adolescents 
(aged 16 ± 1 years). However, BP levels returned to pre-training levels nine months later 
on cessation of physical exercises [61]. Interventions combining both dietary 
recommendations and regular physical exercise result in greater reductions in BP levels 
[60, 62]. 
Pharmacological therapy in children is recommended for symptomatic hypertension; 
secondary hypertension; persistent hypertension despite lifestyle modification therapy; 
hypertension with target-organ damage such as hypertensive retinopathy, 
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microalbuminuria, LVH; and presence of co-morbidities such as diabetes mellitus [63]. 
It is important to treat any underlying cause(s) of high BP. 
Drugs from the angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor 
blocker (ARB), beta-blockers (BB), calcium channel blockers (CCB) and diuretics are 
the first line agents for the treatment of paediatric hypertension [57]. Combination 
treatment with drugs from different classes is recommended if BP control cannot be 
attained with a single drug [59]. Pharmacological therapy aims at preventing organ 
damage and reducing long-term cardiovascular risk associated with hypertension [57]. 
Lifestyle modification remains the cornerstone therapy for primary prevention, treatment 
and control of hypertension and should be maintained when pharmacological treatment 
is initiated. 
1.4 Blood pressure determinants 
High BP is a complex multifaceted disorder; multiple environmental and genetic factors 
play a role in its development [64-66]. The modifiable determinants of BP include 
increased dietary salt intake, obesity, reduced physical activity, smoking, and poor sleep 
quality, while the non-modifiable determinants include gender, ethnicity, genetics and 
prematurity. Low birth weight and both low or high socio-economic status have also been 
associated with BP later in life. 
1.4.1 Environmental (non-genetic) factors 
Several environmental factors such as age [20, 30, 67-69], birth weight [70-75], gender 
[6, 32, 69, 76, 77], postnatal weight gain [74, 78-80], ethnicity [6, 81], waist 
circumference [32, 67, 82], urbanisation [20, 83, 84], socio-economic status [85, 86], 
physical inactivity [87, 88], sleep disorders and duration [11, 77], diet [88], dietary salt 
intake [89], family history of hypertension [90], body mass index (BMI) and obesity [21, 
30, 32, 38, 67, 76, 82, 87] have been linked to BP, further details follow. 
1.4.1.1 Blood pressure and early-life growth 
1.4.1.1.1 Intra-uterine growth 
Birth weight is not only an indicator of maternal gestational health and nutritional status 
but also an indicator of growth in utero and a newborn’s chances of survival [91]. Low 
birth weight may be due to prematurity or intrauterine growth retardation (IUGR) or to 
being small for gestational age (SGA). The relationship between birth weight and BP later 
in life has been extensively studied, with several studies reporting an inverse association 
 18 
between birth weight and BP [70-75]. Most of the studies on the relationship between 
birth weight and later BP come from high- and middle- incomes countries (HMICs). 
As a component of this PhD project, a systematic review of studies on the relationship 
between birth weight and BP in young Africans was conducted. Details are presented in 
chapter 3. In brief the relationship between birth weight and BP was understudied, with 
16 publications from 13 studies in nine African countries [92]. The studies were 
predominantly from South and West Africa and differed in size and design. The 
relationship between birth weight and BP varied with participants’ age, with consistently 
positive associations seen in neonates (0-28 days), predominantly inverse associations in 
children (1-9 years) and a mixed picture (inverse or no association) in adolescents (10-19 
years). A recent study (published after the review was submitted) among 528 rural South 
Africans aged 5 to 15 years, showed that birth weight was not associated with BP [93]. 
The relationship between birth weight and BP among African children and adolescents 
remains unknown and understudied [92]. 
Elsewhere, evidence from 444,000 individuals predominantly of non-African origin 
(aged 0 to 84 years) summarised in [74], showed an inverse relationship between birth 
weight and systolic BP. An inverse relationship between birth weight and systolic BP was 
reported among 66,000 participants aged 7 to 62 years from five European cohorts in 
three countries (United Kingdom [UK], Finland and Faroe Islands) reviewed in [94]. 
Restricting to studies in children and, or adolescents, evidence from 1,570 children aged 
3 to 6 years from China, Guatemala, Chile, Nigeria and Sweden summarised in [95] 
showed that BP was inversely associated with size at birth except in Nigerian children. 
Among 5,600 children aged 3 to 6 years from China, birth weight was positively 
associated with BP [80]. Birth weight was not associated with BP among 250 American 
children and adolescents (1-14 years of age) of whom over 50% were blacks [96]. In 739 
Brazilian children 6 to 10 years of age, birth weight was inversely associated with BP 
[97]. Among 405 British children aged 4 years from Salisbury, BP was inversely related 
to birth weight but positively associated with placenta weight [75]. 
Systematic reviews estimate that, overall, systolic BP drops by 2-4 mmHg for every one 
kg rise in birth weight [74, 98]. The effect of low birth weight on BP is thought to be due 
to fetal growth restriction rather than to prematurity. A study among 1,756 participants 
aged 34-49 years from Finland reported that BP was 7.2 mmHg higher among adults who 
were small for gestational age at birth compared to adults who were preterm with 
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appropriate weight for gestational age and 7.3 mmHg higher compared to those who were 
term and of normal birth weight [99]. 
On average, earlier publications have shown an inverse association between birth weight 
and later BP, but the more recent studies cast doubt on this inverse relationship, indicating 
that the relationship between birth weight and BP could be “U-shaped”: both low and 
high birth weight are associated with high BP. From 31 studies reviewed in [100], 
individuals with high birth weight (³4,000g) compared to those with normal birth weight 
(2,500-4,000 g or the 10-90th percentiles for gestational age) had increased BP in 
childhood. In the Netherlands, low and high birth weight were associated with high BP 
in 392 children aged four years [101]. In the UK, higher maternal intake of carbohydrates 
and proteins in pregnancy was associated with hypertension in the resulting 253 offspring, 
40 years later [102]. 
There may also be a role for effect modifiers of the association between birth weight and 
BP. In a study of 959 15-year-old British adolescents, the relationship between birth 
weight and BP differed by gender: a negative association among males and a positive 
association in females [103]. Studies from the USA have shown racial disparities in the 
relationship between birth weight and BP later in life [104, 105]. A study among 29,710 
mothers and their seven-year-old offspring, reported a positive association between birth 
weight and BP among black children and no association among white children [104]. In 
another study among 262 American children aged five years, systolic BP decreased by 6 
mmHg per kg increase in birth weight in white children and increased by 2 mmHg per kg 
increase in birth weight in African American children [105]. 
The relationship between BP and other measures of birth size including birth length, head 
circumference, placenta size and ponderal index has also been studied. Occipito-frontal 
circumference and head circumference but not length at birth, were inversely associated 
with BP among 756 Zimbabwean school children (average age of 6.5 years) from Harare 
[106]. Except for birth weight which was positively associated with BP, other birth 
parameters (head circumference and length) were not associated with BP in 634 newborn 
healthy Brazilians [107]. A previous systematic review of more than 444,000 participants 
aged 0-84 years, estimated that systolic BP decreases by 0.5 mmHg per centimetre (cm) 
increase in head circumference [74]. Both ponderal index and birth length were inversely 
associated with systolic BP among 122 participants from China followed from birth to 
age 30 years: systolic BP decreased by 1.8 mmHg per unit increase in ponderal index and 
by 3.2 mmHg per cm increase in birth length [108]. Head circumference or birth length 
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or ponderal index were not associated with BP among 1,860 English children aged three 
years [109]. 
Among 449 British adults aged 46 to 54 years, systolic BP was estimated to increase by 
15 mmHg when placental weight increased from £1 lb to >1.5 lb with the highest increase 
among those who were small at birth but had large placentas [73]. Among 13,273 
Americans who were full-term singletons at birth, placental weight was positively 
associated with systolic BP at seven years of age but there were no associations between 
placental weight and systolic BP at four months of age [110]. Gestational age was 
inversely related to BP among 5-7 year olds from the UK [111]. Gestational age was 
inversely correlated with BP among 430 Swedish males aged 49 years, born between 
1926 and 1927, with strong negative correlation (r= -0.46) in preterm (born before 38 
weeks of gestation) but no correlation between BP and gestational age in those born after 
38 weeks of gestation [112]. 
In summary, the weight of evidence suggests that birth weight is inversely related to BP 
later in life. However, current literature suggests that the relationship between birth 
weight and later BP could be U-shaped. The relationship between birth weight and BP 
later in life remains understudied among populations from SSA. Possible effect modifiers 
(such as season of birth or conception and sex) of the relationship between birth weight 
and BP later in life need further investigation. 
1.4.1.1.2 Postnatal growth 
Enhanced postnatal growth (measured as greater than expected weight gain soon after 
birth) in early childhood has been associated with higher BP later in life [74, 78-80]. 
Studies (predominantly from Europe, none from Africa) published between 1996 and 
2000 on individuals aged 3 to 26 years, reviewed in [74] reported positive associations 
between increased postnatal growth (weight gain or change in BMI) [from birth to current 
size] and systolic BP. Another study among 15,600 3- to 6-year-old Chinese children 
(published in 2011) reported a positive relationship between postnatal weight gain and 
hypertension later in life [80]. Individuals who experience IUGR accompanied by 
accelerated postnatal weight gain (“nutritional mismatch”) may be at an increased risk 
for high BP later in life than their counterparts who do not experience accelerated 
postnatal weight gain [78]. 
Among 530 children from Massachusetts, accelerated weight gain in the first six months 
of life was positively associated with systolic BP at three years of age [79]. Rapid weight 
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gain between one and five years of age was associated with the highest increase in BP 
among 22-year-old British adults who were small at birth [113]. In the Seychelles, 
changes in weight during successive periods since birth contributed to high BP among 
children and adolescents, with stronger effects of increased growth in later childhood than 
in infancy and early childhood [114]. The critical growth period(s) which may lead to an 
effect on later BP remains unclear. 
Globally, increased postnatal weight gain in the first years of life is associated with later 
high BP but this relationship differs by size at birth. The effect of increased postnatal 
weight gain on later BP is understudied and remains unknown in individuals from SSA. 
1.4.1.2 Other environmental determinants 
Blood pressure increases with age [68, 69]. A study in the USA among 730 infants, 
showed that average systolic BP increased from 70 mmHg at birth to 85 mmHg at one 
month of age; to 92 mmHg at six months of age; and to 95 mmHg at one year of age [68]. 
Population based studies (each with over 400 participants above the age of 15 years) 
reviewed in [20], showed that the proportion of individuals with high BP increased with 
increasing age. 
On average men have higher BP compared to age-matched women before menopause 
[115]. High BP is more common in male children and adolescents than in their female 
contemporaries [32, 76, 77]. Based on an average of three BP readings at each screening 
in 5,102 children from Texas, USA, the prevalence of high BP was 23% in males but 16% 
in females at first screening and was 6% in males and 3% in females at the third screening 
[76]. Among 1,771 adolescents aged 13 years from Portugal, 35% of males compared to 
30% of females had high BP [77]. 
Over 50 studies among adults, predominantly from middle and high income countries, 
published by March 2014 and reviewed in [85], showed that low socio-economic 
indicators (income, occupation category or level of educational) were each associated 
with increased risk of hypertension. Among 1,008 Nigerian adolescents aged 10 to 17 
years, reduced maternal socio-economic status was associated with increased BP [86]. 
Yet among 410 Brazilian students (mean age of 16 years), there was no association 
between socio-economic factors and BP [116]. 
Urbanisation is another socioeconomic indicator associated with high BP. High BP is 
more prevalent in urban areas than in rural areas [20, 83, 84]. In a systematic review 
involving studies from Africa published between January 1975 and May 2006, prevalence 
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of hypertension was higher in urban populations compared to rural populations in nearly 
all studies that included both urban and rural populations [20]. A multinational study of 
1,216 participants from four sub-Saharan countries of Nigeria, South Africa, Tanzania 
and Uganda reported that the prevalence of both hypertension and pre-hypertension 
differed by occupation and level of urbanisation. The age-standardized hypertension 
prevalence was 26% among nurses compared to 23% in school teachers and 21% in peri-
urban residents compared to 9% in rural residents [84]. But in a nationwide survey 
conducted from March to July 2014 among 3,906 Ugandans aged 18 to 69 years, 
prevalence of hypertension was similar in urban and rural populations at 29% and 26%, 
respectively [83]. Any differences in prevalence between urban and rural areas may be 
due to differences in lifestyle and or infection intensity. Urban areas have higher 
proportions of obese residents, increased daily salt and fat intake (consumed from 
processed and fast foods) and reduced physical activities due to the sedentary lifestyle 
compared to rural residents [20, 117]. 
In Kenya, sickle-cell trait (linked with partial protection against malaria) was associated 
with lower BP in Kilifi (currently a low-moderate but historically a high malaria 
transmission area) but not in Nairobi (no malaria transmission), suggesting a positive 
association between malaria and BP [118]. In rural Ghana, malaria in pregnant women at 
delivery was associated with increased systolic BP in the resulting 155 adolescents (mean 
age of 15 years [119]. 
Among American children, unhealthy food choices (increased sugar-sweetened drinks) 
were associated with increased systolic BP [88, 120]. A nutritional survey in 4,867 
adolescents aged 12 to 18 years from the USA reported that higher intake of sugar-
sweetened beverages was associated with increased systolic BP [120]. Fruit and vegetable 
intake were inversely associated with BP among 163 16- to 17-year-old Americans [121]. 
Increased sodium intake was associated with high BP in a study of 6,235 Americans aged 
8 to 18 years, with the strongest relationship in overweight or obese individuals [122]. 
Increased dietary salt intake is linked with raised BP [123]. Sources of dietary sodium are 
mainly manufactured foods and salt added to cooked food at the table [89]. 
Obese children are three times more likely to develop high BP than their non-obese 
colleagues [124]. Studies summarised in [82], estimated prevalence of hypertension at 
11-30% among obese children and 3-14% in normal weight children [82]. Studies 
published from 1st January 1996 to 2nd February 2017 on 54,196 African children and 
adolescents aged between 2 and 19 years reviewed in [21] reported that the prevalence of 
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high BP was six times higher in obese individuals compared to normal-weight 
participants. High BMI was associated with high BP among 201 Ghanaian youths 15 to 
25 years of age from Accra [87]. Obesity accounted for nearly 20% of the high BP among 
15,612 children aged 5-16 years from the Seychelles [31]. 
Exposure to maternal cigarette smoking (active and or passive smoking) during 
pregnancy was associated with high BP levels in the offspring born in Patras, Greece, 
with a dose-response effect related to the number of cigarettes smoked per day [125]. 
Reduced physical activity was associated with increased BP in 201 Ghanaian youths aged 
15-24 years [87] and 67 Chinese American children with a mean age of 9 years [88]. A 
study among 345 school children, showed that physical activity levels decline with age, 
this decline in physical activity with age was more rapid in females than in males [126]. 
Poor sleep quality was associated with pre-hypertension in 238 healthy adolescents aged 
13 to 16 years in the USA [127]. Short sleep duration and increased television viewing 
were associated with high BP among 4,452 Brazilian adolescents aged 10-12 years [128]. 
However, among 1,771 13-year-old Portuguese adolescents, sleep duration was 
positively associated with BP in females but not among males [77]. Maternal history of 
high BP but not paternal history of high BP was associated with high BP among 3,360 
children of European origin aged 5-7 years from England and Wales [111]. 
1.4.2 Genetic determinants 
Besides environmental influences, genetic factors play important roles in the 
development of high BP [64]. Children with a hypertensive parent are at increased risk 
of developing hypertension [129]. Studies estimate heritability of BP between 15-35% 
[64, 65, 129]. Heritability of systolic BP was estimated at 30% among 8,451 Americans 
aged 45 to 64 at enrollment in the Atherosclerosis Risk in Communities study [130]. 
African ancestry is associated with hypertension [6, 131-133]. 
Among UK adolescents, after adjusting for anthropometry and social exposures, systolic 
BP at age 16 years was 2.9 mmHg greater, on average, in black adolescents compared to 
white adolescents [133]. This excess burden of high BP among blacks may be due to 
increased genetic susceptibility to high BP in individuals of African ancestry. 
Genetic studies of BP have the potential to enhance our understanding and treatment of 
high BP. Genome-wide association studies (GWAS) conducted using participants from 
HICs have identified several single nucleotide polymorphisms (SNPs) associated with 
both systolic and diastolic BP [134, 135]. SNPs in genes such as ATP2B1, MTHFR, 
 24 
YP17A1, FGF5, CSK and STK39 have been linked with hypertension in Caucasian 
populations [135-138], while in African Americans, variants in the C21ORF91 and 
GPR98/ARRDC3 genes have been associated with systolic and diastolic BP, respectively 
[139]. 
The ATP1B1 gene encodes for the β subunit of Na,K-ATPase, a protein for maintaining 
electrochemical gradients of Na+ and K+ across the plasma membrane [140]. Reduced 
Na,K-ATPase activity preceded development of hypertension in experimental rats [141]. 
The MTHFR gene encodes for methylenetetrahydrofolate reductase which metabolises 
folate. Reduced folate levels result in hyperhomocysteinemia, a condition associated with 
hypertension [142]. The STK39 gene encodes for SPAK protein, a protein involved with 
salt transport (renal salt excretion) and osmotic cell volume regulation [143]. 
Replication studies have returned variable results in different populations [135, 144] and 
this lack of consistency across studies weakens any generalisable conclusions. The BP 
GWAS meta-analysis of 29, 378 African Americans identified only the SOX6 locus of 
the five loci that were identified to be associated with BP in a multi-ethnic (African 
American, Europeans and East Asian) sample of 99,382 individuals [145]. Of the 17 
SNPs most strongly associated with BP (p-value <1x10-4) in African Americans, three 
SNPS (rs1867226, rs1550576 and rs8039294) were replicated (p-value <0.05) in a sample 
of West Africans [146]. Loci identified in Caucasian and Asian populations are yet to be 
replicated in African populations [145, 146]. From twin studies, 30% of BP variability 
was due to heritability [64, 65] but, the SNPs associated with BP account for only 2-5% 
of BP variation [147, 148]. Thus, important undiscovered variants associated with BP are 
likely to exist. This “missing heritability” may be due to rare varaints or possibly due to 
combinations of common variants with small effect sizes [149, 150]. 
In summary, high BP is a complex disorder influenced by a combination of environmental 
and genetic factors. Prevalence of high BP remains high world-wide and steadily 
increasing in certain populations. In children and adolescents, most high BP is 
undiagnosed or inaccurately diagnosed. Several environmental and genetic factors are 
associated with high BP. 
1.5 Developmental origins of health and disease hypothesis 
The developmental origins of health and disease (DOHaD) hypothesis proposes that 
early-life environments (periconceptual, fetal and early postnatal) have long-lasting 
influences in offspring to later health and disease susceptibility. 
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Poor maternal nutrition during pregnancy contributes to restricted fetal growth, leading 
to increased susceptibility to high BP later in life. 
We postulated that growth in early-life (utero and or childhood) is associated with high 
BP later in life (an inverse association with birth weight and a positive association with 
early postnatal growth) and that several environmental and genetic factors (more 
commonly present in Africa than in other settings) are associated with BP in young 
Africans. 
1.5.1 Evidence from epidemiological studies 
Initial work on the relationship between fetal environment and later cardiometabolic 
diseases was conducted by David Barker and colleagues at the University of 
Southampton, in the UK. They showed strong geographical correlation between infant 
mortality that occurred between 1921 and 1925 and adult mortality from ischaemic heart 
disease (IHD) occurring from 1968 to 1978 in England and Wales [151]. It was postulated 
that factors that increased the risk of death during infancy also increased susceptibility to 
IHD among those who survived through infancy. The group later showed an inverse 
association between birth weight and BP and a positive relationship between placenta size 
and BP among adults (46 to 54 years) from Preston, Lancashire [73]. 
Subsequently, these findings have been replicated world-wide [70, 71, 152-154], with 
birth weight the most studied birth parameter. Birth weight is an important marker of fetal 
nutrition and growth [91]. Poor maternal nutrition in pregnancy results in low birth weight 
in the newborn, while maternal overnutrition during pregnancy leads to high birth weight 
in newborns [155, 156]. 
Evidence from the Dutch Hunger Winter Study comprising of 2,414 individuals, who 
were term and singleton, born around the Dutch famine (between November 1943 and 
February 1947), suggests that maternal undernutrition during gestation had important 
effects on health in later life for example, those who were small at birth had high BP later 
in life [157, 158]. The effects on health depended on the type and timing of insult or 
stimulus during gestation  [159], for example offspring of mothers who consumed 
relatively little protein in relation to carbohydrate in the third trimester of pregnancy had 
high BP in adult life [158]. 
Epigenetic changes from prenatal malnutrition also influence metabolic phenotypes in 
later life. Epigenetic modulation of pathways by prenatal malnutrition may promote an 
adverse metabolic phenotype in later life [160]. The Swedish Twin Study showed that the 
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shorter twin in a twin pair was more likely to die of heart disease than their taller twin 
sibling [161]. 
Overall, epidemiological studies have provided convincing support for the DOHaD 
hypothesis by showing strong associations between low and or high birth weight and 
subsequent risk of adulthood hypertension. 
1.5.1.1 Fetal growth 
Earlier studies have mainly reported inverse relationships between birth weight and later 
BP. However, recent studies cast a doubt on the inverse relationship between birth weight 
and later BP, suggesting that both low birth weight and high birth weight may be 
important in the development programming of high BP later in life [70-74, 80, 97, 101]. 
This U-shaped relationship between birth weight and later high BP highlights the 
importance of both fetal under- and over-nutrition in the developmental programming of 
later BP. 
1.5.1.2 Postnatal growth 
Recent evidence suggests that postnatal growth rather than or in addition to fetal growth 
is important in the developmental programming of BP, with the fast-growing low birth 
weight offspring at a particularly increased risk for high BP later in life. Increased change 
in weight (a proxy for rapid growth in early childhood) resulting from excess postnatal 
nutrition is associated with higher BP later in life [74, 79, 80]. 
Early-life nutritional deprivation resulting in lower birth weight and or IUGR 
accompanied by later nutritional excesses (rapid postnatal weight gain), resets 
homeostatic systems (such as the endocrine and metabolic) in these offspring [78, 162]. 
Offspring who experience “a nutritional mismatch” between fetal life (slow growth in 
utero) and postnatal life (accelerated postnatal growth) are at an increased risk for later 
high BP [78]. This demonstrates the importance of the “nutritional mismatch” between 
the predicted and realised future in the developmental programming of later diseases. 
1.5.2 Evidence from animal studies 
Animal models have provided the strongest insight into potential DOHaD mechanisms 
[163-166], further details are covered later in section 1.6. Early under- or over-nutrition 
resulting from maternal dietary restriction or impaired placental perfusion are associated 
with hypertension in adulthood [167, 168]. Rats fed on a restricted diet from conception 
through pregnancy or lactation had hypertensive adult offspring. Maternal or fetal 
undernutrition are linked with changes in offspring cardiovascular function [169]. 
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1.6 Programming mechanisms 
The observed phenomena are not fully explained by a single mechanism but could be due 
to interactions between various mechanistic processes. Permanent structural and 
functional changes 
It has been shown that early-life insults or stimuli (such as nutrition or hormones) 
occurring during critical growth periods (periods of rapid development) result in survival 
responses with long term consequences on health and disease susceptibility [170]. In 
humans and in animal models, maternal undernutrition greatly impacts a rapidly growing 
fetus through loss in structural units such as nephrons resulting in changes in organ 
growth, structure, function and metabolism in the resulting offspring [164, 170, 171]. 
During suboptimal nutritional or hormonal levels, the fetus’ immediate aim to survive 
and preserve vital functions occurs at the expense of other less critical functions [172]. 
Diverting blood supply away from these organs (such as the kidneys) alters their normal 
development and results in changes in structure (to small organs) and function (hormonal 
and metabolic) [173-175]. Although, these adaptations are advantageous for short-term 
survival, they can be detrimental for health in the long-term. 
Animal models have shown that early-life environmental conditions can have permanent 
effects on kidney structure and function. A suboptimal early environment leads to a 
reduction in nephron numbers via a reduction in nephrogenesis [176] or increase in 
apoptosis thus leading to a reduction in renal progenitor cells [177]. Placental 
insufficiency in rats was associated with increase in renal apoptosis in IUGR offspring 
[178]. Nutritional restriction in sheet [179] and rats [180, 181] and placental insufficiency 
in rabbits [182] and rats [183] resulted in reduced number of nephron in the offspring. 
The loss of nephrons in a developing kidney programs the growing organ(s) to a reduced 
functional capacity. These small kidneys with a reduced number of functional nephrons 
maintain haemodynamic and excretory functions through increasing local vascular 
resistance, increasing local kidney BP [164]. This gradually leads to loss of more 
functional nephrons and further increases local BP and subsequently increases systemic 
BP. Intrauterine growth retardation (measured as low birth weight) is often due to an 
adverse intrauterine environment such as nutritional deprivation and associated with high 
BP later in life [70-73]. At post-mortem, IUGR was associated with reduced nephron 
numbers among human stillborn infants [184]. The impact of low birth weight and of 
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IUGR on kidney function may be mediated through a reduction in the number of 
functional nephrons [185, 186]. 
 
Figure 1.6-1:Mechanisms for the developmental programming of blood pressure model 
The decrease in nephron endowment is also thought to be secondary to changes in 
regulatory mechanisms such as renin-angiotensin system (RAS) or cyclooxygenase-2 
(COX2) activity. In animal models, administration of steroids or low protein intake in 
pregnancy or reduction in uterine perfusion induces a decrease in RAS activity and thus 
decreased nephron endowment [187, 188]. Administration of converting enzyme 
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inhibitors (CEI) or AT1 receptor antagonists (ARA) during kidney development result in 
low birth weight and reduced nephron endowment. The role of RAS in the developmental 
programming of BP is supported by studies that have shown that administration of CEI 
or AT1 receptor antagonist (ARA) decreases BP [170]. Reductions in Angiotensin II in 
the nephrogenic periods modify kidney function and induce sodium sensitivity during 
aging resulting in angiotensin II–dependent hypertension [189]. Higher renal sensitivity 
to Angiotensin II is associated with renal vasoconstriction [170]. 
Changes in circulation dynamics and organ growth during suboptimal conditions are 
likely to be hormonally-mediated. The glucocorticoids influence cellular differentiation 
and growth. The 11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2) enzyme 
metabolises cortical and corticosterone (glucocorticoids) into inert products, reducing 
amount of maternal glucocorticoid available to the developing fetus, thus, protecting the 
fetus from the effect of exposure to excess maternal glucocorticoids [190]. Maternal 
undernutrition reduces placental 11b-HSD2 increasing the quantity of glucocorticoids 
available to the fetus via placenta transfer [167, 173]. 
Exposure to excess maternal glucocorticoid during pregnancy retards fetal growth and is 
associated with low birth weight and with hypertension in the offspring [167]. The role 
of glucocorticoids in developmental programming of BP is supported by human studies 
that have shown associations between low birth weight and increased cortisol levels [173, 
191]. Rats and ewes exposed to dexamethasone in pregnancy gave birth to offspring with 
reduced nephron numbers and high BP [165, 166]. The offspring of rats fed on maternal 
low-protein (MLP) diet and treated with metyrapone (an inhibitor of maternal 
glucocorticoid synthesis) did not develop high BP [164]. In contrast, pregnant rats fed on 
MLP diet and received corticosterone replacement had hypertensive offspring [164]. 
Maternal anaemia results in poor placental vascularization and deregulation of maternal 
and fetal hormones (including corticotropin-releasing hormone (CRH) and Insulin-like 
growth factor (IGF1), which stimulates fetal growth) [192]. The release of CRH induces 
preterm labour and pre-eclampsia in women and subsequently inhibits the production of 
IGF1 [192]. In the fetus, growth hormone (GH)-IGF-I axis is affected by maternal 
nutrient restriction [186]. Deficiency of GH was associated with increased hypertension 
among men [193]. Also, IGF1 was reduced both in pregnancies that resulted in growth 
retarded neonates and in the cord blood of IUGR neonates [170]. In rodents, maternal 
iron restriction resulted in low birth weight and high BP in the offspring [194, 195]. 
Reduced or poor placental perfusion due to abnormal placental vascularization from 
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preeclampsia often results in IUGR. Placental insufficiency induced via reduction in 
uterine perfusion in pregnant rats resulted in IUGR offspring with increased risk for 
hypertension [163]. 
1.6.1 Epigenetic changes 
Changes in the early environment result in permanent changes in gene expression 
following multiple rounds of cell division [196]. Epigenetic changes (in deoxyribonucleic 
acid (DNA) methylations, histone acetylation and transcriptional activation) alter gene 
expression without changing the genome (DNA sequences) [197]. It has been suggested 
that maternal pregnancy protein restriction may result in hypertensive offspring by 
altering DNA methylation and gene expression [162]. 
In sheep, DNA methylation was associated with high BP in adult sheep [198]. While in 
rats, DNA methylations resulted in changes in glucocorticoid receptor in offspring rats 
[199]. Prenatal treatment of rats with dexamethasone resulted in increased BP and 
increased histone deacetylase1 in the kidneys accompanied by increased angiotensin II 
AT1 receptor in the offspring. Yet treatment with L-citrulline in pregnancy and lactation 
reversed these molecular changes and prevented hypertension in the offspring [200]. 
1.6.2 Genetics 
Genetic mechanisms for the developmental origins of BP are unclear. It is suggested that 
genetic variants/single-nucleotide polymorphisms (SNPs) influence disease by altering 
the gene function or gene expression or the encoded protein [136, 201]. Previous GWAS 
of BP have identified several SNPs associated with BP, in populations from HMICs [134-
139]. The rs17249754 variant in the ATP2B1 gene is one of the SNPS associated with BP 
[135]. The ATP2B1 gene, highly expressed in the vascular endothelium regulates cellular 
calcium levels that are important in vascular smooth muscles contraction and dilatation 
[202]. Also, higher levels of ATP2B1 messenger ribonucleic acid (mRNA) were detected 
in smooth muscle cells of hypertensive rats compared with non-hypertensive controls 
[203]. 
1.7 Study rationale 
Once uncommon on the African continent, prevalence of CVDs has increased and affects 
younger ages than in HICs [14, 15, 17, 19]. The African region has also seen an upsurge 
in CVDs determinants such as high BP, obesity, dyslipidaemia and diabetes mellitus [14]. 
The rising burden of these conditions in Africa has been attributed to a transition from 
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active to more sedentary lifestyles and a rise in unhealthy dietary practices [14, 16, 22], 
characterised by over consumption of saturated and trans fats [24]. 
To date, most literature supporting the DOHaD hypothesis come from HMICs. However, 
the hypothesis may be pertinent to Africa, a continent which continues to suffer a high 
burden of malnutrition (both maternal and infant) and a rapidly increasing burden of 
overnutrition (obesity) and CVDs and related determinants [14, 204-206]. 
Findings from Caucasian populations may not be applicable to African populations and 
cannot be extrapolated to LICs. There are differences in prevalence of environmental 
(lifestyle, infections and infection intensity) and genetic factors between rural, tropical 
Africa, developed or sub-tropical settings and HICs. For example, in HICs, prematurity, 
which can be due to any one of various factors (and their combination), including 
obstetric conditions, maternal BMI, maternal smoking, maternal alcohol consumption 
and environmental exposures, is the leading cause of low birth weight [196, 207, 208]. 
Yet in developing countries, IUGR (often resulting from maternal malnutrition and 
infections such as HIV and malaria, more prevalent in the tropics) accounts for many low 
birth weight infants [209, 210]. Other causes of low birth weight such as maternal alcohol 
and smoking are less common in Africa, than in some other settings in HMICs. 
The burden of malnutrition remains high in Africa [204-206]. A combination of fetal 
undernutrition and rapid postnatal growth may accelerate the rising burden of BP and 
other CVDs risk factors in Africa. High BP initiates early in life, persists into adulthood 
[37, 38] and predicts adulthood hypertension [11, 46]. Children and adolescents are 
important target groups for high BP prevention and control interventions before clinical 
manifestation of BP and, or CVDs. 
Despite African populations having the highest burden of high BP [20, 21], high genetic 
diversity [211] and low linkage disequilibrium (LD) [tendency for groups of genes to be 
inherited together] [212], genetic factors associated with BP in adolescents are unknown 
and remain understudied on the continent. In addition, genetic studies in Caucasians have 
identified several genetic variants associated with BP, but these findings are yet to be 
replicated in individuals residing on the African continent [145, 146]. 
The impact of early-life, life-course and genetic factors on later BP among young 
Africans remains unknown and understudied. This PhD aims to describe early-life, life-
course and genetic factors associated with BP among young Africans. Identifying early-
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life factors associated with BP later in life among Africans has huge potential to inform 
policy and mitigate the escalating burden of high BP and related CVDs in the region. 
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Chapter 2: Thesis aim, objectives, design and structure, candidate’s 
contribution and list of associated publications 
2.1 Introduction 
This chapter presents the thesis aim, objectives, design and structure and the candidate’s 
role and contribution to this thesis. 
2.2 Thesis aim 
The aim of this thesis was to investigate the influence of birth weight, postnatal growth, 
pre-natal, peri-natal and childhood exposures and of genetic polymorphisms on BP 
among young Africans. 
2.3 Thesis objectives 
• Thesis objective 1: Review evidence on the relationship between birth weight and 
BP among African children and adolescents 
• Thesis objective 2: Investigate the relationship between birth weight and BP among 
Ugandan adolescents 
• Thesis objective 3: Investigate the relationship between postnatal growth and BP 
among Ugandan adolescents 
• Thesis objective 4: Identify other factors associated with BP among Ugandan 
adolescents 
• Thesis objective 5: Investigate genetic polymorphisms associated with BP among 
Ugandan adolescents 
Thesis objective 1 was assessed through a systematic review, while thesis objectives 2-5 
were assessed through analysis of longitudinal data collected prospectively in the EMaBS 
birth cohort of 2,345 live born offspring in Wakiso district, Uganda. 
2.4 Thesis design and structure 
2.4.1 Thesis design 
This PhD was designed to use both a systematic review and an observational study to 
describe early-life, life-course and genetic factors associated with BP in young Africans. 
The systematic review assesses published literature on the relationship between birth 
weight and BP among African children and adolescents (aged 0 to 18 years). The 
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observational study uses prospectively collected longitudinal data from the EMaBS birth 
cohort (http://emabs.lshtm.ac.uk/) to examine the impact of early-life (fetal and postnatal 
period) factors, life-course factors and genetic polymorphisms on BP in adolescents. 
2.4.2 Thesis structure 
This thesis comprises of eight chapters and is written following the ‘research paper’ style 
format, with five research papers associated with this PhD project. Each research paper 
was prepared as a stand-alone manuscript and thus there is unavoidably repetition of 
information (such as setting, definitions) among research papers. The research papers are 
presented in an order that makes this thesis cohesive, rather than in the temporal order of 
publication. 
• Chapter 1: The background chapter reviews the literature on the epidemiology of BP 
in children and adolescents, presents the hypothesis, describes current understanding 
of the mechanisms for the developmental programming of later BP and summarises 
the justification for this PhD. 
• Chapter 2: Summarises the thesis aims, objectives, design and structure, and the 
candidate’s role and contributions 
• Chapter 3: The systematic review describes the methods and the findings for thesis 
objective 1 
• Chapter 4: The methods defines and classifies the terms used throughout the thesis 
and describes the methods used to answer thesis objectives 2, 3, 4 and 5 
• Chapter 5: Addresses thesis objective 2 “investigate the relationship between birth 
weight and BP among Ugandan adolescents” and thesis objective 3 “investigate the 
relationship between postnatal growth and BP among Ugandan adolescents” 
• Chapter 6: Addresses thesis objective 4 “identify other factors associated with BP 
among Ugandan adolescents” 
• Chapter 7: Addresses thesis objective 5 “investigate genetic polymorphisms 
associated with BP among Ugandan adolescents” 
• Chapter 8: The discussion summarises the PhD findings in relation to the existing 
literature, implications of the findings, strengths, limitations, proposed future work 
and conclusions 
• Appendices contain important documents relevant to this thesis including ethical 
approval and notification, information, consent and assent forms and an extra 
manuscript (not part of the thesis, hence not included in the main body) produced 
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during the course of the PhD in collaboration with Jonathan Nsamba, a master’s 
student at the LSHTM, which examines association between early-life factors and 
body composition in early adolescence 
2.5 Candidate’s contribution 
Since joining the MRC/UVRI & LSHTM in 2006, I have had the opportunity to serve in 
various roles and contribute substantially to the clinical follow-up of the EMaBS birth 
cohort. 
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Between 2013 and 2015, I was involved with the initiation, design and conduct of the BP 
study, nested within the EMaBS. I was responsible for developing study documents 
(including protocol, questionnaires, standard operating procedures (SOP), study 
information sheets, consent and assent forms); obtaining ethical approvals (including 
subsequent renewals and amendments) from the regulatory authorities; reporting study 
progress to local regulatory authorities; staff training and supervision; data collection, 
management and cleaning; ensuring that the protocol was adhered to; and carrying out 
administrative duties related to the study.
From 2011 to 2015, I was a Project Leader. My responsibilities were to prepare, compile 
and submit study progress reports to management and regulatory authorities; procure 
study supplies, equipment and consumables; train study staff and attached students; 
develop statistical analysis plans; conduct and interpret data analysis; and disseminate 
study results.
I worked as a Medical Officer between 2006 and 2011 and my roles included provision 
of medical care (taking medical history, conducting medical examinations and providing 
necessary treatment) to study participants; obtaining informed consent; interviewing 
study participants and completing study questionnaires; reporting adverse and serious 
adverse events to regulatory authorities; data collection, management and cleaning.
2.5.1 Entebbe Mother and Baby Study birth cohort
2.5.2.1 Role in the systematic review included:
PhD registration was in January 2016
2.5.2 PhD work
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2. Performed database search and retrieved publications for inclusion in the review 
process 
3. Together with my supervisor we independently screened and assessed titles and 
abstracts for inclusion in the full-text review, assessed full-text articles for 
inclusion in the review, extracted data from selected manuscripts and discussed 
inconsistencies with consensus reached at each stage in the selection process. 
4. Drafted and revised the systematic review manuscript following comments from 
the co-authors 
5. Submitted the final version of the manuscript for publication and responded to 
reviewers’ comments in consultation with the co-authors 
2.5.2.2 Role in the longitudinal observational study included: 
1. Conducted extensive data management and cleaning, which included generating 
and resolving data queries and updating databases and archived case report forms 
(CRF) copies, merging datasets and generating a single analysis dataset 
2. Developed data analysis plan and conducted data analysis for thesis objectives 2, 
3, 4, and 5 
3. Drafted manuscripts arising from this work, incorporated feedback from my 
supervisors and co-authors 
4. Submitted manuscripts for publication and responded to reviewers' comments 
5. Presented study findings at various conferences and gatherings 
6. Drafted the thesis report, revised, incorporated and responded to feedback from 
my supervisors 
2.6 Associated publications 
1. Research paper 1: Is birth weight associated with blood pressure among African 
children and adolescents? A systematic review, Journal of Developmental Origins of 
Health and Disease, 2018. 9(3): p. 270-280 
2. Research paper 2: Are birth weight and postnatal weight gain in childhood 
associated with blood pressure in early adolescence? Results from a Ugandan birth 
cohort, International Journal of Epidemiology, 2018 (Epub ahead of print) 
3. Research paper 3: Blood pressure risk factors in early adolescents, results from a 
Ugandan birth cohort, Journal of Human Hypertension (under review) 
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4. Research paper 4: A genome-wide association and replication study of blood 
pressure in Ugandan adolescents, draft in preparation for submission to Clinical 
Genetics 
5. Research paper 5: Effect of birth weight, exclusive breastfeeding and growth rate in 
childhood on fat mass and fat-free mass indices in early adolescence: Results from a 
birth cohort, Current Developments in Nutrition (under review) 
The systematic review protocol and research paper 1 presented in chapter 3 were written 
in accordance with guidelines from the Preferred Reporting Items for Systematic review 
and Meta-Analysis (PRISMA) guidelines [1]. Research papers 2, 3, 4 and 5 from the 
observational study have been written following guidelines from the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) guidelines [2]. 
2.7 Associated conferences and workshop presentations 
1. Health of adolescents and young people in Africa, Mwanza Intervention Trials Unit 
(MITU) Scientific Symposium, 27th-29th November 2018, won one of the three best 
poster presentation prizes. 
2. International Society of Hypertension Conference on the 20th-23rd September 2018, 
Beijing China (Poster Abstract ID: A5593) 
3. The Uganda Virus Research Institute (UVRI) monthly seminar, Non-communicable 
Diseases theme day 27th April 2018 (Oral presentation) 
4. The 5th Symposium of Makerere-Columbia (MUCU) on “Transition in Care: Children 
to adolescents to Young Adults” by the Society of Adolescent Health in Uganda 11th-
12th April 2018 (Oral presentation) 
5. London School of Hygiene Tropical Medicine poster day on the 15th March 2018 
6. The 1st World Congress on Hypertension in Children and Adolescents, 9th-11th 
February 2018, Valencia, Spain (E-poster) 
7. The Developmental Origin of Health and Disease, 15th-18th October 2017, Rotterdam, 
Netherlands (Poster number: PO1.02.04) 
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Chapter 3: Systematic review 
3.1 Introduction 
The systematic review was used to answer thesis objective 1: “review evidence on the 
relationship between birth weight and blood pressure among African children and 
adolescents”. This chapter describes the methods used to conduct the systematic review 
and presents findings of the systematic review. The systematic review protocol was 
developed in consultation with my supervisors prior to starting the review process. 
Findings from the systematic review are summarised in research paper 1 “Is birth weight 
associated with blood pressure among African children and adolescents? A systematic 
review”, as published in the Journal of Developmental Origins of Health and Disease [1]. 
3.2 Methods: Protocol for a systematic review of the relationship between birth 
weight and blood pressure among African children and adolescents 
Abstract 
Introduction 
An inverse relationship between birth weight and blood pressure (BP) has been reported 
by various studies in high-income countries. Despite the high prevalence and the diverse 
causes of low birth weight on the African continent, little has been reported on the 
relationship between birth weight and BP in young Africans. Understanding this 
relationship among young Africans has huge potential to inform policy to mitigate the 
escalating burden of high BP on the continent. 
Aim: Review literature on the relationship between birth weight and BP among African 
children and adolescents. 
Data source and extraction: The Medline, EMBASE, Global Health and Web of 
Science databases will be searched for potential publications. References for relevant 
articles will be scanned for additional potential articles. Results will be reported following 
the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 
guidelines. 
Ethics: The review will be based on published studies; thus, no ethical approval is 
required. The study will provide evidence on the relationship between birth weight and 
BP, identify knowledge gaps and guide future research interests. 
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Dissemination 
Findings will be summarised and published in a peer-reviewed journal. 
Funding and role of the sponsor or funder 
This work is partly supported by the Commonwealth Scholarship Commission (S.L., PhD 
funding at the LSHTM); the Wellcome Trust (A.E., grant number 095778, L.S., grant 
number 098504/Z/12/Z); and the UK Medical Research Council (E.W., grant number 
MR/K012126/1). 
Neither the sponsor nor the funder(s) has participated in the protocol design. 
Introduction 
Hypertension, once uncommon on the African continent [2, 3], is a major risk factor for 
cardiovascular diseases (CVDs). Most people affected by hypertension are unaware of it, 
and among those that are aware, many are not on treatment [4-7]. Among African children 
and adolescents, high blood pressure (BP) prevalence has been reported at 10% in 
Seychelles[8], 17% in Uganda [9] and 21% in South Africa[10]. Nearly 75% of 
hypertension in children and adolescents is undiagnosed [11]. Hypertension, which 
contributes to CVDs mortality and morbidity in adulthood [12-16], has its origins in 
childhood [17-19]. Children with high BP tend to become hypertensive adults [20]. 
Extensive literature from high-income countries (HICs) suggests an inverse relationship 
between birth weight and BP later in life [21-25]. Previous systematic reviews on the 
relationship between birth weight and BP in children or adolescents have included mainly 
studies from HICs. On average, systolic BP increases by 2-4 mmHg for a one kg drop in 
birth weight [26, 27], supporting the fetal origin hypothesis proposed by David Barker 
[28]. Barker hypothesised that intra-uterine nutrition (often measured as birth weight) is 
vital in programming CVDs risk factors including BP. However, not all studies have 
reported an inverse relationship between birth weight and BP. Birth weight was positively 
associated with BP among neonates from Ireland [29], no association was seen among 
adolescents in the USA [30], and the relationship differed by gender among 15-year-olds 
from Scotland, with an inverse association observed for males but a positive association 
for females [31]. 
Overall, men have higher BP than age-matched women before menopause [32]. However, 
few epidemiological studies have investigated the effects of gender on developmental 
origin of BP despite strong evidence from numerous experimental studies that male 
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offspring exhibit increased BP in young adulthood while female offspring remain 
normotensive [32]. 
The birth weight-BP relationship remains unclear in Africa, where low birth weight is 
common [33, 34]. One may propose that among Africans, the birth weight-BP 
relationship might be different to that which is reported in developed countries. The 
causes and prevention strategies for low birth weight differ between rural, tropical Africa 
and developed or sub-tropical settings: for example, malaria (an important cause of low 
birth weight) is restricted to the tropics [35] and prophylactic antimalarial drugs in 
pregnancy reduce the risk of low birth weight [36]. 
It is with this background that we present a protocol for a systematic review to describe 
the relationship between birth weight and BP among young Africans. The review intends 
to discuss literature on the relationship between birth weight and BP among African 
children and adolescents, identify knowledge gaps and guide future research interests. 
The review may provide supporting evidence for future hypertension prevention 
strategies for Africa. 
Objectives 
The review aims to use published literature to examine the relationship between birth 
weight and BP among African children and adolescents. We aim to: 
1) Outline the characteristics and findings of the studies 
2) Describe the current evidence, gaps in evidence and the implications for future 
research and policies 
Search strategy and data extraction 
The protocol and the review will follow guidelines from the preferred reporting items for 
systematic review and meta-analysis protocols (PRISMA-P) checklist and statement [37, 
38]. We will perform the literature search in Medline, EMBASE and Global Health and 
Web of Science to the current date. The search will use key search terms to retrieve 
potentially relevant studies. The key search terms are (hypertension OR blood pressure) 
AND (birth weight) AND (paediatric OR child OR young people OR youth OR juvenile 
OR adolescent OR youngster OR pubescent OR teenage OR newborn OR minor OR 
infant) AND (Africa OR individual names of countries in Africa). Articles will be 
exported into EndNote, de-duplicated and then exported into an excel spreadsheet to 
permit the selection of articles and data extraction. 
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Two independent authors will assess titles and abstracts for inclusion in the full-text 
review and also independently assess full-text articles for inclusion in the data synthesis. 
Inconsistencies will be discussed, and consensus reached at each stage of the selection 
process. Reference lists will also be scanned for additional studies. Eligible papers will 
be accessed through PubMed, HINARI, LSHTM library or the journal's website. 
Information will be extracted independently by two authors using standardized data 
extraction sheets. 
The review will include all primary studies on the relationship between birth weight and 
BP among young Africans (0 to 18 years), residing on the African continent. Studies that 
include both adults and children or adolescents will be included in the review if they 
clearly state the relationship between birth weight and BP in children and, or adolescents 
(ages 0 to 18 years), i.e. separately from results in adults. 
Studies will be excluded if conducted among African populations residing outside the 
African continent, if studying non-systemic hypertension (such as pulmonary 
hypertension, intracranial hypertension), if not accessible within three months of sending 
requests to the authors and if including a wider age range but where it is not possible to 
disaggregate childhood or adolescence data. 
No restriction on language or publication dates will be applied. Multiple articles from the 
same study will be reported as one study. Key information including study characteristics, 
population, design, authors, study area (region of Africa and country), sample size, BP 
measurement protocol, participants’ year(s) of birth, sex, age, mean BP (systolic and or 
diastolic), mean birth weight and information on the direction and strength of evidence 
of association between birth weight and BP, and on potential confounders and effect 
modifiers will be gathered in tables. 
No meta-analysis is planned because it is anticipated that there will be a substantial 
amount of heterogeneity in study populations, designs and methodologies. The study 
selection process will be summarised using a flow diagram. Reasons for exclusion will 
be described. Tables accompanied by narratives will be presented. 
Ethics and dissemination 
The review will be based on published data, therefore ethical approval is not required and 
will not be obtained. This systematic review will serve as a guide for future BP 
aetiological, prevention and control studies among young Africans residing on the 
continent. Results will be published in a peer-reviewed journal and in a PhD thesis. 
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Contributors 
SAL conceived, designed and drafted the protocol, with input and reviews from AME, 
LS and ELW. 
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There is substantial evidence of an inverse association between birth weight and later blood pressure (BP) in populations from high-income countries,
but whether this applies in low-income countries, where causes of low birth weight are different, is not certain. Objective:We conducted a review of the
evidence on the relationship between birth weight and BP among African children and adolescents. Medline, EMBASE, Global Health and Web of
Science databases were searched for publications to October 2016. Papers reporting the relationship between birth weight and BP among African
children and adolescents were assessed. Bibliographies were searched for further relevant publications. Selected papers were summarized following the
preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. In total, 16 papers from 13 studies conducted in nine African
countries (Nigeria, Republic of Seychelles, Gambia, Democratic Republic of Congo, Cameroon, South Africa, Algeria, Zimbabwe and Angola) were
reviewed. Eight studies were cohorts, while ﬁve were cross-sectional. The relationship between birth weight and later BP varied with age of the
participants. Studies in neonates showed a consistently positive association, while predominantly inverse associations were seen among children, and
studies in adolescents were inconsistent. Based on the limited number of studies identiﬁed, the relationship between birth weight and later BP may vary
with age in African children and adolescents. Not all studies adequately controlled for confounding, notably gender or age. Whether the inverse
relationship between birth weight and BP in later life observed in Western settings is also seen in Africa remains unclear.
Received 22 August 2017; Revised 16 November 2017; Accepted 18 November 2017; First published online 22 January 2018
Key words: Africa, birth weight, blood pressure, systematic review
Introduction
A strong geographical correlation between infant mortality (from
1921 to 1925) and adult ischaemic heart disease (IHD) mortality
(from 1968 to 1978) was observed by Barker and Osmond.1 They
postulated that factors that increased the risk of death during
infancy also increased susceptibility to IHD among those who
survived infancy, and later, showed that blood pressure (BP) in
adulthood was positively related to placenta weight but inversely
associated with birth weight.2 They suggested that poor fetal
nutrition indicated by intrauterine growth restriction and low birth
weight was associated with this increased susceptibility to IHD.
Subsequently, several studies [mainly from high-income
countries (HICs)] have investigated the relationship between
birth size parameters (e.g. birth weight, head circumference,
placenta size) and later cardiovascular disease risk (mainly BP),
with birth weight the most widely studied parameter. Results
from several of these studies have shown an inverse association
between birth weight and BP later in life.3–7 A smaller number of
studies have reported positive or no association between birth
weight and later BP. For example, positive associations have been
reported among UK neonates8 and Chinese children,9 whereas
birth weight was not associated with BP among American ado-
lescents.10 The relationship between birth weight and later BP
differed by gender among UK adolescents: a negative association
was seen in the males but a positive association in the females.11
Systematic reviews have reported that, on average, systolic blood
pressure (SBP) drops by 2–4mmHg for every kilogram increase
in birth weight.12,13 These reviews have predominantly comprised
of studies among adults from HICs.
In HICs the prevalence of low birth weight varies between
5 and 8%.14 Low birth weight is more common in Africa (7% in
Nigeria,15 8% Uganda,16 11% Zambia,17 17% Zimbabwe and
Benin18,19 and 28% Ethiopia18) and on average African popula-
tion have lower birth weights when compared with European
populations.20 In HICs, low birth weight is predominantly due to
prematurity (most commonly as a result of maternal smoking in
pregnancy21), whereas, in developing countries, low birth weight
for gestational age constitutes most of the low birth weight
infants.22 The causes of low birth weight differ between rural,
tropical Africa and developed or non-tropical settings: for exam-
ple, malaria (an important cause of low birth weight) is restricted
to the tropics23 and prophylactic antimalarial drugs in pregnancy
reduce the risk of low birth weight.24,25 We hypothesized that the
relationship between birth weight and BP in African settings
might differ from that commonly observed in HICs.
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The role of birth weight in the later development of BP is
important to African countries: these have a high burden of
malnutrition,26–28 low birth weight18,19 and raised BP.29–32
Early life interventions that reduce maternal malnutrition and
extremes of birth weight (both low and high) may thus control
childhood BP (before clinical manifestation of disease) and
could be vital in the prevention of high BP in adulthood.
The absence of birth weight records for adults in many
African countries and the low accuracy of maternally recalled
birth weight33 limits prospects for studying the relationship
between birth weight and BP in adulthood in this setting.
However, the emergence of a number of birth cohorts (with
birth records) in Africa provides opportunities to investigate the
relationship between birth weight and BP among African
children and adolescents. Childhood BP predicts BP in early
adulthood,34,35 thus studies of the relationship between birth
weight and BP among children are important in the identiﬁ-
cation of at-risk groups for targeted interventions early in life.
We conducted a qualitative assessment of the direction and
consistency of the relationship between birth weight and BP
among African children and adolescents using a systematic
review of existing literature.
Methods
A literature search covering publications up to 15 October
2016 with no restriction on start date was performed using
Medline, EMBASE, Global Health and Web of Science data-
bases. The search was performed on combinations of the key-
words: (hypertension OR blood pressure) AND (birth weight)
AND (paediatric OR child OR young people OR youth OR
juvenile OR adolescent OR youngster OR pubescent
OR teenage OR new-born OR minor OR infant) AND (Africa
OR individual names of countries in Africa).
Original papers on the relationship between birth weight
and BP among children and or adolescents, between ages 0 and
19 years and resident in Africa were reviewed. No restrictions
on language or publication dates were applied. Publications on
children and or adolescents of African ancestry not residing in
Africa were excluded. Papers on the same participants were
considered as one study. If more than one paper reported on
the same participants at the same age, the most complete paper
was included in the review. Papers reporting on the same par-
ticipants were included and reviewed separately if they reported
on the relationship between birth weight and BP at different
ages. No additional information was sought from authors.
Reference lists of the included papers were searched for addi-
tional relevant publications.
Search results were exported to Endnote reference manage-
ment software (Thomson Reuters, version ×7) and duplicates
removed. Two independent authors (S.L. and E.W.) assessed
titles and abstracts for inclusion in the full-text review and then
assessed full-text articles for inclusion in the data synthesis.
Inconsistencies were discussed and consensus reached at each
stage of the selection process.
Data were extracted independently by two authors (S.L. and
E.W.) using standardized data extraction sheets on the year of
publication, year of birth, location, age of participants, study
design, number of participants, exclusion criteria, study aim,
mean birth weight, source of birth weight data, BP measure-
ment procedure, mean BP [SBP and, or, diastolic blood pres-
sure (DBP)], relationship between birth weight and BP and
how this was assessed, and whether there was adjustment for
confounders. Information was recorded as presented in the
original publication, except where the overall mean BP or birth
weight was missing; in this case, where possible the overall
mean was calculated from any stratum-speciﬁc means pre-
sented. Studies were assessed for selection bias and adjustment
for confounding. Meta-analysis was not performed due to
diversity in studies included in the review, in terms of their
design, analysis, source population and covariates controlled for
in the analysis. Guidelines from the preferred reporting items
for systematic review and meta-analysis (PRISMA)36 were
followed.
Results
A total of 990 published abstracts were retrieved from four
databases, of these 366 duplicates were removed, leaving 624
abstracts for review (Fig. 1). Of these, 562 were excluded and of
the remaining 62 papers that were subjected to full-text review,
46 were excluded. Of the 46 papers excluded, two papers37,38
were duplicates (reported on the same participants at the
same age) of one of the included papers. Thus, 16 papers from
13 studies describing, but not necessarily focussing on, the
relationship between birth weight and BP were included in the
ﬁnal review and data extraction (Fig. 1).
Of the 16 papers reviewed, six were from West Africa,39–44
six Southern Africa,45–50 two Central Africa,51,52 one East
Africa53 and one North Africa.54 Four papers from Southern
Africa were from the same cohort but presented data on BP at
different ages of follow-up.46–49 Four papers reported results in
neonates (0–28 days),41,43,44,51 four in children (1–9
years),39,40,49,55 four in adolescents (10–19 years)42,47,48,54 and
four in both children and adolescents.45,46,52,53 The papers
were published between 1989 and 2016.
The main characteristics of the reviewed papers are shown in
Table 1. Brieﬂy, all papers included both males and females.
The number of participants ranged from 157 to 2743 indivi-
duals per paper, with ﬁve papers reporting on more than 1000
participants. Seven papers had less than 500 participants. Two
of the reviewed papers did not present quantitative information
on the relationship between birth weight and BP. Eleven of the
papers (from eight studies) described results from cohorts,
while ﬁve papers reported results from cross-sectional studies.
Except for one paper, in which the source of participants was
unclear, participants were recruited from schools
(n= 5),45,50,52–54 hospitals (n= 4)41,43,44,51 and communities
(n= 6; representing three studies).40,42,46–49 Preterm children
were excluded in seven papers: all four of the hospital-based
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studies,41,43,44,51 one school-based52 and one community-
based.42 Twins were excluded in six papers (representing three
studies).41,46–48,50 Children who were small for gestational age
or who weighed <2.5 kg at birth were excluded from three
papers; one in neonates,44 one in children39 and one in children
and adolescents.52 There was variability in the study aims of the
papers included: only six described assessing the association
between birth weight and BP as one of their main
aims.39,50,52–54,56
Table 2 summarizes birth weight and BP measurements and
values, statistical analysis methods and the relationship between
birth weight and BP in the reviewed papers.
Birth weight ascertainment
Birth weight was either measured and recorded immediately
after birth (predominantly in the cohort studies), or extracted
from birth or child health card records. In one study,52 par-
entally recalled birth weight was used when birth records were
missing (in an unknown number of participants). Mean birth
weight varied from 2.4 to 3.4 kg.
BP assessment
BP procedures were relatively similar across studies. All studies
used automated devices, except for one study, which used the
sphygmomanometer machine. Eleven papers reported a resting
period (from 5 to 20min) before proceeding with measuring
the BP. In four studies, measurements were taken on the left
arm, whereas in six studies measurements were on the right
arm; the remaining studies did not include this information.
BP was measured in triplicates in the majority of papers
(n= 12) with one paper reporting single measurement, two
reporting double measurement and one reporting ﬁve mea-
surements. The rest period between consecutive BP measure-
ments varied from 1 to 3min.
Of the 12 papers that measured BP in triplicate, ﬁve used the
mean of all three measurements in data analysis, ﬁve used the
990 abstracts identified: 
• Medline (317) 
• Embase (340) 
• Global health (119) 
• Web of Science (214) 
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Fig. 1. Flow diagram for systematic review.
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mean of the last two measurements, one used the lowest DBP
(with matching SBP) and one was unclear. For the paper where
BP was measured ﬁve times and one of the two papers where
BP was measured in duplicate, it was unclear which measure-
ments or combination thereof were used for data analysis. In
the other paper where BP was measured in duplicate, the mean
of the two measurements was used in the analysis.
Among neonates, mean SBP varied from 65.1 to
71.0mmHg and in children and adolescents from 89.3 to
118.1mmHg. Mean DBP varied from 36.1 to 63.9mmHg in
neonates and between 56.2 and 71.4mmHg among children
and adolescents. Mean SBP and DBP generally increased with
age over the course of childhood and adolescence, this was
especially apparent in the four papers that reported results from
the same cohort study at different ages.
Birth weight and BP relationship
The relationship between birth weight and SBP varied across
papers; seven papers reported no association,39,40,42,45,47,51,54
six an inverse association46,48–50,52,53 and three a positive
association.41,43,44 Among the neonates, three out of four
papers reported a positive association while one reported no
association. Of the four papers in children, two reported inverse
associations and two no association. The papers on children
and adolescents predominately found inverse associations
(three out of four papers) while among adolescents, three
papers found no association and one an inverse association.
Of the seven papers with participant size less than 500
individuals,39,41,43–45,48,51 three papers reported no association
between birth weight and SBP, one an inverse association and
three a positive association.43–45,51 Studies with larger partici-
pant sizes (greater than 500 individuals) were more likely to
report inverse associations. Of the nine studies with participant
size over 500, three reported no association between birth
weight and SBP, ﬁve an inverse association and one reported a
positive association.
In three of the six papers reporting inverse associa-
tions,46,48,53 analyses were conducted at different ages and, or,
separately for males and females, with inverse associations only
seen among particular subgroups (girls at 12.5 years,53 boys
only46,48) and analyses from other subgroups showing no
evidence of association.
Analysis approaches used to assess the relationship between
birth weight and BP were diverse, varying from simple corre-
lation analysis with no adjustment for potential confounders, to
more complex group-based trajectory modelling approaches.
Multivariable analysis, adjusting for potential confounder(s)
[often including age, sex or body size (weight or height)] was
conducted in eight papers, of these ﬁve reported an inverse
association, two no association and one a positive association.
In comparison, of the eight papers that did not undertake
adjustment for confounders, one reported an inverse associa-
tion between birth weight and SBP, ﬁve reported no association
and two a positive association.
The relationship between birth weight and DBP was
described in eight papers; a positive association was seen in two
papers, inverse association in two papers and no association was
reported in four papers. Of these eight papers, two were in
neonates, two in children, three in children and adolescents,
and one in adolescents only.
Discussion
Overall, this systematic review of existing literature showed
varied results. We identiﬁed 16 papers from 13 studies
addressing the question of whether the inverse relationship
between birth weight and BP in later life seen in Western set-
tings is also present in Africa. The relatively small number of
studies and their heterogeneity in design and analysis prohibits
deﬁnitive conclusions. However, we found some evidence to
suggest that the relationship between birth weight and SBP in
Africa varies with the participants’ age: positive associations
were seen in neonates and inverse associations mainly in chil-
dren. Among adolescents, the relationship was either inverse or
showed no evidence of association. Only a few papers reported
on the relationship between birth weight and DBP, with most
papers reporting no relationship between birth weight
and DBP.
This review supports an earlier review by Law12 that did not
include any of the papers reviewed herein (only two of the
papers included in the present review had been published at the
time of the Law review, and of these Margetts et al.40 was
excluded for missing quantitative information while Youmbissi
et al.51 was not mentioned). The Law review reported incon-
sistencies in the relationship between birth weight and BP,
especially among adolescents. Generally, inverse associations
were among children and positive associations in neonates,
inconsistencies could be due to differences in age, sample sizes
and statistical analysis approaches. Interestingly, results from
the cohort studies included in our review, that measured BP at
more than one-time point (different ages), did not show
evidence of increasing strength of the association between birth
weight and BP with age as reported by the earlier review.12
Studies in neonates consisted mainly of less than 500 partici-
pants and reported positive associations. Studies with smaller
participant numbers are more likely to be underpowered to
detect real associations, but also to produce spurious positive or
negative associations.57 However, this may not be a factor for
the results among neonates, which are consistent.
The relationship between birth weight and BP among ado-
lescents has been reported in previous reviews as either incon-
sistent12 or inverse with smaller effects than observed among
(prepubescent) children.13 Similarly, this review found an
inconsistent relationship between birth weight and BP among
adolescents, while the relationship among younger children was
generally inverse. The positive relationship observed in neo-
nates is as expected, with the duration between birth and BP
assessment too short to allow for any impact of subsequent
weight trajectory. Explanations for the changing relationships
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among children and adolescents are uncertain, but could pos-
sibly relate to different growth patterns, for example, catch-up
growth among those of low birth weight, and hormonal
changes occurring at adolescence.12,58
Adjustment for possible confounding factors varied and was
often incomplete. Consistent with previous reviews, which
mainly included papers from HICs, studies adjusting for cur-
rent body size (weight and, or, height) were more likely to
report an inverse relationship59,60 than those that did not make
such an adjustment. Adjusting for current size has been noted
to lead to a stronger inverse relationship between birth weight
and BP compared with results without such adjustments.6 In
most of the reviewed papers, that reported estimates adjusted
for current size, unadjusted estimates for the effect of birth
weight on BP were not reported. Therefore, we were unable to
establish whether adjusting for current weight leads to stronger
inverse relationships in these populations. The interpretation of
ﬁndings adjusting for current weight is complex6,59 because
current weight may be seen as a confounder or mediator of the
effect of birth weight on BP.6
Several mechanisms such as obesity, salt-sensitivity, renin–
angiotensin system and endothelial activation are important in the
pathophysiology of hypertension. None of the reviewed papers
investigated the role of these factors and their impact on BP. Recent
evidence suggests that the relationship between birth weight and BP
could be U shaped,61 highlighting the importance of both reduced
and excessive nutrition in utero. It was not possible to examine this
hypothesis from the papers reviewed. Compared with birth weight,
other measures such as birth body mass index or pendular index
may more accurately reﬂect the birth size, but none of the studies
reviewed included these measures.
Studies were subject to selection bias as individuals most
likely to be low birth weight (such as preterm and twins) were
excluded in many studies. This could have led to an under-
estimation of the effect of birth weight on BP. Furthermore,
characteristics [such as maternal hypertension, parasitic infec-
tions, socioeconomic status (past or current)] that inﬂuence
birth weight and may also be associated with BP in offspring
were not adjusted for in these studies. Hence, estimates were
subject to residual confounding. It remains uncertain what role
(if any) such factors have in the relationship between birth
weight and subsequent BP in children or adolescents.
Inconsistencies seen between reviewed papers are less likely
to be due to differences in BP measurement procedures, as
studies followed a similar approach. For nearly all papers, there
was an initial rest period (before starting BP procedure) and
between successive BP measurements, automated devices were
used and analysis was based on the average of two or three
measurements. In the majority of studies, early life information
including birth weight was prospectively collected thus studies
were less prone to misclassiﬁcation and recall bias.
Generally, studies reviewed came from all the African regions
but with a strong representation of West Africa and Southern
Africa. East Africa and North Africa had the least number of
papers (one each) reviewed. The only paper from East Africa
reported on an island population, thus there were no results on
the mainland population of East Africa.
In conclusion, relatively few studies have investigated the
relationship between birth weight and BP later in life in Africa.
The relationship between birth weight and BP varied depend-
ing on the age of the participants. Our review emphasizes the
need for larger studies on the relationship between birth weight
and later BP from Africa, applying appropriate control of
potential confounding factors. Accumulating evidence on
raised BP in Africa and understanding the impact of growth in
early life and of prenatal exposures on BP later in life is key in
identifying at-risk groups and developing early life interven-
tions to reduce BP risk in later life.
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Chapter 4: Methods 
4.1 Introduction 
This chapter defines and classifies the terms used in the thesis, and also describes in detail 
the methods for the longitudinal observational study used to address thesis objectives 2, 
3, 4 and 5. Statistical methods for each of the thesis objectives 2, 3, 4 and 5 are described 
in detail in the data analysis plan presented later in section 4.6 and in specific published 
research papers 2, 3 and 4 presented in respective chapters 5 to 7. 
4.2 Definitions and classification 
4.2.1 Blood pressure 
In children and adolescents (0 to 18 years of age), BP classification is based on the 
normative distribution of BP and interpreted on the basis of BP percentile specific for 
sex, age and height. This thesis uses BP classifications and thresholds based on 
international criteria (the Fourth Report on the Diagnosis, Evaluation, and Treatment of 
High Blood Pressure in Children and Adolescents [1] and the 2009 guidelines by the 
European Society of Hypertension [2]). 
• Hypertension: average systolic and/or diastolic BP ³95th percentile for sex, age 
and height based on readings done on three or more separate occasions. 
Hypertension severity is staged as: 
§ Stage 1 hypertension: average systolic or diastolic BP between 95th and 99th 
percentile plus 5 mmHg 
§ Stage 2 hypertension: average systolic or diastolic BP >99th percentile plus 5 
mmHg 
• Pre-hypertension: average systolic BP and/or diastolic BP ³90th percentile but 
<95th percentile for sex, age, and height based on measurements done on three or 
more separate occasions 
• Normal BP: average systolic and diastolic BP levels <90th percentiles for sex, age 
and height based on measurements done on three or more separate occasions 
Sine no standards exist for young African, this PhD used the USA standardised BP 
thresholds [3] to dichotomise individuals into pre-hypertensive, hypertensive and normal 
in this African population, thus allowed for easier comparison of pre-hypertension and 
hypertension prevalence from different studies or populations. The prevalence of high BP 
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in the population under study was anticipated to be low, thus data analysis was planned 
to use continuous BP values, allowing for more powerful and meaningful analysis than 
using binary categories of hypertensive and normal. 
4.2.2 Birth weight 
• Birth weight: body weight of a new-born measured in the first 72 hours [4]. Birth 
weight is categorised into: 
§ Low birth weight: weight <2,500g irrespective of gestational age 
§ Normal birth weight: weight ³2,500g but <4,000g 
§ High birth weight: weight ³4,000g 
The duration of gestation and or intrauterine growth rate determine birth weight, thus low 
birth weight may be due to short gestation (prematurity, also known as preterm) and or 
IUGR and or SGA [5]. 
• Prematurity: birth occurring before completion of 37 weeks of gestation [6]. 
• Intrauterine growth restriction: rate of fetal growth that is less than normal in 
light of the growth potential of that specific infant [7]. The fetus or the new-born 
is smaller than normal for their gestational age because of reduced growth rate 
inside the womb. 
• Small for gestational age: fetuses or new-borns, smaller in size than normal for 
their gestational age, with weight below the 10th percentile for the gestational 
age [8]. 
In the EMaBS, gestational age was not estimated as ultrasound scanning was not a routine 
antenatal care procedure. Thus, it is not possible to differentiate between IUGR and SGA. 
4.3 The Entebbe Mother and Baby Study 
PhD thesis objectives 2, 3, 4 and 5 were addressed using an observational study with 
prospectively collected longitudinal data in the EMaBS birth cohort from Wakiso district, 
Uganda. 
4.3.1 Design of the Entebbe Mother and Baby Study 
The EMaBS comprises of two phases. The first phase was a deworming treatment trial 
[ISRCTN32849447] in 2,507 healthy pregnant women and their 2,345 live born offspring 
up to five years of age. This has been followed by an observational follow-up phase in 
the offspring after five years of age. 
 82 
The first (trial) phase of the EMaBS began in early 2000s. Between April 2003 and 
November 2005, healthy pregnant women in their second or third pregnancy trimester 
were enrolled into a deworming trial. This phase was completed in May 2011 when all 
offspring had turned five years of age. The trial investigated the impact of helminth 
infections and anthelminthic treatment in pregnancy and in early childhood on the 
incidence of infectious and atopic disease events in childhood (including pneumonia, 
diarrhoea, malaria, measles, tuberculosis, human immunodeficiency virus (HIV), atopic 
eczema, allergic rhinitis, conjunctivitis, urticaria and wheeze) and vaccine (BCG, measles 
and tetanus toxoid) immune responses in childhood. It was hypothesised that helminth 
infections modulate the host immune response both to themselves and to unrelated 
immunogens, pathogens and allergens. An overview of the EMaBS trial protocol has been 
published elsewhere [9]. 
For each child the trial phase ended when they reached five years of age. Overall, the trial 
ended on 6th May 2011. Results from the trial phase showed that helminths and their 
treatment in pregnancy had no effect on infants’ response to vaccines; maternal 
gestational hookworm infection was inversely associated with childhood eczema [10]; 
anthelminthic treatment in pregnancy was associated with increased incidence of infantile 
[11] and childhood eczema [12]; and albendazole treatment in childhood was associated 
with reduced childhood malaria [12]. 
The second (follow-up) phase of the EMaBS began in 2008. For each child, the follow-
up phase started when the intervention was completed i.e. when they reached five years 
of age. The participants continued to be seen annually (as close to their birthday as 
possible). The follow-up phase aimed at investigating the long-term impact of helminth 
infections and anthelminthic treatment in pregnancy and early childhood on outcomes 
such as asthma, eczema and allergies between five and 13 years of age. Consent was 
obtained to collect additional anthropometric information and examine stool for 
helminthic infections. 
It was hypothesised that early-life (pre-natal and pre-school) exposure to helminth 
infections provides long-term protection against asthma, eczema and allergies; and that 
anthelminthic treatment in pregnancy and early childhood increases susceptibility to 
asthma, eczema and allergies in children. 
Results from the follow-up phase showed that i) sensitisation to allergen started early in 
childhood and increased with age, ii) wheeze and eczema declined as children grew older 
and were less common by nine years of age [13] , and iii) there was no effect of gestational 
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treatment with albendazole or praziquantel or of childhood quarterly treatment with 
albendazole on wheeze in the preceding 12 months or on skin prick testing response at 
nine years of age [14]. 
4.3.2 Study setting and population 
The EMaBS was conducted in Entebbe Municipality and the neighbouring Katabi sub-
county (Figure 4.3-1) in Wakiso district, Uganda; a peninsula on the northern shores of 
Lake Victoria at 0.05 degrees north and 32.46 degrees east. 
 
Figure 4.3-1: Map of the Entebbe Mother and Baby Study catchment area1 
Entebbe is located approximately 40 km southwest of the Ugandan capital, Kampala. The 
study area is a community in transition undergoing rapid urbanisation, especially along 
the Kampala-Entebbe highway. Figure 4.3-2 shows the settings of the study area. 
The Uganda National Population and Housing Census of 2014 reported that Entebbe 
municipality and Katabi sub-county had 69,958 individuals and 104,335 individuals 
respectively [15]. Overall in 2014, Uganda’s population was 34.6 million people, an 
increase of 10.4 million people from the 2002 census, representing a population annual 
                                               
1 Source Prof. Alison Elliott (MRC/UVRI & LSHTM Uganda Research Unit) 
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growth rate of 3% between 2002 and 2014 [15]. In the same period, Wakiso district 
population grew at a 7% annual rate. In 2014, 46% and 51% of Ugandans were aged 0 to 
14 years and 15 to 64 years, respectively [15]. The Baganda at 17% and Banyankole at 
10 % are the largest tribes in Uganda [15]. At enrollment, 49% of the women in the 
EMaBS were of the Baganda tribe [16]. 
 
Figure 4.3-2: Showing the setting for the Entebbe Mother and Baby Study catchment 
area. 
Results from the Uganda Demographic and Health Survey (UDHS) 2016 found that the 
median number of years of formal education reported by adult women had increased from 
1 year in 1995 to 3 years in 2016 [17]. In Uganda as a whole, 19% of women have no 
formal education [17]. At enrollment in the EMaBS, 4% of the women had no education, 
50% had primary education, 37% had senior education and 8% had tertiary education. 
Data from the UDHS further showed that 17% of women (15 to 49 years of age) were 
employed, of these 50% were involved with agriculture [17]. In Uganda, agriculture is 
mainly subsistence agriculture. At enrollment in the EMaBS, 63% of the women were 
 85 
unemployed or housewives and 82% of the women had a monthly personal income of 
less than 30,000 Ugandan shillings (US$20) [18]. Women enrolled in EMaBS were on 
average, more highly educated and with a higher income than Ugandan women as a 
whole. 
The EMaBS was based at Entebbe Hospital, the district referral hospital where the 
majority (over 70%) of pregnant women in the study area attend for antenatal care [19]. 
The sixth round of the UDHS conducted between June and December 2011, reported a 
10% prevalence of low birth weight among Ugandan newborns [20]. In the EMaBS birth 
cohort, the prevalence of low birth weight (<2.5 kg) was 8% [4]. 
Prevalence of stunting, wasting, being underweight and being overweight among children 
aged 6-59 months was 29%, 4%, 11% and 4%, respectively, in the UDHS 2016 report 
[17]. At one year of age, 14% of the EMaBS participants were stunted, 8% were 
underweight and 4% were wasted [21] 
Helminths and malaria are endemic to the study area. Worm prevalence among pregnant 
women in Entebbe has declined since the inception of the EMaBS. Between 2003 and 
2005, the prevalence of helminths in pregnant women in Entebbe Hospital was 68% [12], 
but dropped to 26% in 2009 (A. Elliott, unpublished data). Largely, in this birth cohort, 
the annual worm prevalence in the offspring has been low [12], less than 10% for a given 
worm type, details shown in Figure 4.3-3. 
The Uganda Population-Based HIV Impact Assessment (UPHIA), conducted between 
August 2016 and March 2017 showed that HIV prevalence was 8% among women aged 
15 to 64 years, with a higher burden among urban women at 10% compared to 7% of 
women living in rural areas. In children (0-14 years of age) HIV prevalence was 1% [22]. 
The national HIV prevalence was lower than the EMaBS prevalence of 12% in pregnant 
women [16] and 2% in children [23]. 
In Entebbe, malaria transmission occurs all year round, with peak transmissions 
corresponding to the peak rainfall [24]. The area enjoys an equatorial climate with two 
rainy seasons: the first rains from March to May and the second rains from September to 
November [24]. Among the EMaBS offspring, malaria incidence in the first five years of 
life was 34 episodes per 100 child-years with the highest incidence in the first two years 
of life. The annual prevalence of asymptomatic malaria between the ages 1 and 5 years 
varied between 5-7% [25]. 
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Figure 4.3-3: Worm prevalence by age among the Entebbe Mother and Baby Study birth 
cohort offspring 
As earlier described elsewhere [4, 18], 15,035 women were registered at the antenatal 
clinic at Entebbe hospital during the recruitment period, of these 11,783 were screened 
and 3,163 were eligible for enrollment. The most common reasons for ineligibility were 
residence outside the study area (n=6,243), lack of willingness to have an HIV test 
(n=1,186), unwillingness to participate in the study (n=874) and enrolment during an 
earlier pregnancy (n=115) [16, 18]. Of the 3,163 eligible women, 2,507 were enrolled 
[16, 18], eight were excluded because of double enrolment (as a result of enrolment for 
an earlier pregnancy) and 596 were lost to follow-up [18]. Those lost to follow-up were 
screened but then did not come back to the hospital for enrolment. There were no major 
differences between women enrolled and those screened but not enrolled, except that 
women screened and not enrolled were more likely to be primigravida or younger [18]. 
A detailed flow of participants in the EMaBS is provided in Figure 5.2-1, chapter 5. 
A community-wide household survey conducted in July to August 2008, surveyed 173 
community children aged 3 to 5 years in the study area and compared these children to 
199 EMaBS children of the same age who attended the study clinic during the same time 
period. This study found that 60% of the mothers in the community-based household 
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survey would have been eligible for enrolment into the trial, of these 30% had been 
enrolled [26]. Overall, mothers enrolled into the trial had higher educational status and, 
or better employment status than their community-survey contemporaries. The EMaBS 
children were more likely to use footwear or sleep under an insecticide treated bed net 
than the community-based comparison group. However, there were no differences in 
reported incidences of common infections between community and EMaBS children [26]. 
4.3.3 Maternal procedures 
4.3.3.1 Enrolment 
At enrolment, information on women’s anthropometry, family, general health and socio-
demographic characteristics was collected. Blood and stool samples were collected and 
examined for infections. Pregnant women were enrolled if they were in their second or 
third trimester of pregnancy, planning to deliver in hospital, willing to know their HIV 
status and residing in the study area. They were excluded if they had evidence of 
helminth-induced pathology (haemoglobin <8 g/dl, severe liver disease or bloody 
diarrhoea), history of adverse reaction to anthelminthics, abnormal pregnancy (as 
assessed by the midwife) or were enrolled for an earlier pregnancy [19]. Those with 
evidence of helminth-induced pathology were investigated, treated with albendazole and 
haematinics, and transfused with blood if necessary. 
As part of routine antenatal care, pregnant women received care comprising of: history 
taking, clinical examination, anthropometric measurements, daily haematinics (ferrous 
sulphate and folic acid), intermittent presumptive treatment (sulfadoxine/pyrimethamine) 
for malaria at 16 and 26 weeks of gestation, tetanus immunisation and treatment for 
common infections including sexually transmitted infections, and HIV counselling and 
testing was also done. 
4.3.3.2 Randomisations and trial intervention 
Participants were randomised to three interventions at two time-points, in a (2x2)x2 
factorial design; 2x2 in pregnant women and x2 in their resulting offspring, as shown in 
Figure 4.3-4. Randomisation codes were generated by the trial statistician using Stata 
version 7 (College Station, Texas, USA), with numbers allocated in blocks of 100 and 80 
for the mothers’ and children’s treatment groups, respectively; all three randomisations 
were independent of each other. Colleagues at the MRC/UVRI & LSHTM Uganda 
Research Unit in Entebbe who were otherwise not working on the trial packed and sealed 
the interventional drugs in envelopes labelled with allocation numbers. 
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Figure 4.3-4: The three randomisations at two time points2 
Intervention treatments were allocated to women at enrolment in a numerical order by 
trained interviewer-counsellors; who also administrated the interventions. Women 
received single-dose oral albendazole or matching placebo (400mg; GlaxoSmithKline, 
Brentford, UK) and single-dose oral praziquantel or matching placebo (40mg/kg; 
Medochemie Ltd, Limassol, Cyprus). All women received albendazole and praziquantel, 
six weeks after giving birth. 
4.3.3.3 Infections and illnesses 
Stool samples collected at enrolment were examined for helminths (hookworm [Necator 
americanus], Schistosoma mansoni, Trichuris trichiura and Ascaris lumbricoides) using 
Kato-Katz methods [27] and for Strongyloides stercoralis using charcoal culture [19]. 
Blood was examined for microfilariae (Mansonella perstans) and malaria parasites using 
modified Knott’s method and Leishman’s stain, respectively [28]. Thick blood smears 
were examined for Plasmodium falciparum ring forms or gametocytes by reading fields 
through 200 white blood cells and at least 100 high-power fields were examined before a 
film was declared negative. 
HIV serology was performed on whole blood using the serial triple rapid testing algorithm 
with: Determine, (Abbott Laboratories Co. Ltd., Tokyo, Japan); Statpack (Chembio 
Diagnostic Systems, Medford, NY, USA); and Unigold, (Trinity Biotech plc, Bray, 
                                               
2 Source Prof. Alison Elliott (MRC/UVRI & LSHTM Uganda Research Unit) 
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Ireland) [19, 21]. Only samples positive on Determine were re-tested on Statpack. 
Discordant samples on Determine and Statpack were further tested using Unigold. 
Women were considered HIV positive if they were positive on at least two test kits and 
HIV negative if they were negative on Determine or both Statpack and Unigold. 
HIV positive women were offered single-dose oral nevirapine (200 mg) and single dose-
oral neonatal nevirapine (2 mg/kg) for use at the onset of labour and within one week of 
delivery, respectively for prevention of mother-to-child HIV transmission. HIV positive 
women were also offered daily cotrimoxazole (sulfamethoxazole/trimethoprim) 960 mg 
for prophylaxis against opportunistic infections. They were referred for antiretroviral 
therapy (ART) if their CD4 cell counts were £200 cells/μl or if they had WHO clinical 
stages 3 or 4 HIV infection, irrespective of their CD4 count. 
4.3.4 Childhood procedures 
4.3.4.1 Growth assessment 
In Entebbe hospital, birth weight was measured immediately after birth using baby scales 
(Fazzini SRL, Vimodrone, Italy) to the nearest 0.1 kg, while for those delivered 
elsewhere, birth weight was recorded as it appeared on the child health card. Offspring in 
the EMaBS were seen regularly at the study clinic. At six weeks and six months of age, 
children were weighed using CMS weighing equipment, model MP25 [Chasmors Ltd, 
London, UK]). Thereafter they were weighed annually starting at one year of age using 
Seca weighing scales (Seca: gmbh & co.kg, Hamburg, Germany). 
Height was measured to the nearest 0.1 cm as recumbent length at six weeks and six 
months of age using an adjustable child-length measuring board (Seca; Vogel & Halke, 
Hamburg, Germany). From one year of age, height was measured annually (as close to 
the child’s birthday as possible) using stadiometers (Seca 213; gmbh & co.kg, Hamburg 
Germany). 
4.3.4.2  Trial intervention 
At 15 months of age, children were randomized to receive quarterly oral albendazole or 
matching placebo until the age of five years. Trained study nurses allocated the 
randomisation codes sequentially and administered the intervention drug. They received 
syrups (5ml) equivalent to 200mg albendazole or matching placebo labelled according to 
their randomisation code up to 21 months of age. From 2 to 5 years of age, they received 
chewable albendazole (400mg) tablets or matching placebo, packaged and sealed in 
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envelopes labelled according to the randomisation code. Study participants and staff 
continue to be blinded to the drug allocation both in pregnancy and in childhood. 
4.3.4.3 Follow-up, infections and illnesses 
Offspring were seen regularly at the study clinic for scheduled visits or when ill. Through 
home visits and telephone calls, clinic-based fieldworkers reminded participants of their 
appointments and invited them for new sub-studies or additional procedures. 
During the scheduled visits (at six weeks, six months of age and then annually [as close 
to the child’s birthday as possible], starting at one year of age) additional data was 
collected from the offspring. Stool samples were examined for helminths using Kato-Katz 
methods [27], while blood samples were examined for malaria parasites using Field’s 
stains [A and B] and for Mansonella perstans using modified Knott’s method [28]. 
Children with clinical malaria, asymptomatic malaria or worm infections were treated 
accordingly. Initially, asymptomatic or simple malaria was treated with chloroquine 
(25mg base/kg) for three days then combined therapy of chloroquine (25mg base/kg) for 
three days with single-dose Fansidar (sulfadoxine and pyrimethamine) was used. 
Currently, simple malaria is treated with oral artemisinin-based combination therapies 
(artemether and lumefetrine). Complicated malaria is managed with parenteral 
intravenous quinine 10mg/kg every eight hours in 10-20 ml/kg of 5% dextrose initially 
until child is able to tolerate oral therapy. This was followed with either oral quinine at 
10 mg/kg every 8 hrs until completion of a 7-day course or a full treatment course of an 
oral artemisinin-based therapy. 
Schistosomiasis was treated with praziquantel (40mg/kg). Single-dose albendazole 
(200mg if <2 years and 400mg for those ³2years) was used to treat Ascaris, hookworm 
and Trichostronglyus. Strongyloides and Trichuris were treated with albendazole (200mg 
if <2 years and 400mg if ³2years) twice daily for 3 days. 
Sick participants were seen at the study clinic, where treatment was provided free of 
charge. They were managed following the national treatment guidelines at the time. Those 
requiring hospitalisation were admitted to Entebbe hospital and followed until they were 
discharged. 
At six weeks of age, dried blood spots from children exposed to maternal HIV in 
pregnancy were investigated for vertical HIV transmission using polymerase chain 
reaction (PCR) and quantitative reverse transcription (RT)-PCR. After 18 months of age, 
HIV status of children exposed to maternal HIV in pregnancy was determined using the 
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serial triple rapid testing algorithm starting with Determine, (Abbott Laboratories Co. 
Ltd., Tokyo, Japan), followed by Statpack, (Chembio Diagnostic Systems, Medford, NY, 
USA) and then Unigold, (Trinity Biotech plc, Bray, Ireland) [19, 21]. Children were 
considered HIV positive if they had a positive PCR test or were positive on the rapid 
testing algorithm and HIV negative if they were negative on both PCR and the serological 
serial testing algorithm. 
Infants born to HIV positive women received daily prophylaxis with cotrimoxazole 
(sulfamethoxazole/trimethoprim, 40mg/200mg per 5ml). Cotrimoxazole was 
discontinued if they were HIV negative after 18 months of age. HIV positive children 
were started on ART if their CD4 percentage was £15% or had WHO clinical stage 3 or 
4 HIV infection(s). 
4.3.4.4 Whole-genome genotyping 
In 2012, ethical approval was granted to generate genotypic data from stored (at -80oC 
until processing) samples collected at one year of age. Whole-genome genotyping of 
1,391 infants was done, aimed at identifying and characterising mechanisms of human 
genetic variants impacting on immune responses and protective efficacy of vaccines 
delivered in early infancy. DNA was extracted from the erythrocyte layer using Qiagen 
QIAamp DNA Mini or Midi Kits (Qiagen, Hilden, Germany) following recommended 
protocols. 
Approximately 2.2 million genetic variants were generated at Wellcome Trust Sanger 
Institute in collaboration with the University of Oxford, using the Illumina 
HumanOmni2.5M-8 (‘octo’) Beadchip arrays, version 1.1 (Illumina Inc., San Diego, 
USA). Whole genome was amplified and fragmented before hybridisation of genomic 
DNA to specific oligonucleotides bound to 3μm diameter silica beads. Genotypes were 
called from intensities using two clustering algorithms (Illuminus and GenCall) in 
GenomeStudio (Illumina Inc., San Diego, USA) incorporating data from proprietary pre-
determined genotypes. 
Quality control (using standard pipelines) was done at the Wellcome Centre for Human 
Genetics, University of Oxford, to remove individuals and variants with high levels of 
missingness or deviations from expected levels of heterozygosity or Hardy-Weinberg 
equilibrium (p-value <1x10-8) using standard PLINK (version 1.7) commands (run on 
Unix) [29]. 
 92 
4.4 Blood Pressure Study 
Extra ethical approvals were granted to study BP in 10- and 11-year olds participants in 
the EMaBS. Between 20th May 2014 and 16th June 2016, information on BP was collected 
from adolescents attending the study clinic for their annual visit. 
4.4.1 Inclusion and exclusion criteria 
Adolescents were included in the BP study if they were aged 10 or 11 years and provided 
additional consent and assent. They were excluded if they were aged 11 years and had 
previously enrolled in the BP study at 10 years of age. Enrolment was postponed for those 
with malaria (fever with malaria parasites) or other illness until they were well after being 
treated by the study team. 
4.4.2 Adolescence procedures 
Supplementary clinical procedures were done and additional questionnaires on 
participants’ medical and family history, diet and physical activity were completed in the 
presence of both the participant and their parent or guardian. 
4.4.2.1 Anthropometry 
Additional anthropometric information on weight, height and waist circumference at the 
time of BP measurement were collected using Seca weighing scales, Seca stadiometers 
and Seca tape measures (Seca 201; Seca: gmbh & co.kg, Hamburg, Germany) 
respectively. Waist circumference was measured using a tape measure at the mid-way 
position between the lowest rib and the iliac crest and recorded to the nearest 0.1 cm. 
4.4.2.2  Blood pressure assessment 
After five minutes rest, trained nurses measured BP thrice five minutes apart on the right 
arm supported at the heart level with the participants seated upright all the way to the 
back of the chair with their legs uncrossed and feet flat on the floor. Omron (M6) machines 
fitted with appropriate-sized cuffs were used for BP measurement [3]. Figure 4.4-1 shows 
a study participant having her BP measurements taken. 
For purposes of clinical assessment and care, the mean of the three readings was 
estimated. The Centers for Disease Control and Prevention (CDC) height percentile charts 
and the 2004 updated National Health and Nutrition Examination Survey (NHANES) 
Working Group on Children and Adolescents BP tables were used to obtain BP 
percentiles [1, 3]. Those with systolic and or diastolic BP ³95th percentile for sex, age and 
height on this first occasion (day-one) were invited for repeat BP measurements on up to 
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two additional occasions one to three weeks apart. Adolescents with BP (systolic and or 
diastolic) <95th percentile for sex, age and height percentile on the second day were not 
invited for repeat BP measurement for a third occasion. Those with sustained BP (systolic 
and or diastolic) ³95th percentile for gender, age and height on the third day were further 
investigated and referred for specialist evaluation at Mulago National Hospital. 
 
Figure 4.4-1: Entebbe Mother and Baby Study participant undergoing blood pressure 
measurement at 10/11 years of age. 
Non-pharmacologic measures (emphasising a healthy diet rich in fruits and vegetables; 
reducing dietary sodium intake; maintaining normal body weight; and regular physical 
exercise such as runs and walks) were recommended to participants with BP (systolic and 
or diastolic) ³90th percentile for sex, age and height. 
4.4.2.3 Puberty and the Tanner stages 
From 6th January 2015 to 16th June 2016, trained clinicians assessed puberty based on 
breast and pubic hair development adolescents enrolled in the BP study following 
Tanner’s method [30, 31]. 
4.4.2.4 Body composition assessment 
Extra ethical approval was obtained to collect body composition data from 10- and 11-
year old participants in the EMaBS blood pressure study. Between 21st January 2015 and 
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23rd December 2015, body composition parameters including fat mass (FM, the total 
weight of fat mass in the body), fat free mass (FFM, the total amount of muscle, bone, 
tissue, water and all other fat free mass in the body) and total body water mass (TBW, the 
amount of water retained in the body) were collected using a segmental body composition 
analyser machine (TANITA BC-418, TANITA Corporation, Tokyo Japan). Briefly, 
barefooted adolescents stood upright on the posterior electrode base while simultaneously 
holding strongly onto the two anterior electrodes handles of the body composition 
analyser machine. 
4.4.3 Quality control 
The Vector Control Programme at the Ministry of Health, Uganda, provided quality 
control for Kato-Katz analyses, while malaria parasitology quality control was provided 
by the UK National External Quality Assessment Schemes. 
The MRC/UVRI & LSHTM Uganda Research Unit laboratories in Entebbe provided HIV 
quality control testing using the non-rapid enzyme-linked immunosorbent assay (ELISA) 
tests on a proportion of samples which included all samples with discordant results from 
the serological serial testing algorithm. 
The CMS weight scales were regularly calibrated using a standard ten-kilogram stone, 
made for this purpose. The Omron (M6) digital BP machines were validated and 
calibrated every six months by the Uganda National Bureau of Standards. 
4.4.4 Sample size and study power 
The sample size of 1,119 was determined by the number of adolescents enrolled into the 
BP study. Of these, 932 (83%) had a birth weight record of whom 65 (7%) had low birth 
weight (birth weight <2.5kg). Respectively, the SD for systolic and diastolic BP was 8.2 
mmHg and 7.3 mmHg. Table 4.4-1 shows the power to detect a difference in mean 
systolic or diastolic BP between low birth weight and non-low birth weight children at a 
5% significance level among the 932 adolescents with a recorded birth weight. Birth 
weight was also analysed as a continuous explanatory variable thus yielding greater 
power to detect effects on BP than when using dichotomised birth weight variables [32]. 
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Table 4.4-1:Power calculations for the Blood Pressure Study (N=932) 
Increase in BP (mmHg) Systolic BP Diastolic BP 
4.0 96.6% 98.9% 
3.5 91.2% 96.1% 
3.0 81.1% 89.1% 
2.5 65.9 % 75.8% 
2.0 47.9 % 56.7% 
1.5 29.5% 35.8% 
N; numbers of participants, BP; blood Pressure 
 
The genetic analysis included 815 participants with both genotypic and phenotypic data. 
Table 4.4-2 shows the detectable difference for 80% or 90% power to detect an 
association at genome-wide significance level (p-value <5x10-8) for a range of minor 
allele frequencies and assuming SD of 8.2 mmHg and 7.3 mmHg for systolic BP and 
diastolic BP, respectively. 
4.5 Statistical methods 
This section describes data management processes, variable/data manipulation and 
categorisation, and analysis strategies for this PhD work. In addition, succinct 
descriptions of the statistical methods for each thesis objective are given in each published 
research paper. 
Table 4.4-2: Power calculations for the Genetic Association Study (N=815) 
Systolic BP   Study Power 
MAF  80% 90% 
20% 3.2mmHg 3.4mmHg 
15% 3.6mmHg 3.8mmHg 
10% 4.3mmHg 4.6mmHg 
5% 5.9mmHg 6.3mmHg 
1% 13.0mmHg 13.9mmHg 
Diastolic BP    
MAF 80% 90% 
20% 2.9mmHg 3.1mmHg 
15% 3.2mmHg 3.4mmHg 
10% 3.8mmHg 4.1mmHg 
5% 5.3mmHg 5.6mmHg 
1% 11.6mmHg 12.4mmHg 
N; numbers of participants, MAF; minor allele frequency, BP; blood pressure 
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4.5.1 Data management 
Clinicians, nurses and laboratory technicians captured data on duplicate pre-coded CRFs 
which were later checked for consistency, batched and double entered into Microsoft 
Access (Microsoft Corp., Redmond, WA, USA). The original CRFs have been archived 
in MRC/UVRI & LSHTM Uganda Research Unit sites at Kyamulibwa and Entebbe with 
duplicate copies maintained in participants’ files at the study clinic. 
The PhD candidate generated data cleaning and merging queries which were resolved by 
the PhD candidate together with the study team by cross-checking with the original and 
or duplicate CRF copies. Changes were later made in the database, participants’ files and 
archived documents. The process was repeated until no more queries could be generated. 
Various datasets were merged into a single analysis dataset and unique identifiers dropped 
from the final analysis dataset. 
4.5.2 Categorisation of variables 
Data was grouped and re-coded into categories thought to be appropriate for a given 
variable or analysis. The study area was divided into zones based on topography and 
settlements using the geographical positioning system (GPS) data. This was grouped into 
urban (Entebbe town, Abaita and Nkumba trading centres, Kigungu, and roadside villages 
of Katabi) or rural areas of Kisubi and Katabi extending south to Lake Victoria (Figure 
4.3-1) [18]. Household socioeconomic index (1 [lowest] to 5 [highest]) was based on 
previously done principal components analysis of characteristics that reflected socio-
economic status such as household possessions, building materials, and the number of 
rooms [16]. This grouping for study area and household socioe-conomic status has been 
used before in previous analysis and publications [16, 18]. 
Data on monthly rainfall for the study area for the months in which an EMaBS child was 
born was obtained from the Department of Meteorology in Entebbe. The median of these 
monthly rainfalls was then calculated and used to categorise season of birth as either dry 
or wet depending on whether the monthly rainfall was below or above this median value. 
Birth weight was considered for analysis both as a continuous variable and a categorical 
variable, grouped as £2.5kg, 2.5 to 2.9kg, 3.0-3.5 kg and >3.5kg or as low birth weight 
(<2.5kg) verses non-low birth weight (³2.5kg). Place of delivery was Entebbe hospital or 
home or others, while feeding status at six weeks was grouped as exclusively breastfed 
or mixed fed or weaned. Sex of the participants was male or female. Trial interventions 
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in pregnancy were praziquantel or placebo and albendazole or placebo, whereas in 
childhood the intervention treatment was albendazole or placebo. 
HIV status was either positive or negative for women at enrolment and unexposed, 
exposed not infected or exposed infected for the offspring. Helminth (Schistosoma, 
Ascaris, Hookworm and Trichuris) infections were each coded as infected or not infected. 
Childhood malaria was investigated as both clinical malaria (history of fever or axillary 
temperature ≥37.5°C and parasitaemia) and asymptomatic malaria (parasitaemia in 
absence of fever at any of the annual visits from age one to five years. Family history of 
hypertension or diabetes was classified as yes or no. 
Weight-for-age Z-score (WAZ), weight-for-height-Z score (WHZ), height-for-age-Z 
score (WAZ) and body-mass-index- for-age Z score (BMIZ) at birth, six weeks of age, 
six months of age and then annually from one to five years of age was calculated using 
the 2006 World Health Organization (WHO) standard references [33, 34]. The 2006 
WHO references were from a Multicentre Growth Reference Study for the assessment of 
the growth and development of 0 to 5-year-old children. In addition, BMI at 10/11 years 
of age was calculated as weight in kilograms divided by height in meters squared. Fat 
mass index (FMI)=FM (kg)/height(m2), fat free mass index (FFMI)=FFMI 
(kg)/height(m2) and total body water index (TBWI)= TBWI (kg)/height(m2) were 
respectively used as indices for FM, FFM and TBW, as scaling by height avoids 
ambiguities that arise from reporting percentages to tall malnourished persons have 
similar FM or FFM percentages as shorter well-nourished persons [35]. 
Puberty was assessed using breast and pubic hair development based on Tanner’s method 
[30, 31] and grouped as pre-pubertal (stage 1) or pubertal (stages 2, 3, 4 or 5). Sleep 
pattern was based on self-reported duration of night’s sleep in hours on a standard night 
or snoring (yes or no). The type of school attended was day or boarding. Participation in 
physical education activities at school as yes or no and smoking in the household as yes 
or no. 
Information on diet in the previous month was collected as the numbers of days in a 
typical week for which a given food (fruits, vegetable, sugared drinks, animal proteins, 
starchy staple foods) was consumed. This was grouped into 0-2 or 3-7 for fruits, 
vegetable, animal proteins, starchy staples foods but none, 1-3, or 4-7 for sugared drinks.  
Grouping for fruits, vegetables sugared drinks, animal proteins and starchy staple food 
aimed at having roughly similar distributions in the groups. Adding salt to cooked food 
at the table was yes or no. 
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4.6 Data analysis plan 
4.6.1 Summary 
This data analysis plan was developed before analysis was done for each of thesis 
objectives 2, 3, 4 and 5. The data analysis plan outlines the methods for data handling, 
processing and analysis for each objective. 
Study aim: Investigating the impact of early-life, life-course and genetic factors 
on blood pressure among young Africans 
Inclusion criteria • Cohort members still under-follow-up 
• Age 10 or 11 years 
• Consent to additional procedures 
Exclusion criteria • Eleven-year-olds already enrolled at 10 years of age 
• Enrolment was postponed for offspring with malaria (fever 
and parasitaemia) or other illnesses until they were well 
Analysis packages • Stata 14.2 
• GCTA version 1.22 
• R version 3.4.0 
4.6.2 Dealing with missing information 
Missing data will be summarised for the main exposures and for the potential 
confounders. Participants with missing data for a given variable will be omitted from 
any analysis involving that variable. Except for genetic analysis, missing data will not 
be imputed but sensitivity analysis will be conducted for birth weight and change in 
WAZ data at the end of analysis for the relevant objective. For example, missing values 
for birth weight will be replaced with the maximum birth weight recorded among 
children with non-missing birth weight, and final analysis models re-run and the 
sensitivity of results to this simple imputation examined. This process will be repeated 
with the minimum non-missing birth weight replacing the missing values. 
Untyped genetic variants and variants identified for the replication analysis will be 
imputed at the Wellcome Trust Centre for Human Genomics, University of Oxford 
using an integrated panel consisting of the 1000 Genomes [36] African genome 
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variation project (AGVP) [37] and Uganda 2000 Genomes (UG2G); genomes of 
Ugandan individuals of diverse ethnicity from rural Uganda). SHAPEIT2 (version 2 
790) [38] and IMPUTE2 (version 2.3.2) [39] [genotype imputation and haplotype 
phasing programs] will be used for imputation with settings recommended for African 
populations. 
4.6.3 Testing assumptions underlying linear regression modelling 
Graphical methods will be used to assess for linear regression analysis assumptions. 
4.6.4 Thesis objective 2: Investigate the relationship between birth weight 
and BP among Ugandan adolescents 
Outcomes • Mean BP (systolic and diastolic) 
Exposures • Birth weight 
Forced variables  • Sex 
• Age at BP measurement 
Confounders • Maternal factors during antenatal period and, or delivery 
1. Socio-demographic 
2. Anthropometric 
3. Infections and illnesses 
• Children’s characteristics 
1. Socio-demographic 
2. Anthropometric 
3. Infections and illnesses 
Sub-group analysis • Sex 
• Treatment allocation group 
• Location (rural or urban) of residence 
• Season of birth 
4.6.4.1 Analysis strategy 
Descriptive statistics will be presented as frequencies and percentages for categorical 
data while continuous data will be presented as either mean and their standard 
deviation for normally distributed data or median and their interquartile range for non-
normally distributed data. Graphical displays will also be used. Early-life 
characteristics will be compared between offspring who participated and did not 
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participate in the BP study. Pearson correlation coefficients will be used to examine 
the relationships between anthropometric variables in childhood and BMI at BP 
measurement. The means and the 95% confidence interval for the first, second and 
third BP reading of the first occasion will be assessed and compared. 
A modelling approach using linear regression will be fitted separately for systolic BP 
and diastolic BP. Birth weight will be investigated as both a continuous and categorical 
exposure variable to understand the pattern of its relationship with the outcome 
variables and determine if a linear or non-linear relationship best fits the data. Birth 
weight categories of width 500g (or 250g depending on the distribution of birth weight 
values) will be generated. 
First, the crude association between birth weight and BP (systolic or diastolic) will be 
determined. Likelihood ratio test will be used to investigate effect modification by 
gender, season of birth, treatment allocation group and area of residence of the crude 
relationship between birth weight and BP (systolic or diastolic). 
Then models for BP containing birth weight and forced variables as predictor variables 
will be adjusted for each potential confounder in turn, and factors changing the 
regression coefficient for the relationship of birth weight on BP by an important 
amount will be considered for model building. One factor at a time will be added, 
starting with those having the strongest effect i.e. those, which when adjusted for, cause 
the largest change in the regression coefficient for the association between birth weight 
and BP. The process will be repeated for the remaining variables until there are no 
more variables that change the effect of birth weight on BP by an important amount. 
Effect modification in the final model will be examined for factors that showed effect 
modification at crude analysis. 
Controlling for many variables may lead to data sparsity and/or multicollinearity 
(correlation of exposure with the controlled confounders or between two confounders). 
The change in standard error (s.e) for the effect of birth weight on BP will be used for 
assessing multicollinearity and where it exists, factors introducing multicollinearity 
will not be included in the model. 
Except for current weight, variables on the causal pathway between birth weight and 
BP will not be included in the models. Some previous reports have adjusted for current 
weight (adjusting and not adjusting for current weight remains a controversial topic) 
thus including current weight in our final model will enable comparison with previous 
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results. Models with and without adjusting for current weight will be compared and 
differences summarised. 
Finally, sensitivity analysis will be conducted for birth weight. Missing values for birth 
weight will be replaced with the maximum birth weight recorded among children who 
are non-missing for birth weight, and final analysis models will be re-run. Results from 
this simple imputation will be compared to those from the main analysis. This process 
will be repeated using the minimum non-missing birth weight to replace missing 
values. 
4.6.5 Thesis objective 3: Investigate the relationship between postnatal 
growth and BP among Ugandan adolescents 
Outcomes • Mean BP (systolic and diastolic) 
Exposures • Postnatal growth (change in weight-for-age Z (WAZ) 
scores) between birth and 5 years and for each of the 
shorter growth periods: birth to 0.5 years, 0.5 to 1 year, 1 
to 2 years and 2 to 5 years 
Confounders • Factors adjusted for in thesis objective 2 
• Breastfeeding status at 6 weeks of age 
Sub-group analysis • Birth weight (categorised into < 2.5 kg and ³ 2.5 kg) 
• Sex 
4.6.5.1 Analysis strategy 
Linear regression modelling will be used to assess the effect of postnatal weight gain 
between birth and 5 years overall and separately for various growth periods (0 to 6 
months, 6 to 12 months, 12 to 24 months and 24 to 60 months) on adolescents’ BP. 
The 2006 World Health Organization (WHO) standard references will be used to 
estimate the weight-for-age Z (WAZ) scores at birth, six months, 1 year, 2 years and 5 
years of age. For each participant, the change in WAZ scores for each of the growth 
periods defined above will be calculated. Models for the effect of the change in WAZ 
will be fitted separately for systolic BP and diastolic BP. The crude associations for 
each postnatal growth period and BP will be determined. To assess the independent 
effect of each postnatal weight gain period on BP, a multivariable model adjusting for 
confounders (adjusted for in thesis objective 2) and breastfeeding status at six weeks 
of age will be run. Each postnatal growth variable will be adjusted for the effect of all 
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earlier postnatal growth periods. Effect modification by birth weight (as a categorical 
variable) or sex will be examined using the likelihood ratio (LR) test. 
Sensitivity analysis for changes in weight gain will be conducted. The maximum 
estimated changes in WAZ for those who were non-missing for change in WAZ for a 
given period will substitute the missing values for changes in WAZ, and the final 
model analysis will be re-run. Results from this simple imputation will be compared 
to those from the main analysis. This process will be repeated with the minimum non-
missing values of the change in WAZ substituting the missing values. 
4.6.6 Thesis objective 4: Identify other factors associated with BP among 
Ugandan adolescents 
Outcomes • Mean BP (systolic or diastolic) 
Exposures • Maternal factors in pregnancy 
1. Socio-demographic characteristics (age, 
household socio-economic status, education, 
marital status and area of residence) 
2. Body mass index 
3. Illnesses and Infections (HIV, malaria, 
hypertension, worms [microfilaria, ascaris, 
hookworm, schistosoma and Trichuris]) 
4. Trial interventions (praziquantel and albendazole) 
 • Infancy and early childhood factors 
1. Birth weight 
2. Season of birth 
3. Place of birth 
4. Mode of delivery 
 5. Sex 
6. Breastfeeding status at 6 weeks of age 
 • Late childhood 
1. Infections and illnesses (malaria, HIV and 
worms) 
2. Trial intervention 
 • Adolescent factors 
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1. Anthropometry (body mass index, waist 
circumference) 
2. Age at BP measurement 
3. Physical activity 
4. Sleep quality and duration 
5. Diet 
6. Puberty stage (breast and pubic hair 
development) 
Forced variables • Sex 
• Age 
• Body mass index 
Potential confounders • All the above exposures are potential confounders for 
other exposures (excluding those on the causal pathway) 
4.6.6.1 Analysis strategy 
Crude relationships between each factor and the outcome (systolic or diastolic BP) will 
be fitted separately for systolic and diastolic BP using linear regression methods. The 
20% significance level will be used to decide factors to consider for multivariable 
analysis. This will ensure that potential confounders (which need only be weakly 
associated with the outcome if they are strongly associated with the exposure, in order 
to cause confounding) are included. 
Multivariable analyses will follow a hierarchical approach following the conceptual 
framework published in chapter 6. Factors will be added to the model in a sequential 
process starting with distal factors and the proximal factors last. Factors at the same 
level will be added at the same time and considered potential confounders for each 
other and for proximal factors. For each factor, regression coefficients will only be 
adjusted for those variables at the same level or more distal. Statistical significance 
will be determined by LR test. A factor crudely associated at p-value <0.2 will still be 
adjusted for (and the adjusted results shown for it) regardless of its p-value in 
multivariable models. 
Multicollinearity will be assessed for factors thought to be correlated using the change 
in s.e method and where it exists, the factor introducing multicollinearity will be 
dropped from the model. 
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4.6.7 Thesis objective 5: Investigate genetic polymorphisms associated with 
BP among Ugandan adolescents 
Outcomes • Mean BP (systolic or diastolic) 
Main exposure • Genetic variants (single nucleotide polymorphisms (SNPs)) 
4.6.7.1 Analysis strategy 
Genotypic data from 1,391 EMaBS offspring will be merged with BP data from 1,119 
EMaBS participants to generate the analysis dataset of participants with both genotypic 
and phenotypic data. 
The Genome-wide Complex Trait Analysis (GCTA) programme will be used for 
analysis. Genome-wide association study (GWAS) analyses will be conducted first. 
Mixed linear model regression analysis including age and BMI as fixed effects will be 
used. SNPs associated with BP (systolic or diastolic) as a quantitative trait at 
significance level p-value <5x10-8 will be considered as statistically significant. Only 
SNPs with minor effect allele frequency >0.01 will be reported. If no SNP is identified 
as associated with BP at this GWAS significance level, then candidate gene analyses 
will be undertaken. This will involve investigating the strength of the association for 
these SNPs with BP in the EMaBS participants. Candidate gene analysis will be based 
on prior knowledge: genetic variants previous reported to be associated with BP 
(systolic or diastolic) from earlier GWAS at significance level of p-value <5x10-8. A 
Bonferroni corrected p-value threshold will be estimated for statistical significance. 
4.7 Ethical considerations and permissions 
Parents or guardians of the EMaBS participants provided written, informed consent at the 
various cohort stages (intervention in pregnancy, intervention in the offspring, 
genotyping, follow-up phase and BP study). The offspring provided written assent 
starting from eight years of age to allow for continued follow-up and for participation in 
the BP study. 
The Uganda Virus Research Institute (UVRI) Research and Ethics Committee (REC); the 
Uganda National Council of Science Technology (UNCST); and the London School of 
Hygiene & Tropical Medicine (LSHTM) granted ethical approvals for EMaBS, including 
the subsequent protocol amendments (including genotyping, follow-up and BP study). 
The Oxford Tropical Research Ethics Committee also granted ethical approval for the 
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genotyping. Ethical clearance was obtained from the Ethics Committee of the LSHTM to 
conduct this PhD work, Appendix 1. 
The adolescents who sustained a high BP (systolic and/or diastolic >95th percentiles for 
sex, age and height) after the third occasion were further investigated (additional blood 
tests were conducted), referred for specialist assessment in Mulago hospital and managed 
according to appropriate guidelines as mentioned earlier and treatment was offered if 
required. 
Blood pressure assessment carried no major risk to the child except causing very minor 
discomfort. The process of obtaining blood samples also causes minor discomfort to 
participants. 
Unique identifiers used on study questionnaires to link data to an individual during data 
cleaning and merging data sets were removed from the final analysis dataset. 
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Chapter 5: The relationship between birth weight and postnatal 
weight gain, and adolescent blood pressure. 
5.1 Introduction 
This chapter uses observational data from the EMaBS birth cohort to address thesis 
objectives 2 and 3, with results presented in research paper 2, “Are birth weight and 
postnatal weight gain in childhood associated with blood pressure in early adolescence? 
Results from a Ugandan birth cohort”, as published in the International Journal of 
Epidemiology [268]. In addition, the chapter presents data on the flow of participants in 
the EMaBS birth cohort, unpublished supplementary tables and results of graphical 
investigations of the assumptions underlying linear regression analysis, which were not 
included in the paper for reasons of space. 
5.2 Participants’ flow in the birth cohort 
Briefly, 11,783 women attending antenatal care at Entebbe hospital were screened, 3,163 
were eligible for enrollment and 2,507 were enrolled into the EMaBS, resulting in 2,345 
live offspring. Of the live born infants, 2,315 (99%) were singleton births. Overall, 
follow-up in the cohort was higher than anticipated at study design; a 10% loss to follow-
up per year was expected [237]. 
Of the 2,345 live born offspring, 2,218 (95%) were seen at the study clinic at 6 weeks of 
age and 1,654 (71%) seen at 6 months of age, 1,722 (73%) seen at one year of age, 1,586 
(68%) seen at two years of age, 1,510 (64%) seen at three years of age and 1,622 (69%) 
seen at five years of age. 
Respectively, phenotypic data on BP and genotypic data (from stored samples) was 
available for 1,119 (48%) at 10/11 years of age and 1,391 (59%) of the live born offspring. 
Both phenotypic and genotypic data were available for 815 (35%) of the live born 
offspring. Detailed flow of participants in the EMaBS is shown in Figure 5.2-1. 
Respectively, detailed characteristics of EMaBS participants with phenotypic data and 
with genotypic data are presented in supplementary tables 1 (Table S1) in chapter 5 and 
(Table S1) in chapter 7. 
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Figure 5.2-1: Showing the number of Entebbe Mother and Baby Study participants seen 
at selected study time points  
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Abstract
Background: In Africa, where low birthweight (LBW), malnutrition and high blood pres-
sure (BP) are prevalent, the relationships between birthweight (BW), weight gain and BP
later in life remain uncertain. We examined the effects of early life growth on BP among
Ugandan adolescents.
Methods: Data were collected prenatally from women and their offspring were followed
from birth, with BP measured following standard protocols in early adolescence. Weight-
for-age Z-scores (WAZ) were computed using World Health Organization references.
Linear regression was used to relate BW, and changes in WAZ between birth and 5 years,
to adolescents’ BP, adjusting for confounders.
Results: Among 2345 live offspring, BP was measured in 1119 (47.7%) adolescents,
with mean systolic BP 105.9 mmHg and mean diastolic BP 65.2 mmHg. There was little evi-
dence of association between BW and systolic [regression coefficient b ¼ 0.14, 95% confi-
dence interval (CI) (-1.00, 1.27)] or diastolic [b ¼ 0.43, 95% CI (-0.57, 1.43)] BP. Accelerated
weight gain between birth and 5 years was associated with increased BP: systolic b ¼ 1.17,
95% CI (0.69, 1.66) and diastolic b ¼ 1.03, 95% CI (0.59, 1.47). Between birth and 6 months
of age, effects of accelerated weight gain on adolescent BP were strongest among the
LBW (both premature and small-for-gestational-age) children [BW<2.5 kg: b ¼ 2.64, 95%
CI (0.91, 4.37), BW2.5 kg: b ¼ 0.58, 95% CI (0.01, 1.14), interaction P-value ¼ 0.024].
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Conclusions: Findings from this large tropical birth cohort in Uganda suggest that post-
natal weight gain rather than BW is important in the developmental programming of BP,
with fast-growing LBW children at particular risk. Efforts to control BP should adopt a life
course approach.
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Introduction
Several studies from high-income settings have linked
growth in early life (fetal and/or early childhood) with
blood pressure (BP) later in life; data suggest an inverse re-
lationship with birthweight (BW) (a proxy for fetal
growth)1 but a positive association with postnatal weight
gain (a proxy for growth in childhood).2 The risk is great-
est in individuals who experience a ‘nutritional mismatch’
(slow uterine growth leading to low BW followed by accel-
erated postnatal growth).2 Size at birth, postnatal weight
gain and ‘nutritional mismatch’ could be important in the
developmental programming of later BP.
In Africa, where low BW (LBW),3–6 malnutrition (early
life undernutrition and later obesity)7–9 and high BP10–12
are prevalent, the relationship between BW or postnatal
weight gain and BP later in life remains unclear. Recent
systematic reviews showed that mean systolic and diastolic
BP varied from 102.0 mmHg to 118.1 mmHg and from
62.0 mmHg to 71.4 mmHg, respectively, in African chil-
dren and adolescents aged 5–19,13 whereas the prevalence
of high BP varied between 1% and 25% among African
children and adolescents aged 2–19 years.14
In high-income settings, LBW is mainly due to prematu-
rity, which can be due to any of a number of factors (and
their combination), including obstetric conditions, mater-
nal body mass index (BMI), maternal smoking and alcohol
intake,15 whereas in developing countries, small-for-
gestational-age (SGA) (often resulting from maternal
malnutrition and infections such as HIV and malaria, more
prevalent in the tropics) accounts for many LBW
infants.6,16 Other causes of LBW such as maternal alcohol
intake and smoking are less common in Africa.
The relationships between BW, postnatal weight gain
and BP in low-income settings may differ from those seen in
high-income countries. Interventions in pregnancy such as
prophylactic antimalarial drugs and anthelminthic treat-
ment, common in these settings, have been shown to be as-
sociated with birthweight. For example, maternal treatment
with mebendazole in pregnancy was associated with in-
creased birthweight in Nepal.17 In contrast, our earlier work
in Uganda found no impact of maternal treatment with pra-
ziquantel and or albendazole in pregnancy on birthweight.5
However, the impact of such infections and interventions, and
of catch-up nutrition in the small or malnourished African
infant, on later BP remains unknown and understudied.
Understanding early life determinants of later BP could
be vital in the development of interventions that prevent or
control high BP before clinical manifestation of subsequent
disease(s). We used data from the Entebbe Mother and
Baby Study (EMaBS) birth cohort in Uganda, to investigate
the relationship between (i) BW and BP in early adoles-
cence, and (ii) accelerated weight gain in childhood and BP
in early adolescence.
Methods
Study design and population
Adolescents from the EMaBS, a randomized, double-blind,
placebo-controlled trial designed to investigate the effects
of worms and their treatment in pregnancy and childhood
Key Messages
• Among Ugandan adolescents, systolic and diastolic blood pressures were positively associated with accelerated
weight gain in early childhood, but not with birthweight.
• The effects of accelerated weight gain in the first years of life on later blood pressure were similar among males and
females but differed by size at birth, with the strongest effect among those who were born small.
• Blood pressure control strategies should adopt a life course approach rather than focusing specifically on adults or
on the prenatal period.
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on vaccine responses and infections in the children,18 were
enrolled into the BP study.
As previously described,18 from 2003 to 2005, pregnant
women attending antenatal care at Entebbe Hospital and
residing in the study area were enrolled and randomized to
receive single-dose praziquantel or matching placebo and
single-dose albendazole or matching placebo in a 2 x 2 fac-
torial design. Those with evidence of helminth-induced pa-
thology or history of adverse reaction to anthelminthics or
abnormal pregnancy, or who had enrolled for an earlier
pregnancy, were excluded.19
At 15 months, the resulting offspring were randomized
to receive quarterly albendazole or matching placebo up to
age 5 years.18 Demographic, socioeconomic and health in-
formation was collected prenatally (from pregnant women)
and from birth onwards from the live-born offspring.
Measurements
Birthweight was measured immediately after birth using
scales (Fazzini SRL, Vimodrone, Italy) for those delivered in
Entebbe hospital. For offspring delivered elsewhere, BW
was recorded as written on the child health card. Weight
was measured at 6 weeks and 6 months of age, using CMS
weighing equipment (model MP25: Chasmors Ltd, London,
UK) and then annually (close to the child’s birthday) using
weighing scales (Seca, Hamburg, Germany). Height was
measured as recumbent length at age 6 weeks using an ad-
justable child-length measuring board (Seca, Hamburg,
Germany), then annually (from age 1 year) using stadiome-
ters (Seca 213, Hamburg, Germany). BMI was weight in
kilograms (kg) divided by height in metres (m) squared.
Children continued under follow-up after the trial inter-
vention ended in 2011. Between 2 May 2014 and 1 June
2016, those attending their visit at ages 10 or 11 years and
not presenting with an illness were enrolled in the BP
study; 11-year-olds were excluded if they were previously
enrolled as 10-year-olds.
Trained nurses measured BP thrice 5 minutes apart, us-
ing an appropriate-sized cuff20 on the right arm supported
at the heart level, with the participant seated upright all
the way to the back of the chair, legs uncrossed and feet
flat on the floor. Automated Omron (M6, HEM-700)
machines, validated every 6 months by the Uganda
National Bureau of Standards, were used. Means of the
three systolic and diastolic BP were calculated. Blood pres-
sure percentiles were obtained using Center for Disease
Control height percentile charts and National Health and
Nutrition Examination Survey Working Group on
Children and Adolescents BP tables.20,21 Adolescents with
mean BP (systolic and/or diastolic) measurements 95th
percentile for gender, age and height on day 1 had BP
measured for up to two extra days. Those sustaining a high
BP on day 3 were referred for specialist attention. Non-
pharmacological management was recommended to
adolescents with BP (systolic and/or diastolic) 90th per-
centile for age, gender and height.
The study was approved by ethics committees of the
Uganda Virus Research Institute, the London School of
Hygiene and Tropical Medicine and the Uganda National
Council for Science and Technology. Written informed
consent and assent were obtained.
Statistical methods
Data were double-entered in Microsoft Access and analysed
using Stata 14 (College Station, TX, USA). Characteristics
of cohort members enrolled and not enrolled in the BP
study were compared using chi-square tests. The study out-
comes were systolic and diastolic BP. The mean of the
second and third day-1 BP measurements was used for
analysis, as these were on average different from and lower
than the first day-1 measurements (Supplementary Figure
1, available as Supplementary data at IJE online).
Key exposures were BW and postnatal weight gain.
Postnatal weight gain was change in weight-for-age
Z-score (WAZ) between birth and age 5 years, with shorter
growth periods (birth to 6 months, 6 to 12 months, 12 to
24 months and 24 to 60 months) also examined. The 2006
World Health Organization standard references22,23 were
used to calculate WAZ, weight-for-height Z-score (WHZ)
and BMI-for-age Z-score (BMIZ).
Potential confounders were maternal characteristics in-
cluding sociodemographic (age, education, area of residence,
socioeconomic status), BMI, pregnancy anthelminthic trial
interventions, illness and infections (hypertension, HIV,
malaria, worms), and child’s characteristics including sex,
feeding status, BMI, age, childhood anthelminthic trial inter-
vention, illness and infections (malaria, worms).
Pearson correlation coefficients between BMI at age
10–11 years and anthropometric variables (WAZ, WHZ
and BMIZ) at birth, 6 weeks, 6 months and annually from
1 to 5 years were calculated. Linear regression (fitted sepa-
rately for systolic and diastolic BP) was used to assess the
association between each key exposure and adolescent BP.
Adolescents’ age and sex were included a priori in all mod-
els. Regression models were adjusted for each potential
confounder in turn, with those causing an important
change in the effect of the exposure of interest on BP
retained in the final model. Final models with and without
current weight were fitted.
For BW, we assessed whether a linear or non-linear
(categorical or quadratic) relationship provided a better fit
to the data. Likelihood ratio test (LRT) was used to
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examine for effect modification by gender, original trial
interventions and birth season. Since the timing of wet sea-
sons in this setting is subject to variability, birth months
were categorized as either dry or wet depending on
whether the total monthly rainfall was below or above the
median rainfall for all birth months.
For weight gain, as well as for those confounders identi-
fied in the BW exposure analysis, the effect of each growth
period was adjusted for earlier postnatal weight gain peri-
od(s) and feeding status at 6 weeks. Effect modification by
gender or BW (<2.5 kg versus 2.5 kg) was assessed using
LRT.
Sensitivity analysis assessing the impact of missing val-
ues for the main exposures was conducted: missing BW
values were replaced with the minimum (1.26 kg) and the
maximum (5.50 kg) non-missing value of BW recorded,
and final models re-run for both scenarios. Similarly, miss-
ing values for WAZ change were replaced with the small-
est and largest change in WAZ for the given growth
period.
Results
Of the 2345 adolescents born into the cohort, 107 (4.6%)
had died and 1119 (47.7%) were enrolled. Of those en-
rolled, 583 (52.1%) were males, 1100 (98.3%) were sin-
gletons, 65 (7.0%) had BW<2.5 kg, 824 (73.7%) were
delivered and weighed in Entebbe hospital, 651 (58.2%)
were delivered in the dry season and 36 (2.9%)
were HIV-positive (Supplementary Table 1, available as
Supplementary data at IJE online).
Participants and non-participants in the BP study were
similar for most characteristics (Supplementary Table 1,
available as Supplementary data at IJE online), with the
exceptions that enrolled adolescents were less likely to be
HIV positive (P-value ¼ 0.049) but more likely to be sin-
gletons (P-value ¼ 0.048), and born to more educated
(P-value<0.001) and married/cohabiting mothers (P-val-
ue ¼ 0.001), who were less likely to have had hookworm
infections (P-value ¼ 0.002) at enrolment.
Participants’ median age was 10.2 years [interquartile
range (IQR): 10.0 to 10.9], mean BW was 3.2 kg [standard
deviation (SD) 0.5], mean systolic BP was 105.9 mmHg
(SD 8.2; range: 74.5–142 mmHg) and mean diastolic BP
was 65.2 mmHg (SD 7.3;range: 44-96.5 mmHg). On day
1, 117 (10.5%) had pre-hypertension (mean systolic and/
or diastolic BP 90th but<95th percentile for gender, age
and height), and 94 (8.4%) had hypertension (mean sys-
tolic and/or diastolic BP 95th percentile for gender, age
and height) of whom 76 (80.9%) had stage one and 18
(19.1%) had stage two hypertension. Of those due for a
day-2 BP assessment, 72 (76.6%) returned; of these 23
(31.9%) had pre-hypertension and 24 (33.0%) had hyper-
tension. Finally, 18 (75.0%) of those due for a day-3 BP
measurement returned, among whom six (33.3%) had pre-
hypertension and seven (38.9%) had hypertension.
Allowing for loss to follow-up between days 1 to 3, the es-
timated hypertension prevalence was 1.1%.
Relationships between anthropometric variables in
childhood and BMI at 10–11 years are shown in Figure 1.
Correlations between anthropometric variables in child-
hood and BMI at 10–11 years increased dramatically be-
tween birth and 1 year of age, before continuing to
increase more gradually. For example, the correlation be-
tween WAZ up to and including 6 weeks of age and BMI
at age 10–11 years was weak (r< 0.3); the correlation be-
tween WAZ at age 0.5–4 years and BMI at age 10–11 years
was moderate (0.3 r<0.5); and the correlation between
WAZ at age 5 years and BMI at age 10–11 years was
strong (r0.5).
Effect of birthweight on blood pressure
Crudely, there was a slight suggestion of a U- or J-shaped
relationship between BW and BP (Figure 2). Compared
with those with BW 3.00–3.49 kg, the difference in
adjusted mean systolic BP wasþ0.30 mmHg, 95% CI
(1.87,þ2.47), 0.07 mmHg, 95% CI (1.50,þ1.35)
andþ0.78 mmHg, 95% CI (0.56,þ2.11) among those
with BW<2.5 kg, 2.5–2.99 kg and 3.5 kg, respectively
(Supplementary Table 3, available as Supplementary data
at IJE online). However, confidence intervals were wide
and treating BW as a categorical variable in the regression
model did not improve the fit of the model to the data
compared with a linear model (P-values for departure from
Figure 1. Relationship between anthropometric parameters in child-
hood and body mass index at the time of blood pressure measurement
(10–11 years of age) in adolescents from the Entebbe Mother and Baby
Study cohort.
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linearity 0.253 and 0.404 for systolic and diastolic BP, re-
spectively). Regardless of whether or not BW was modelled
as categorical or linear, there was no evidence for associa-
tion between BW and BP; for example, linear model regres-
sion coefficients were b ¼ 0.14, 95% CI (-1.00, 1.27) for
systolic and b ¼ 0.43, 95% CI (-0.57, 1.43) for diastolic
BP (Table 1).
The effect of BW on systolic BP did not differ by sex
(interaction P-value ¼ 0.464), birth season (interaction
P-value ¼ 0.515) or maternal deworming drugs (prazi-
quantel interaction P-value ¼ 0.230, albendazole interac-
tion P-value ¼ 0.594). Likewise, the effect of BW on
diastolic BP did not differ by season of birth, child’s sex or
maternal anthelminthic treatment(s). Additionally, adjust-
ing for current weight, the regression coefficients for the ef-
fect of BW on systolic BP were -0.91 mmHg, 95% CI (-
1.99, 0.18) and -0.35, 95% CI (-1.32, 0.61) for systolic
and diastolic BP, respectively. Results from sensitivity anal-
yses were consistent with the main findings
(Supplementary Table 2, available as Supplementary data
at IJE online); for example, the effect of BW on systolic BP
varied from a 0.04-mmHg reduction to a 0.07-mmHg in-
crease in systolic BP (compared with the main analysis b
point estimate: 0.14 mmHg).
Effect of weight gain on blood pressure
[b ¼ 1.71, 95% CI (1.23, 2.20)] and 5 years [b ¼ 2.27,
95% CI (1.72, 2.81)]. A similar trend was observed for di-
astolic BP.
Rapid weight gain between birth and age 5 years was
associated with increased BP. Respectively, systolic and di-
astolic BP increased by 1.17 mmHg and 1.03 mmHg per
unit increase in WAZ between birth and 5 years of age
(Figure 3). This relationship did not differ by sex or BW
(Table 3).
Rapid weight gain during each growth period up to 2
years was independently associated with increased systolic
BP, after adjusting for weight gain in the preceding periods.
For example, systolic BP increased by 0.77 mmHg, 95% CI
(0.26, 1.27) per unit increase in WAZ between birth and
age 6 months, by 1.07, 95% CI (0.16, 1.98) between
6 months and 1 year, adjusting for change in WAZ be-
tween birth and 6 months, and by 1.21, 95% CI (0.22,
2.20) between 1 and 2 years, adjusting for change in WAZ
between birth and 6 months and between 6 months and 1
year (Table 2). Between 2 and 5 years of age, there were no
additional effects of increased WAZ on systolic BP among
adolescents. For diastolic blood pressure, only rapid weight
gain in the first 6 months of life was associated with BP in
early adolescence (Table 2).
The effect of accelerated weight gain to age 6 months
on systolic BP was stronger among adolescents who were
small at birth: b ¼ 2.64, 95% CI (0.91, 4.37) for
BW< 2.5 kg and b ¼ 0.58, 95% CI (0.01, 1.14) for
BW2.5 kg (interaction P-value 0.024; Table 3). There
was no evidence of effect modification by sex. Results
from sensitivity analyses were generally consistent with
Figure 2. Crude relationship between birthweight and blood pressure among 10- and 11-year olds in the Entebbe Mother and Baby Study.
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Crudely, systolic BP was not associated with WAZ at birth 
[b ¼ 0.34, 95% CI (-0.16, 0.83)] but was strongly associ- 
ated with WAZ at 6 months [b ¼ 1.14, 95% CI (0.66, 
1.61)], 1 year [b ¼ 1.46, 95% CI (1.02, 1.91)] 2 years
120
those from the main analysis (Supplementary Table 4,
available as Supplementary data at IJE online).
Discussion
For the first time in mainland East Africa, we described the
relationship between BW, postnatal weight gain and BP in
adolescents. Birthweight was not associated with BP
among early adolescents, but accelerated postnatal weight
gain, particularly in the first 2 years of life, was associated
with systolic BP, with strongest effects among those born
small.
Studies among children and adults have often reported
inverse associations between BW and BP, whereas those
among adolescents have been inconsistent.24,25 We found
no evidence of association, although the relationship be-
tween BW and later BP became more inverse on adjusting
for current weight, according with previous studies.26,27
We reported results adjusted for current weight, to enable
comparison with earlier studies that have done so, al-
though current weight could be considered a mediator
rather than a confounder.
Studies from Africa have mainly shown no associations
between BW and BP among adolescents (reviewed in Lule
et al.13) Exceptions to this were inverse associations ob-
served among adolescents from Kinshasa, and among boys
but not girls from Soweto.28,29 In our study child’s sex,
worm treatment in pregnancy, or season of birth did not
modify the effect of BW on later BP. As hypothesized, accel-
erated postnatal weight gain was associated with high BP,
with the strongest effects among those born small. This sug-
gests that LBW babies may well be at increased risk of later
high BP in this setting, not because of being LBW, but be-
cause they are more likely to have rapid early weight gain.
Table 1. Crude and adjusted effect of birth weight on blood pressure among Entebbe Mother and Baby Study adolescents
Blood pressure Number Mean birth
weight (Kg)
Mean BP
(mmHg)
Crude association Adjusted association
b (95% CI) b (95% CI) b (95% CI)c
Systolic BP 1119 3.19 105.87 0.73 (0.33, 1.80) 0.14 (1.00, 1.27)a 0.91 (1.99, 0.18)
Diastolic BP 1119 3.19 65.20 0.66 (0.27, 1.59) 0.43 (0.57, 1.43)b 0.35 (1.32, 0.61)
b; linear regression coefficient: mean difference in blood pressure measured in mmHg per 1 kg increase in birth weight, CI: confidence interval.
aAdjusted for maternal factors at enrolment (age, household socioeconomic status, body mass index, asymptomatic malaria, education, parity) and child fac-
tors (sex, age, family history of blood pressure).
bAdjusted for maternal factors at enrolment (age, household socioeconomic status, body mass index, asymptomatic malaria, education, parity) and child fac-
tors (sex, age, asymptomatic malaria, family history of blood pressure).
cAdditionally adjusted for current weight.
Figure 3. The effect of postnatal weight gain on adolescents’ blood pressure in the Entebbe Mother and Baby Study.
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Table 3. Effect of postnatal weight gain on blood pressure stratified by birth size and sex among adolescents in the Entebbe
Mother and Baby Study
Postnatal growth period Birthweight <2.5 kg (n 5 65) Birthweight 2.5 kg (n 5 867) Interaction P-value
Adj. b (95% CI) Adj. b (95% CI)
Systolic blood pressurea
D WAZ birth-0.5 year 2.64 (0.91, 4.37) 0.58 (0.01, 1.14) 0.024
D WAZ 0.5-1 year 0.13 (3.44, 3.19) 1.18 (0.23, 2.13) 0.448
D WAZ 1-2 years 2.20 (0.80, 4.20) 1.16 (0.10, 2.20) 0.504
D WAZ 2-5 years 1.00 (4.182.18) 0.26 (0.61, 1.13) 0.444
D WAZ birth-5 years 2.41 (0.52, 4.30) 1.30 (0.74, 1.87) 0.268
Diastolic blood pressureb
D WAZ birth-0.5 year 1.99 (0.49, 3.48) 0.96 (0.47, 1.46) 0.139
D WAZ 0.5-1 year 0.25 (3.14, 2.65) 0.85 (0.02, 1.68) 0.168
D WAZ 1-2 years 0.05 (2.63, 2.72) 0.82 (0.12, 1.76) 0.121
D WAZ 2-5 years 0.79 (2.08, 3.66) 0.40 (0.39, 1.18) 0.793
D WAZ birth-5 years 2.08 (0.38, 3.77) 1.20 (0.69, 1.71) 0.323
Males (n 5 583) Females (n 5 536) P-value
Adj. b (95% CI) Adj. b (95% CI)
Systolic blood pressurea
D WAZ birth-0.5 year 1.19 (0.50, 1.89) 0.27 (0.47, 1.01) 0.069
D WAZ 0.5-1 year 0.47 (0.80, 1.74) 1.65 (0.41, 2.89) 0.177
D WAZ 1-2 years 1.02 (0.23, 2.28) 1.47 (0.02, 2.92) 0.626
D WAZ 2-5 years 0.03 (1.19, 1.13) 0.40 (0.81, 1.62) 0.612
D WAZ birth-5 years 1.46 (0.80, 2.13) 1.30 (0.51, 2.10) 0.743
Diastolic blood pressureb
D WAZ birth-0.5 year 1.27 (0.67, 1.88) 0.57 (0.08, 1.23) 0.116
D WAZ 0.5-1 year 0.41 (0.70, 1.51) 0.95 (0.15, 2.04) 0.479
D WAZ 1-2 years 0.83 (0.28, 1.95) 0.20 (1.09, 1.49) 0.437
D WAZ 2-5 years 0.03 (1.01, 0.94) 0.54 (0.48, 1.55) 0.424
D WAZ birth-5 years 1.103 (0.59, 1.47) 0.83 (0.16, 1.50) 0.438
D WAZ: change in weight-for-age-Z score. b: linear regression coefficient: mean difference in blood pressure measured in mmHg per 1 unit increase in DWAZ
in the specified time interval.
aEach growth period was adjusted for the earlier postnatal growth period, maternal factors at enrolment (age, household socioeconomic status, body mass in-
dex, asymptomatic malaria, education, parity) and child’s factors (sex, age, feeding status at 6 weeks, family history of blood pressure).
bEach growth period was adjusted for the earlier postnatal growth period, maternal factors at enrolment (age, household socioeconomic status, body mass in-
dex, asymptomatic malaria, education, parity) and child’s factors (sex, age, feeding status at 6 weeks, asymptomatic malaria, family history of blood pressure).
Table 2. The association between postnatal weight gain and blood pressure among 10- and 11-year-old adolescents in the
Entebbe Mother and Baby Study
Postnatal growth Number Crude b (95% CI) Adjusted b (95% CI)
Systolic blood pressure
D WAZ birth-0.5 year 705 0.71 (0.21, 1.21) 0.77 (0.26, 1.27)a
D WAZ 0.5-1 year 733 0.76 (0.04, 1.56) 1.07 (0.16, 1.98)a
D WAZ 1-2 years 793 0.06 (0.69, 0.82) 1.21 (0.22, 2.20)a
D WAZ 2-5 years 802 0.20 (0.54, 0.94) 0.13 (0.89, 0.64)a
D WAZ Birth-5 years 829 1.17 (0.70, 1.64) 1.17 (0.69, 1.66)a
Diastolic blood pressure
D WAZ birth-0.5 year 705 0.88 (0.45, 1.31) 0.95 (0.50, 1.40)b
D WAZ 0.5-1 year 733 0.45 (0.25, 1.15) 0.68 (0.12, 1.47)b
D WAZ 1-2 years 793 0.39 (-1.06, 0.27) 0.57 (0.32, 1.45)b
D WAZ 2-5 years 802 0.48 (0.18, 1.15) 0.24 (0.46, 0.94)b
D WAZ birth-5 years 829 1.01 (0.59, 1.42) 1.03 (0.59, 1.47)b
D WAZ: change in weight-for-age-Z score. b: linear regression coefficient: mean difference in blood pressure measured in mmHg per 1 unit increase in DWAZ
in the specified time interval.
aAdjusted for any earlier postnatal growth period(s), maternal factors at enrolment (age, household socioeconomic status, body mass index, asymptomatic ma-
laria, education, parity) and child factors (sex, age, feeding status at 6 weeks, family history of blood pressure).
bAdjusted for the earlier postnatal growth period, maternal factors at enrolment (age, household socioeconomic status, body mass index, asymptomatic ma-
laria, education, parity) and child factors (sex, age, feeding status at 6 weeks, asymptomatic malaria, family history of blood pressure).
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Consistent with literature from high-income countries,2,25,30
there was a positive association between rapid weight gain
and adolescent BP. Few studies from low-middle-income
countries have examined the impact of rapid weight gain
on later BP. Notably in Seychelles, rapid weight gain was
associated with BP in children and adolescents although,
contrary to our findings, later rapid weight gain was more
strongly associated with later BP than was rapid weight
gain in infancy.31 Our observation that individuals who
were small in early life and experienced accelerated postna-
tal weight had higher levels of BP accords with findings
among Senegalese adults32 but differs from results in
Chinese children aged 3–6 years.33
Findings relating to diastolic BP were consistent with
those for systolic BP; thus fetal growth and postnatal
growth have similar influences on both systolic and dia-
stolic BP, except that accelerated weight gain up to 2 years
of age was associated with systolic BP whereas the effect of
rapid weight gain on diastolic BP occurred during the first
6 months.
Strengths of this study included the availability of well-
documented prospectively collected data on important
covariates including BW, minimizing recall and reporter
bias. Exposures and confounders were determined before
the BP study was conceptualized and designed. Robust
methods were used to measure BP.
Potential limitations include residual confounding from
unmeasured confounders, and selection bias resulting from
exclusion of pregnancies considered to be abnormal by the
midwife (most likely to result in LBW), thus potentially
resulting in an underestimation of LBW prevalence or its
impact on later BP. Data on prematurity and SGA were
not collected, and therefore we were unable to determine
the independent effect of each on later BP. Although 187
(16.7%) adolescents were missing BW data, results from
sensitivity analyses were similar to the main analysis
findings.
Whereas 52% of the adolescents born into this cohort
were not enrolled in the BP study, cohort loss to follow-up
was below 60%, a level considered to introduce bias if
data were missing completely at random or missing at ran-
dom.34 After excluding those who had died by the time of
this study, the proportion included in the study was 50%,
higher than anticipated (10% loss to follow-up per year
was expected).18 Furthermore, there were no major differ-
ences between cohort members enrolled and not enrolled
in the BP study. Our findings are generalizable to this co-
hort but may not be generalizable to the wider population.
Our previous work has suggested that cohort members
may, on average, be of somewhat higher socioeconomic
status than community residents35 and, as a consequence
of study participation, they have received free medical care
so their health outcomes may be better than in the general
population.
Strategies in childhood that prevent excessive weight
gain, especially among infants born small, could be impor-
tant in preventing later high BP. Disease prevention strate-
gies should enhance optimal growth through good
maternal and infant nutrition to reduce both LBW and
rapid weight gain in early childhood. Future research
should seek to evaluate the impact of catch-up nutritional
programmes in malnourished infants or infants born small
on BP later in life.
In summary, ‘nutritional mismatch’ in early life is criti-
cal in the developmental programming of BP among ado-
lescents in developing countries. Strategies that prevent
LBW and excessive weight gain in early childhood or re-
verse their effects on BP could prevent high BP and diseases
attributable to high BP.
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5.5 Supplementary figures 
 
Figure S1: Means and their 95% confidence intervals for the three day-one BP 
measurements 
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Table S1: Characteristics of the Entebbe Mother and Baby Study participants enrolled and 
not enrolled into the blood pressure study (N=2345) 
Mothers’ characteristics 
during pregnancy 
Participated (n=1119) Did not participate (n=1226) 
Number Percentage/Mean (SD) Number Percentage/Mean (SD) 
 Age (years)* 1119 24.4 (5.5) 1226 23.1 (5.1) 
 Parity (number of children) * 1119 3.0 (1.8) 1226 2.7 (1.7) 
 Body mass index* 1110 24.1 (3.4) 1208 24.0 (3.1) 
 Household SES 1104 3.8 (1.2) 1197 3.5 (1.2) 
 Education level     
  None 28 2.5 58  4.7 
  Primary 542 48.5 650 53.1 
  Senior 438 39.2 433 35.4 
  Tertiary 109 9.8 83 6.8 
 Marital status     
  Single 116  10.4 191 15.6 
  Married/cohabiting 967 86.5 999 81.5 
  Separated/widowed 35 3.1 36  2.9 
 Area or residence     
  Urban 770 69.6 831 68.9 
  Rural 336 30.4 376 31.2 
 Infections     
  Asymptomatic malaria 109 9.9 139 11.6 
  Schistosomiasis 204 18.4 217 17.7 
  Hookworm 450 40.5 575 47.0 
  Ascaris 28 2.5 26 2.1 
  Trichuris  97 8.7 109 8.9 
  Trichostrongylus 11 1.0 11 0.8 
 Trial intervention 1     
  Placebo 566 50.6 609 49.7 
  Albendazole 553 49.4 617 50.3 
 Trial intervention 2     
  Placebo 564 50.4 611 49.8 
  Praziquantel 555 49.6 615 50.2 
Participants’ characteristics     
 Birthweight (Kg)* 932 3.2 (0.5) 964 3.1 (0.5) 
 Sex     
  Males 583 52.1 628 51.3 
 Birth type     
  Singleton 1100 98.3 1190 97.1 
  Multiple 19  1.7 36 2.9 
 Feeding at 6 weeks of age     
  Exclusive Breastfeeding 748 67.6 724 65.3 
  Mixed feeding 344 31.1 377 34.0 
  Weaned 14 1.3 7 0.6 
 HIV status     
  Unexposed  1001 89.5 1064 86.8 
  Exposed not infected 100 8.9 126 10.3 
  Infected 18 1.6 36 2.9 
 Birth season     
  Wet 651 58.2 683 55.9 
  Dry 468 41.8 539 44.1 
 Place of birth     
  Entebbe Hospital 824 73.7 856 70.3 
  Home 120 10.7 144 11.8 
  Others 174 15.6 218 17.9 
 Mode of delivery     
  Normal 1005 90.0 1111 91.1 
  Caesarean section 103 9.2 94 7.7 
  Instrumentation 9 0.8 15 1.2 
 Trial intervention 3     
  Placebo  553 50.0 453 49.8 
  Albendazole 554 50.1 456 50.2 
 5.6  tables Supplementary   
126
* Mean value with standard deviation (SD) presented 
Percentages may total to ± 100 due to rounding 
Household socioeconomic status (SES) was a composite variable and could take values 1 (low) to 6 (high) 
Missing data for (a) mother’s characteristics: body mass index 27; education 4; household SES 44; marital status 
1; place of residence 32; asymptomatic malaria 43; schistosomiasis 9; hookworm 9; ascaris 9; trichuris 9; 
trichostrongylus 9; (b) child’s characteristics: sex 2; birth weight 449; feeding status 131; birth season 4; place of 
delivery 9; mode of delivery 8; trial intervention 329. 
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Table S4 Sensitivity analysis of the association between postnatal weight gain and blood 
pressure among 10 and 11-year-old adolescents in the Entebbe Mother and Baby 
Study  
Lowest change in weight 
Postnatal growth Numbers Crude b (95% CI) P-value Adjusted b (95% CI) P-value 
a) Systolic blood pressure    
 D WAZ Birth-0.5 years 1119 0.33 (0.11, 0.55) 0.004 0.29 (0.04, 0.54)1 0.024 
 D WAZ 0.5-1 year 1119 0.46 (0.14, 0.78) 0.005 0.39 (-0.17, 0.95)1 0.172 
 D WAZ 1-2 years 1119 0.08 (-0.24, 0.40) 0.622 0.12 (-0.45, 0.69)1 0.679 
 D WAZ 2-5 years 1119 -0.11 (-0.42, 0.21) 0.506 -0.17 (-0.49, 0.15)1 0.300 
 D WAZ Birth-5 years 1119 0.26 (0.03, 0.50) 0.030 0.32 (0.05, 0.59)1 0.019 
b) Diastolic blood pressure   
 D WAZ Birth-0.5 years 1119 0.38 (0.19, 0.57) <0.001 0.47 (0.25, 0.69)2 <0.001 
 D WAZ 0.5-1 year 1119 0.44 (0.16, 0.72) 0.002 0.33 (-0.16, 0.82)2 0.184 
 D WAZ 1-2 years 1119 0.01 (-0.28, 0.29) 0.968 -0.09 (-0.56, 0.43)2 0.787 
 D WAZ 2-5 years 1119 -0.03 (-0.31, 0.24) 0.808 -0.07 (-0.35, 0.22)2 0.641 
 D WAZ Birth- 5 years 1119 0.27 (0.06, 0.48) 0.011 0.40 (0.16, 0.64)2 0.001 
Highest change in weight 
a) Systolic blood pressure      
 D WAZ Birth-0.5 years 1119 0.29 (0.09, 0.49) 0.005 0.25 (0.02, 0.48)1 0.032 
 D WAZ 0.5-1 year 1119 -0.17 (-0.36, 0.03) 0.093 0.20 (-0.18, 0.57)1 0.300 
 D WAZ 1-2 years 1119 -0.05 (-0.33, 0.22) 0.711 0.58 (0.09, 1.07)1 0.020 
 D WAZ 2-5 years 1119 0.16 (-0.12, 0.44) 0.267 0.12 (-0.17, 0.41)1 0.410 
 D WAZ Birth -5 years 1119 0.26 (0.05, 0.48) 0.018 0.33 (0.08, 0.58)1 0.010 
b) Diastolic blood pressure     
 D WAZ Birth-0.5 years 1119 -0.05 (-0.26, 0.15) 0.607 0.08 (-0.16, 0.32)2 0.499 
 D WAZ 0.5-1 year 1119 -0.20 (-0.38, -0.03) 0.019 0.04 (-0.28, 0.37)2 0.791 
 D WAZ 1-2 years 1119 -0.12 (-0.37, 0.12) 0.322 0.36 (-0.07, 0.79)2 0.099 
 D WAZ 2-5 years 1119 0.18 (-0.07, 0.43) 0.158 0.16 (-0.10, 0.41)2 0.232 
 D WAZ Birth-5 years 1119 0.19 (-0.01, 0.38) 0.058 0.18 (-0.05, 0.40)2 0.126 
D WAZ; change in weight-for-age-Z scores, b; linear regression coefficient: mean difference in blood pressure 
measured in mmHg per 1 unit increase in DWAZ 
1 Each growth period was adjusted for the earlier postnatal growth period, maternal factors at enrolment (age, 
household socioeconomic status, body mass index, asymptomatic malaria, education, parity) and child’s factors 
(sex, age, feeding status at six weeks, family history of blood pressure) 
2 Each growth period was adjusted for the earlier postnatal growth period, maternal factors at enrolment (age, 
household socioeconomic status, body mass index, asymptomatic malaria, education, parity) and child’s factors 
(sex, age, feeding status at six weeks, asymptomatic malaria, family history of blood pressure) 
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 5.7    Supplementary tables (unpublished data) 
 
Table S5:  Correlation between early life (infancy or childhood) anthropometric 
parameters Z-scores and adolescents’ anthropometric parameters Z-scores 
in the Entebbe Mother and Baby Study 
 Current Weight Current height Current waist 
circumference 
Age Pearson correlation Pearson correlation Pearson correlation 
At birth    
 Weight 0.2410 0.1877 0.1747 
Six weeks    
 Weight  0.2103 0.1591 0.1820 
 Height/length  0.1011 0.1323 0.0843 
Ten weeks    
 Weight 0.2474 0.2026 0.2199 
Six months     
 Weight  0.4266 0.3418 0.3395 
Nine months    
 Weight 0.4544 0.3641 0.3523 
One year     
 Weight  0.5056 0.4345 0.4060 
 Height  0.3923 0.5059 0.2631 
Two years    
 Weight  0.5753 0.4879  0.4754 
 Height  0.4826 0.6387 0.3228 
Three years    
 Weight  0.5992 0.5042 0.4747 
 Height  0.5327 0.6779 0.3703 
Four years    
 Weight  0.6437 0.5354 0.5164 
 Height  0.5127 0.6705 0.3586 
Five years    
 Weight  0.6980 0.5812 0.5488 
 Height  0.5091 0.6779 0.3463 
Six years    
 Weight  0.7386 0.6120 0.5574 
 Height  0.6194 0.7633 0.4028 
Seven years    
 Weight  0.7470 0.6001 0.5937 
 Height  0.4299 0.5601 0.2777 
Eight years    
 Weight  0.7584 0.6181 0.6030 
 Height  0.5073 0.6991 0.3013 
Nine years    
 Weight  0.8177 0.6155 0.6664 
 Height  0.5689 0.7583 0.3614 
Current     
 Weight  - 0.7281 0.7331 
 Height  0.728 - 0.446 
 Waist  0.733 0.446 - 
Current refers to age at blood pressure measurement (10 or 11 years) 
Strong (r ³0.5) or moderate (0.3£ r >0.5) correlations 
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5.8 Testing assumptions underlying linear regression analysis 
Inference from linear regression analyses are contingent on certain assumptions being 
correct. Assumptions underlying linear regression are: 
1. A linear relationship between the dependent variable (systolic or diastolic BP) and 
the main predictor variable (birth weight) 
2. Observations are independent 
3. Homoscedasticity: the true residual variance is constant 
4. The true residuals are normally distributed 
It is not common for all the assumptions underlying linear regression to hold. Departures 
from assumptions are less important for large datasets than for small ones. Graphical 
methods were used to investigate the assumptions underlying linear regression for the 
effect of birth weight on BP. 
5.8.1 Scatter plots of blood pressure (dependent variable) against birth weight 
(predictor variable) 
Figure 5.8-1 shows scatter plots of systolic and diastolic BP against birth weight, the plot 
is important for identifying heteroscedasticity, non-linearity and outliers. 
 
Figure 5.8-1: Relationship between blood pressure and birth weight 
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These plots show little suggestion of a non-linear relationship (assumption 1) for either 
systolic or diastolic BP. Both systolic and diastolic BP increase per unit increase in birth 
weight. The plots show that the scatters are consistent along the regression lines, evenly 
distributed and there are no obvious outliers. 
To further investigate assumption 1, I examined whether a quadratic relationship might 
better explain any association between BP and birth weight than a linear relationship. 
Quadratic and linear relationships were fitted on the same plot. Fgure 5.8-2 shows results 
from both modelling approaches for systolic and for diastolic BP. The quadratic 
regression model describes a non-linear relationship between systolic or diastolic BP (Y 
variable) and birth weight (X variable). There was little evidence for a quadratic 
relationship between systolic BP and birth weight (p-value=0.779) and little evidence for 
a quadratic relationship between diastolic BP and birth weight (p-value=0.726). The data 
were consistent with a linear relationship between birth weight and BP (p-values for 
departure from linearity were 0.253 and 0.404 for systolic and diastolic BP respectively). 
s 
Figure 5.8-2: Fitting both linear and quadratic relationships between blood pressure and 
birth weight 
Assumption 2, “observations are independent” could not be tested graphically and there 
is no reason to think that the observations might not be independent. 
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5.8.2 Plots of residuals against birth weight (predictor) variables and against fitted 
values 
Linear regression assumptions hold when the true residuals are normally distributed with 
constant variance (assumption 3). Figure 5.8-3 and Figure 5.8-4 show that the points are 
equally distributed above and below zero on the Y axis for both systolic and diastolic BP. 
The variance of residuals is constant across y and x. The distribution of residuals for 
systolic and diastolic BP are normally distributed. Figure 5.8-4 shows residuals plotted 
against fitted values in Figure 5.8-3 
 
Figure 5.8-3: Scatter of standardized residuals versus fitted values 
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Figure 5.8-4: Scatter of residuals versus fitted values 
5.8.3 Normal plot of residuals 
 
Figure 5.8-5: Histogram of blood pressure residuals 
Figure 5.8-5 shows that the residuals come from a normal distribution and are 
independent from each other (assumption 4)
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Chapter 6: Other environmental factors associated with blood 
pressure among Ugandan adolescents 
6.1 Introduction 
This chapter uses phenotypic data from the EMaBS birth cohort to answer thesis objective 
4 which aims to identify other factors associated with BP among Ugandan adolescents. 
6.2 Research paper 3: Blood pressure risk factors in early adolescents: Results 
from a Ugandan birth cohort 
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Abstract 
We aimed to investigate life-course factors associated with blood pressure (BP) among 
Ugandan adolescents. Between 9th April 2003 and 24th November 2005, 2,507 pregnant 
women from Entebbe municipality and Katabi sub-county were enrolled into a 
deworming trial. The resulting 2,345 live born offspring were followed to age 10 or 11 
years, when between 20th May 2014 to 16th June 2016, BP was measured following 
standard protocols. Factors associated with BP were assessed using multivariable linear 
regression. BP was measured in 1,119 adolescents with a median age of 10.2 years. Mean 
systolic BP and diastolic BP was 105.9 mmHg (standard deviation (SD) 8.2) and 65.2 
mmHg (SD 7.3), respectively. Maternal gestational body mass index (BMI), higher 
maternal education status and family history of hypertension were positively associated 
with adolescent BP. Childhood (age ≤5 years) malaria was associated with lower 
adolescent systolic BP. Factors measured at time of BP measurement positively 
associated with systolic BP were age, BMI, waist circumference and Trichuris 
(whipworm) infection; higher vegetable consumption was associated with lower systolic 
BP. Results for diastolic BP were similar, except higher fruit, rather than higher vegetable 
consumption was associated with lower diastolic BP and there was no association with 
waist circumference or Trichuris infection. In summary, life-course exposures were 
associated with adolescent BP in this tropical birth cohort. Malaria early in life could 
impact later BP. Interventions initiated early in life targeting individuals with family 
history of hypertension, aiming to reduce adiposity (in pregnancy and adolescence) and 
promoting fruit and vegetable consumption might contribute to reducing the risk of high 
BP and subsequent CVDs. 
Keywords: blood pressure, risk factors, adolescents, birth cohort, Uganda 
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Summary 
What is known about the topic? 
• High blood pressure and cardiovascular diseases (CVDs) are increasing in Africa. 
• Scarcity of data on BP risk factors among African children and adolescents. 
• The risk factors for high BP may differ from those seen in high-income non-tropical 
settings. 
What this paper adds? 
• Malaria infection in childhood is associated with reduced blood pressure among 
adolescents. Effects of childhood malaria on later blood pressure may be partially 
mediated through chronic reduction in weight and height. 
• Current infection with Trichuris is associated with increased blood pressure. 
• Interventions during pregnancy, childhood and early adolescence could be vital in the 
prevention of high BP later in life. 
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Introduction 
Once uncommon in Africa [1], high blood pressure (BP) and cardiovascular diseases 
(CVDs) have escalated on the continent over the last three  decades [2], affecting 
populations at younger ages than in more affluent countries [3], The rising burden of high 
BP in Africa has been attributed to a transition from active to more sedentary lifestyles 
and a rise in unhealthy dietary practices [2]. Data on individual level BP risk factors in 
African adolescents and children is sparse. 
Although high BP is less common in children and adolescents than in adults, it initiates 
early in life, persists into adulthood [4] and predicts adulthood hypertension [5]. 
Diagnosis of CVDs is uncommon until middle-age, yet its antecedents, mainly 
cardiovascular and metabolic changes, begin early in life [6]. Globally, the high BP 
burden in younger age groups has risen [7], with estimated prevalence of 1-25% among 
African children and adolescents [8]. 
Severe persistent high BP is associated with increased risk of stroke and heart failure [9]; 
treatment reduces long-term sequelae [9]. In children and adolescents, high BP is often 
asymptomatic and unnoticed, despite international recommendations for regular BP 
measurement from three years of age [10]. Hypertension diagnosis is commonly missed 
or inaccurately classified in children and adolescents [11]. Consequently, over 75% of 
high BP among children and adolescents remains undiagnosed worldwide [12]. 
Earlier studies, mainly in adults, have demonstrated the role of established risk factors for 
high BP such as obesity [13] and physical activity [14]. There is little literature on 
childhood and adolescent BP determinants from Africa; in particular the impact of 
childhood infections (of special importance in Africa) remains understudied and 
unknown. 
Childhood and adolescence are opportune periods for high BP control or prevention 
before clinical manifestation of hypertension or related CVDs. Identification of life-
course BP risk factors unique to Africa is needed for the development of appropriate BP 
control strategies. We used longitudinally collected data from the Entebbe Mother and 
Baby Study (EMaBS), a large tropical birth cohort, to describe factors associated with 
adolescent BP. 
Methods 
Study design, setting and population 
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This longitudinal observational study investigated perinatal and life-course factors 
associated with BP among adolescents born in Wakiso district, Uganda. The EMaBS was 
a randomised double-blind placebo-controlled factorial trial [trial number; 
ISRCTN32849447], designed to investigate effects of worms and their treatment in 
pregnancy and childhood on response to childhood vaccines and on infections [15]. 
The study was conducted in Entebbe municipality and Katabi sub-county (a peninsula on 
the northern shores of Lake Victoria). In 2003-2005, 2,507 women attending Entebbe 
Hospital antenatal clinic, in their second or third trimester were invited, enrolled and 
randomised to receive albendazole (400mg) or placebo and praziquantel (40 mg/kg) or 
placebo [15]. 
Data were collected prenatally from women and resulting 2,345 live-born offspring 
followed from birth. As previously described [16], at 15 months offspring were 
randomised to receive quarterly single-dose albendazole or placebo up to age five years. 
Children continued under follow-up (seen at routine annual visits and when sick) after 
trial completion. Between 20th May 2014 and 16th June 2016, additional data, including 
BP measurements, anthropometry, puberty, physical activity and diet were collected from 
10 and 11-year-olds. Enrolment was postponed for those with malaria (fever with malaria 
parasites) or other illness until they were well after being treated by the study team. 
Adolescents participated once, on their first 10 or 11-year annual visit occurring during 
the study period.  
Study procedures 
Birth weight was measured and recorded immediately after birth in Entebbe hospital or 
from child health cards for deliveries conducted elsewhere [17]. Weight and height at 
10/11 years were measured with scales (Seca, Hamburg, Germany) and stadiometers 
(Seca 213, Hamburg Germany), respectively. Waist circumference was measured to the 
nearest 0.1cm using a Seca tape measure (Seca 201, Hamburg, Germany). BMI was 
calculated as weight in kilograms (kg) divided by height squared (m2). Trained clinicians 
examined and performed Tanner staging [18]. 
Whole-genome genotyping of 1,391 EMaBS samples was conducted at the Wellcome 
Trust Sanger Institute using Illumina HumanOmni2.5M-8 (‘octo’) Beadchip arrays, 
version 1.1 (Illumina Inc., San Diego, USA). Sickle-cell trait was imputed using a merged 
1000 Genomes and African-specific reference panel [19]. 
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For participants taking part in the BP study from the 21st January 2015 to 23rd December 
2015, extra data on fat mass (FM), fat-free mass (FFM) and total body water mass (TBW) 
was collected by trained nurses using a segmental body composition analyser machine 
(SBCAM) (TANITA BC-418, TANITA Corporation, Tokyo Japan). Briefly, participants 
stood barefooted on the posterior electrode base while holding two anterior electrodes 
handles of the SBCAM. Fat mass index=FMI (kg)/height(m2), fat-free mass index=FFMI 
(kg)/height(m2) and total body water mass index=TBWI (kg)/height(m2) were computed. 
Stool and blood samples were collected from women at enrolment and annually from 
children. Stool was examined for helminth ova and Strongyloides larvae using Kato-Katz 
[20] and charcoal culture [21] methods, respectively. Blood was examined for malaria 
parasites using Leishman’s stains [16]. Modified Knott’s method [22] was used for 
Mansonella perstans. Maternal HIV status at enrolment and children’s HIV status after 
18 months of age were assessed using a rapid serial testing algorithm described elsewhere 
[21, 23]. In infancy, HIV status was determined using polymerase chain reaction [21]. 
At the 10 or 11-year annual visit, three BP measurements (at approximately five minute 
intervals) were taken after five minutes rest using automated devices (Omron M6), with 
appropriate sized cuffs [5], by trained nurses following standard protocols described 
elsewhere [17]. 
For clinical care purposes, means of the three systolic BP and three diastolic BP 
measurements were calculated and BP percentiles determined using Centre for Disease 
Control height charts and 2004 updated National Health and Nutrition Examination 
Survey BP tables specific for sex, age and height [5, 10]. Those with mean systolic BP or 
diastolic BP ≥95th percentile (“high BP”) had their BP re-measured on up to two extra 
days, 1-2 weeks apart. “Pre-hypertension” was defined as systolic or diastolic BP ³90th 
but <95th percentile. Those with persistent high BP on three different days were referred 
for specialist attention. Lifestyle modification was recommended for participants with 
systolic or diastolic BP ³90th percentile. 
For data analysis purposes, the means of the second and third systolic / diastolic BP 
readings on day-one were used: day-one second and third BP readings were lower than 
the first BP reading but similar to each other [17]. 
Ethical approval was granted by the Uganda Virus Research Institute Science and Ethics 
Committee; the Uganda National Council for Science and Technology; and the London 
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School of Hygiene and Tropical Medicine. Written informed assent and consent were 
obtained. 
Statistical methods 
Data were collected on pre-coded questionnaires and analysed with Stata 14.2 (College 
Station, TX, USA). Chi-squared tests (for categorical variables) and t-tests (for 
continuous variables) were used to compare characteristics of cohort members who 
participated and did not participate in the BP study. 
Study outcomes were mean systolic BP and mean diastolic BP, based on the second and 
third day-one measurements. The decision was made to model these two continuous BP 
outcome variables rather than to dichotomise outcomes (for example, into normal versus 
hypertensive) since an analysis using these binary outcomes would be underpowered. 
Maternal, perinatal, and offspring life-course factors considered as exposures and 
potential confounders were: maternal and adolescent socio-demographic and 
anthropometric characteristics; EMaBS trial interventions (praziquantel or albendazole); 
sickle-cell trait; illnesses and infections from birth to time of BP measurement; and body 
composition, puberty stage, diet, sleep pattern and physical activity at time of BP 
measurement. Area of residence was grouped into urban versus rural area using zones 
based on topography and settlements generated from geographical positioning system 
data [24]. Household socioeconomic index was generated using principal components 
analysis of building materials, household size and items owned [23]. Birth season was 
dichotomised into dry (rainfall below monthly median) and wet (rainfall above monthly 
median) season. Malaria infection in childhood (age ≤5 years) was investigated as clinical 
malaria (history of fever within the last 48 hours or axillary temperature ≥37.5°C and 
parasitaemia) and asymptomatic malaria (parasitaemia without fever at any annual visit 
up to five years). Information on diet was obtained as the number of days in a typical 
week over the previous month for which a given food was consumed. Puberty was 
grouped into pre-pubertal (stage 1) or pubertal (stages 2-5) for breast or pubic hair 
development using Tanner methods [18]. 
Linear regression analysis was used. Data satisfied the assumptions for linear regression. 
Crude associations were examined for each covariate and a 20% significance level used 
for selecting covariates for multivariable models. Adolescents’ sex, age and BMI were 
confounders a priori. Multivariable analysis followed a hierarchical approach adding 
factors sequentially (Figure 6.2-1). 
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Figure 6.2-1 Conceptual framework 
Because of a large proportion of missing data, puberty and body composition variables 
were not included in model building for other exposures but their effects were each 
adjusted for variables included in the final multivariable model. Multicollinearity was 
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assessed by considering the change in standard error, when potentially multicollinear 
variables were included in the same model. 
The study was approved by the Research and Ethics Committee of the Uganda Virus 
Research Institute, the Uganda National Council for Science and Technology and the 
London School of Hygiene & Tropical Medicine. Consent and assent were obtained for 
study participation. 
Results 
Participant characteristics 
A total of 1,119 EMaBS participants were enrolled into the BP study: 583 (52%) were 
males; 1,100 (98.3%) singletons; 18 (2%) HIV positive; and 344 (31%) mixed feeding by 
six weeks. EMaBS adolescents participating in the BP study were similar to non-
participants, except that mothers of participants were more likely to be of higher 
education status or married/cohabiting; offspring were less likely to be HIV positive or 
of a multiple birth, details published earlier [17]. 
At age 10/11 (median participant age 10.2 years (interquartile range (IQR): 10.0-10.9)), 
117 (11%) were attending boarding schools, 441 (72%) were pre-pubertal stage for pubic 
hair development and 178 (65%) of girls were pre-pubertal stage for breast development. 
Mean BMI was 15.8kg/m2 (SD 1.9) and mean waist circumference 58.1cm (SD 4.9). 
Body composition data were available for 176 (16%) participants, with mean fat mass 
index 2.9kg/m2 (SD 1.2), fat-free mass index 12.8kg/m2 (SD 1.4) and total body water 
mass index 9.5kg/m2 (SD 0.9). 
Over the previous month, starchy staple foods, animal proteins, fruit, vegetables and sugar 
drinks were consumed on average for 6.9 days/week (SD 0.8), 2.2 days/week (SD 1.7), 
3.0 days/week (SD 2.2), 3.4 days/week (SD 2.3), and 1.7 days/week (SD 2.1), 
respectively. Nearly all adolescents (98%) reported adding salt to cooked food. 
Mean systolic BP was 105.9mmHg (SD 8.2) and mean diastolic BP was 65.2mmHg (SD 
7.3). There was no difference in mean systolic BP (p-value=0.971) or diastolic BP (p-
value=0.141) between males and females. None of the adolescents had had a prior BP 
measurement or high BP diagnosis. 
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Table 1: Factors investigated for association with systolic blood pressure among adolescents from the 
Entebbe Mother and Baby Study (N=1119) 
Factors Mean BP 
(SD) 
Crude  
b (95% CI) 
P-value Adjusted  
b (95% CI) 
P-
value 
Level 1: Maternal factors at enrolments     
 Age (years)  0.06 (-0.03, 0.15) 0.178 0.02 (-0.07, 0.12) 0.604 
 Household SES (n=1104)  0.23 (-0.16, 0.63) 0.245   
 Parity  0.04 (-0.23, 0.31) 0.751   
 Body mass index (n=1110)  0.27 (0.13, 0.42) <0.001 0.26 (0.11, 0.40) <0.001 
 Education status      
  None (n=28) 104.5 (8.7) -0.54 (-3.65, 2.56)  -0.62 (-3.77, 2.53)  
  Primary (n=542) 105.0 (7.7) Reference  Reference  
  Senior (n=438) 106.5 (8.2) 1.45 (0.42, 2.48)  1.43 (0.39, 2.47)  
  Tertiary (n=109) 108.2 (9.8) 3.19 (1.51, 4.87) <0.001 3.14 (1.45, 4.84) <0.001 
 Marital status      
  Single (n=116) 104.7 (7.6) -1.34 (-2.92, 0.25)    
  Married/cohabiting 
(n=967) 
106.0 (8.3) Reference    
  Separated/widowed 
(n=35) 
105.3 (6.1) -0.78 (-3.56, 1.99) 0.229   
 Area of residence      
  Urban (n=770) 106.0 (8.3) Reference    
  Rural (n=336) 105.5 (8.0) -0.47 (-1.52, 0.59) 0.386   
 Alcohol use      
  No (n=775) 105.8 (8.4) Reference    
  Yes (n=343) 106.0 (7.8) 0.15 (-0.90, 1.19) 0.781   
 Infections      
  HIV      
   Uninfected (n=1002) 106.0 (8.3) Reference  Reference  
   Infected (n=117) 104.8 (7.2) -1.17 (-2.74, 0.41) 0.146 -0.88 (-2.48, 0.72) 0.279 
  Asymptomatic malaria      
   Uninfected (n=991) 105.8 (8.2) Reference    
   Infected (n=109) 106.2 (8.6) 0.42 (-1.20, 2.05) 0.609   
  Schistosomiasis       
   Uninfected (n=908) 105.8 (8.3) Reference    
   Infected (n=204) 106.2 (7.9) 0.35 (-0.90, 1.61) 0.578   
  Hookworm        
   Uninfected (n=662) 105.8 (8.1) Reference    
   Infected (n=450) 105.9 (8.4) 0.10 (-0.89, 1.09) 0.844   
  Ascaris       
   Uninfected (n=1084) 105.9 (8.3) Reference    
   Infected (n=28) 105.7 (6.7) -0.17 (-3.27, 2.92) 0.912   
 Intervention one      
  Placebo (n=566) 105.5 (8.2) Reference  Reference  
  Albendazole (n=553) 106.2 (8.3) 0.67 (-0.29, 1.63) 0.173 0.84 (-0.12, 1.80) 0.087 
 Intervention two      
  Placebo (n=564) 106.0 (8.1) Reference    
  Praziquantel (n=555) 105.8 (8.4) -0.20 (-1.16, 0.77) 0.686   
Level 2: Factors in childhood     
 Birth weight (kg) (n=932)  0.73 (-0.33, 1.80) 0.178 0.18 (-0.93, 1.29) 0.751 
 Sex      
  Male (n=583) 105.9 (7.5) Reference  Reference  
  Female (n=536) 105.9 (9.0) -0.02 (-0.98, 0.95) 0.971 0.12 (-1.18, 0.94)  0.819 
 Sickle cell trait      
  HbAA (n=661) 106.0 (8.4) Reference    
  HbAS (n=141) 105.8 (7.9) -0.28 (-1.79, 1.23) 0.717   
 Season of birth      
  Dry (n=651) 106.1 (8.1) Reference    
  Wet (n=468) 105.5 (8.3) -0.56 (-1.54, 0.42) 0.261   
 Place of delivery      
  Entebbe Hospital (n=824) 105.8 (8.2) Reference  Reference  
  Home (n=120) 104.9 (8.6) -0.86 (-2.43, 0.71)  -0.37 (-3.71, 2.96)  
  Others (n=174) 106.8 (8.0) 0.95 (-0.39, 2.29) 0.166 0.90 (-0.87, 2.68) 0.582 
 Feeding status (6 weeks of age)     
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  Exclusively breast fed 
(n=748) 
106.1 (8.2) Reference    
  Mixed fed (n=344) 105.4 (8.4) -0.70 (-1.75, 0.35)    
  Weaned (n=14) 105.8 (7.1) -0.28 (-4.63, 4.08) 0.430   
 Intervention three      
  Placebo (n=553) 105.5 (8.4) Reference    
  Albendazole (n=554) 106.1 (8.0) 0.61 (-0.36, 1.58) 0.218   
 HIV status      
  Unexposed (n=1001) 106.0 (8.3) Reference  Reference  
  Exposed not infected 
(n=100) 
105.2 (7.3) -0.83 (-2.52, 0.86)  -0.29 (-2.15, 1.57)  
  Infected (n=18) 102.7 (6.1) -3.34 (-7.17, 0.49) 0.156 -3.85 (-7.81, 0.12) 0.157 
 Malaria infection below 5 years of age     
  Clinical or asymptomatica      
   None (n=456) 106.6 (8.0) Reference  Reference  
   Yes (n=663) 105.3 (8.3) -1.31 (-2.29, -0.33) 0.009 -1.24 (-2.32, -0.17) 0.023 
  Clinical malariaa      
   None (n=474) 106.6 (8.0) Reference  Reference  
   Yes (n=645) 105.4 (8.3) -1.19 (-2.17, -0.22) 0.016 -1.08 (-2.15, -0.02) 0.045 
  Episodes of clinical malariaa     
   None (n=474) 106.6 (8.0) Reference  Reference  
   1-2 (n=382) 105.4 (8.4) -1.13 (-2.24, -0.03)  -1.11 (-2.32, 0.11)  
   ≥ 3 (n=263) 105.3 (8.2) -1.28 (-2.52, -0.04) 0.026 [trend] -1.05 (-2.41, 0.31) 0.133 
  Asymptomatic malariaa      
   None (n=983) 106.1 (8.2) Reference  Reference  
   Yes (n=124) 103.7 (8.0) -2.41 (-3.94, -0.88) 0.002 -1.95 (-3.70, -0.20) 0.028 
  Schistosomiasis       
   Uninfected (n=1076) 105.9 (8.2) Reference    
   Infected (n=33) 104.8 (7.9) -1.09 (-3.94, 1.76) 0.452   
  Ascaris        
   Uninfected (n=1052) 105.9 (8.3) Reference    
   Infected (n=57) 105.3 (7.3) -0.62 (-2.82, 1.57) 0.576   
  Hookworm        
   Uninfected (n=1085) 105.9 (8.2) Reference    
   Infected (n=24) 103.8 (8.9) -2.06 (-5.38, 1.27) 0.225   
  Trichuris       
   Uninfected (n=997) 105.9 (8.2) Reference    
   Infected (n=112) 105.6 (8.6) -0.28 (-1.89, 1.33) 0.731   
  Microfilaria       
   Uninfected (n=1102) 105.8 (8.2) Reference    
   Infected (n=8) 109.4 (8.9) 3.58 (-2.13, 9.28) 0.219   
Level 3: Factors in adolescence     
 Age (years)  2.12 (1.17, 3.08) <0.001 1.35 (0.32, 2.39) 0.009 
 Body mass index (kg/m2)  1.27 (1.02, 1.51) <0.001 0.78 (0.42, 1.14) <0.001 
 Waist circumference  0.46 (0.36, 0.55) <0.001 0.21 (0.08, 0.35) 0.002 
 Family history      
  High blood pressure      
   No (n=1000) 105.7 (8.1) Reference  Reference  
   Yes (n=105) 107.6 (8.3) 1.88 (0.24, 3.52) 0.025 1.84 (0.12, 3.56) 0.034 
  Diabetes      
   No (n=927) 105.8 (8.0) Reference    
   Yes (n=186) 106.4 (9.2) 0.69 (-0.61, 1.99) 0.296   
 Body composition analysis c      
  Fat mass indexb (kg/m2) (n=176) 3.27 (2.29, 4.24) <0.001 1.50 (-0.38, 3.38) 0.089 
  Fat free mass indexb (kg/m2) (n=176) 1.54 (0.65, 2.43) 0.001 -0.86 (-2.25, 0.54) 0.188 
  Total body water indexb (kg/m2) (n=176) 4.20 (2.97, 5.42) <0.001 2.51 (-0.24, 5.27) 0.052 
 Adding salt to food      
  No (n=20) 106.2 (7.3) 0.36 (-3.28, 4.00)    
  Yes (n=1086) 105.9 (8.2) Reference 0.846   
 Days a fruit is eaten/week      
  0-2 (n=543) 106.3 (8.0) Reference  Reference  
  3-7 (n=541) 105.5 (8.5) -0.83 (-1.82, 0.15) 0.098 -0.83 (-1.84, 0.19) 0.106 
 Days vegetables eaten/week      
  0-2 (n=461) 106.4 (8.2) Reference  Reference  
  3-7 (n=635) 105.5 (8.3) -0.94 (-1.93, 0.05) 0.063 -1.13 (-2.15, -0.10) 0.029 
 Days animal-protein eaten/week     
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  0-2 (n=726) 105.4 (7.8) Reference  Reference  
  3-7 (n=374) 106.6 (8.8) 1.17 (0.16, 2.19) 0.024 0.99 (-0.06, 2.04) 0.062 
 Days sugared drinks taken/week     
  None (n=427) 105.4 (8.1) Reference  Reference  
  1-3 (n=492) 105.9 (8.0) 0.54 (-0.53, 1.61)  -0.05 (-1.14, 1.05)  
  4-7 (n=174) 107.2 (9.1) 1.81 (0.36, 3.26) 0.051 0.96 (-0.53, 2.44) 0.358 
 Days a fruit is eaten/week  -0.05 (-0.27, 0.18) 0.687   
 Days vegetables eaten/week  -0.18 (-0.39, 0.03) 0.085 -0.19 (-0.40, 0.03) 0.081 
 Days animal-protein eaten/week 0.21 (-0.07, 0.50) 0.138 0.10 (-0.20, 0.39) 0.502 
 Days starchy foods eaten/week 0.14 (-0.45, 0.73) 0.636   
 Days sugared drinks taken/week 0.23 (0.00, 0.46) 0.049 0.11 (-0.12, 0.35) 0.325 
 Breast development (girls only)b     
  Pre-pubertal (n=178) 103.9 (7.8) Reference  Reference  
  Pubertal (n=97) 108.0 (10.5) 4.07 (1.87, 6.26) <0.001 1.17 (-1.26, 3.59) 0.318 
 Pubic hair developmenta       
  Pre-pubertal (n=441) 104.7 (7.4) Reference  Reference  
  Pubertal (n=170) 106.5 (9.3) 1.83 (0.42, 3.24) 0.011 0.51 (-0.96, 1.98) 0.486 
 Snoring      
  No (n=932) 105.8 (8.2) Reference    
  Yes (n=163) 106.3 (8.2) 0.53 (-0.83, 1.90) 0.444   
 Duration of night sleep      
  < 9 hrs (n=306) 106.1 (8.0) Reference    
  9 hrs (n=382) 105.8 (8.8) -0.28 (-1.51, 0.96)    
  > 9hrs (n=405) 105.7 (7.7) -0.39 (-1.61, 0.83) 0.818   
 Smoking in household      
  No (n=962) 106.0 (8.3) Reference  Reference  
  Yes (n=147) 104.9 (7.5) -1.03 (-2.46, 0.40) 0.157 -0.65 (-2.10, 0.80) 0.372 
 Type of school      
  Day (n=117) 105.7 (7.9) Reference  Reference  
  Boarding school (n=719) 107.5 (10.3) 1.76 (0.19, 3.34) 0.038 0.28 (-1.38, 1.95) 0.733 
 Physical education at school      
  No (n=385) 105.5 (8.5) Reference    
  Yes (n=719) 106.0 (8.1) 0.48 (-0.54, 1.50) 0.360   
 Infections at BP measurement     
  Asymptomatic malaria      
   Uninfected (n=1067) 106.0 (8.2) Reference  Reference  
   Infected (n=22) 103.1 (9.3) -2.85 (-6.31, 0.61) 0.106 -1.50 (-5.02, 2.02) 0.397 
  Schistosomiasis      
   Uninfected (n=964) 105.9 (8.3) Reference    
   Infected (n=112) 105.7 (8.4) -0.25 (1.88, 1.38) 0.764   
  Hookworm      
   Uninfected (n=1066) 105.9 (8.3) Reference    
   Infected (n=10) 103.8 (10.0) -2.10 (-7.27, 3.07) 0.425   
  Ascaris      
   Uninfected (n=1073) 105.9 (8.3) Reference  Reference  
   Infected (n=3) 98.7 (1.6) -7.34 (-16.65, 2.17) 0.132 -7.04 (-15.97, 1.88) 0.117 
  Trichuris      
   Uninfected (n=1036) 105.8 (8.3) Reference  Reference  
   Infected (n=40) 107.9 (8.3) 2.16 (-0.46, 4.78) 0.106 3.48 (0.79, 6.18) 0.010 
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). 
Factors at the same level were added to the model at the same time and considered confounders for each other and for proximal factors. 
A p-value <0.20 was used for considering factor for inclusion and maintaining factors in the model. 
Adjusted b with 95% CI excluding 0 in bold. 
b; linear regression coefficient: mean difference in blood pressure (BP) measured in mmHg. 
a Not included in the model together but each was adjusted for all other model variables. 
b Not included in multivariable model building for other exposures because of large proportion of missing information but each was 
adjusted for variables in the final model building. 
c Not adjusted for body mass index because body mass index is on the causal pathway. 
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Table 2: Factors investigated for association with diastolic blood pressure among adolescents from 
the Entebbe Mother and Baby Study (N=1119) 
 
Level 1: Maternal factors 
Mean BP 
(SD) 
Crude  
b (95% CI) 
P-value Adjusted  
b (95% CI) 
P-value 
 Age (years)  0.08 (-0.00, 0.15) 0.058 0.05 (-0.03, 0.13) 0.247 
 Household SES (n=1104)  0.22 (-0.13, 0.56) 0.225   
 Parity  0.08 (-0.16, 0.32) 0.530   
 Body mass index (n=1110)  0.16 (0.03, 0.29) 0.014 0.14(0.01, 0.27) 0.030 
 Education status      
  None (n=28) 65.1 (9.3) 0.44 (-2.32, 3.19)  0.08 (-2.71, 2.89)  
  Primary (n=542) 64.6 (6.7) Reference  Reference  
  Senior (n=438) 65.5 (7.5) 0.92 (0.01, 1.84)  1.00 (0.07, 1.92)  
  Tertiary (n=109) 66.8 (8.0) 2.14 (0.65, 3.64) 0.023 2.08 (0.57, 3.59) 0.022 
 Marital status      
  Single (n=116) 64.2 (6.4) -1.19 (-2.59, 0.21)  -1.26 (-2.69, 0.16)  
  Married/cohabiting (n=967) 65.4 (7.4) Reference  Reference  
  Separated/widowed (n=35) 63.5 (6.0) -1.91 (-4.36, 0.54) 0.089 -1.91 (-4.38, 0.54) 0.075 
 Area of residence      
  Urban (n=770) 65.3 (7.5) Reference    
  Rural (n=336) 64.9 (6.8) 0.49 (-1.42, 0.44) 0.302   
 Alcohol use      
  No (n=775) 65.3 (7.5) Reference    
  Yes (n=343) 65.0 (6.6) -0.34 (-1.26, 0.59) 0.477   
 Infections      
  HIV      
   Uninfected (n=1002) 65.2 (7.3) Reference    
   Infected (n=117) 64.9 (6.5) -0.35 (-1.74, 1.05) 0.626   
  Asymptomatic malaria      
   Uninfected (n=991) 65.2 (7.4) Reference    
   Infected (n=109) 64.9 (6.6) -0.29 (-1.73, 1.15) 0.695   
  Schistosomiasis       
   Uninfected (n=908) 65.2 (7.1) Reference    
   Infected (n=204) 65.5 (7.7) 0.31 (-0.79, 1.41) 0.579   
  Hookworm        
   Uninfected (n=662) 65.1 (7.1) Reference    
   Infected (n=450) 65.4 (7.4) 0.27 (-0.60, 1.14) 0.539   
  Ascaris       
   Uninfected (n=1084) 65.3 (7.3) Reference    
   Infected (n=28) 65.1 (5.5) -0.18 (-2.90, 2.54) 0.896   
 Intervention one      
  Placebo (n=566) 65.0 (6.9) Reference    
  Albendazole (n=553) 65.4 (7.7) 0.39 (-0.46, 1.24) 0.366   
 Intervention two      
  Placebo (n=564) 65.4 (7.3) Reference    
  Praziquantel (n=555) 65.0 (7.2) -0.44 (-1.29, 0.42) 0.315   
Level 2: Factors in childhood      
 Birth weight (kg) (n=932)  0.66 (-0.27, 1.59) 0.164 0.57 (-0.40, 1.53) 0.246 
 Sex      
  Male (n=583) 64.9 (7.2) Reference  Reference  
  Female (n=536) 65.5 (7.4) 0.64 (-0.21, 1.49) 0.141 0.49 (-0.43, 1.42) 0.294 
 Sickle cell trait      
  HbAA (n=661) 65.4 (7.1) Reference    
  HbAS (n=141) 65.5 (7.4) 0.15 (-1.16, 1.46) 0.825   
 Season of birth      
  Dry (n=651) 65.5 (7.3) Reference  Reference  
  Wet (n=468) 64.7 (7.2) -0.79 (-1.65, 0.07) 0.073 0.59 (-1.52, 0.35) 0.214 
 Place of delivery      
  Entebbe Hospital (n=824) 65.1 (7.1) Reference    
  Home (n=120) 65.4 (8.5) 0.36 (-1.03, 1.76)    
  Others (n=174) 65.7 (7.3) 0.61 (-0.58, 1.80) 0.564   
 Feeding status (6 week of age)      
  Exclusive Breastfed (n=748) 65.4 (7.4) Reference    
  Mixed fed (n=344) 64.7 (7.0) -0.63 (-1.56, 0.30)    
  Weaned (n=14) 67.1 (4.4) 1.78 (-2.07, 5.63) 0.251   
 Intrvention three      
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  Placebo (n=553) 64.9 (7.0) Reference  Reference  
  Albendazole (n=554) 65.5 (7.5) 0.62 (-0.24, 1.47) 0.156 0.56 (-0.37, 1.48) 0.233 
 HIV status      
  Unexposed (n=1001) 65.2 (7.3) Reference    
  Exposed not infected 
(n=100) 
65.1 (6.7) -0.12 (-1.62, 1.37)    
  Infected (n=18) 63.5 (5.1) -1.71 (-5.10, 1.68) 0.609   
 Malaria infection below 5 years of age     
  Clinical or asymptomatic malariaa     
   No (n=447) 65.9(7.1) Reference  Reference  
   Yes (n=663) 64.6 (7.3) -1.28 (-2.14, -0.41) 0.004 -1.47 (-2.41, -0.53) 0.002 
  Clinical malariaa      
   None (n=474) 66.0 (7.2) Reference  Reference  
   Yes (n=645) 64.6 (7.3) -1.38 (-2.24, -0.51) 0.002 -1.33 (-2.26, -0.39) 0.005 
  Episodes of clinical malariaa      
   None (n=474) 65.9 (7.2) Reference  Reference  
   1-2 (n=382) 64.5 (7.3) -1.45 (-2.42, -0.47)  -1.53 (-2.59, -0.46)  
   ≥ 3 (n=263) 64.9 (7.4) -1.02 (-2.12, 0.07) 0.011 -1.03 (-2.22, 0.16) 0.015 
  Asymptomatic malariaa      
   None (n=983) 64.5 (7.3) Reference  Reference  
   Yes (n=124) 64.9 (7.4) -1.45 (-2.80, -0.10) 0.035 -1.35 (-2.89, 0.18) 0.082 
  Schistosomiasis       
   Uninfected (n=1076) 65.2 (7.3) Reference    
   Infected (n=33) 64.5 (5.8) 0.67 (-3.18, 1.84) 0.602   
  Ascaris        
   Uninfected (n=1052) 65.2 (7.3) Reference    
   Infected (n=57) 64.5 (7.1) -0.75 (-2.68, 1.18) 0.445   
  Hookworm        
   Uninfected (n=1085) 65.2 (7.3) Reference  Reference  
   Infected (n=24) 62.9 (5.8) -2.29 (-5.22, 0.64) 0.125 -1.79 (-4.93, 1.35) 0.261 
  Trichuris       
   Uninfected (n=997) 65.1 (7.2) Reference    
   Infected (n=112) 65.8 (7.7) 0.67 (-0.74, 2.09) 0.353   
  Microfilaria       
   Uninfected (n=1102) 65.1 (7.2) Reference    
   Infected (n=8) 67.3 (3.3) 2.12 (-2.91, 7.14) 0.409   
Level 3: Factors in adolescence      
 Age (years)  1.85(1.00, 2.70) <0.001 1.53 (0.63, 2.43) <0.001 
 Body mass index (kg/m2)  0.28 (0.20, 0.36) <0.001 0.74 (0.42, 1.05) <0.001 
 Waist circumference (cm)  0.88 (0.66, 1.10) <0.001 0.07 (-0.05, 0.18) 0.279 
 Family history      
  High blood pressure      
   No (n=1000) 65.0 (7.2) Reference  Reference  
   Yes (n=105) 66.7 (7.6) 1.65 (0.19, 3.12) 0.027 1.57 (0.08, 3.06) 0.037 
  Diabetes      
   No (n=927) 65.2 (7.2) Reference    
   Yes (n=186) 65.5 (7.8) 0.35 (-0.80, 1.49) 0.553   
 Body composition analysis c      
  Fat mass indexb (kg/m2)  (n=176) 1.75 (0.83, 2.69) <0.001 0.87 (-0.73, 2.47) 0.255 
  Fat-free mass indexb (kg/m2) (n=176) 1.19 (0.40, 1.98) 0.003 0.28 (-0.90, 1.45) 0.622 
  Total body water indexb (kg/m2) (n=176) 2.13 (0.95, 3.30) <0.001 1.51 (-0.86, 3.88) 0.180 
 Adding salt to food      
  No (n=20) 67.4 (6.1) 2.19 (-1.04, 5.41)  2.72 (-0.39, 5.82)  
  Yes (n=1086) 65.2 (7.3) Reference 0.184 Reference 0.083 
 Days a fruit is eaten/week      
  0-2 (n=543) 65.7 (7.1) Reference  Reference  
  3-7 (n=541) 64.7 (7.5) -0.98 (-1.85, -0.11) 0.028 -0.96 (-1.83, -0.10) 0.027 
 Days vegetables eaten/week      
  0-2 (n=461) 65.4 (7.1) Reference    
  3-7 (n=635) 65.1 (7.5) -0.27 (-1.15, 0.60) 0.540   
 Days animal-protein eaten/week     
  0-2 (n=726) 65.1 (6.9) Reference    
  3-7 (n=374) 65.4 (8.0) 0.30 (-0.61, 1.20) 0.523   
 Days sugared drinks taken/week     
  None (n=427) 65.0 (7.1) Reference  Reference  
  1-3 (n=492) 65.2 (7.4) 0.25 (-0.70, 1.20)  0.12 (-0.84, 1.08)  
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  4-7 (n=174) 66.0 (7.5) 1.06 (-0.23, 2.35) 0.271 0.54 (-0.75, 1.83) 0.707 
 Days a fruit is eaten/week      
 Days vegetables eaten/week  0.02 (-0.16, 0.1) 0.800   
 Days animal-protein eaten/week 0.14 (-0.11, 0.39) 0.284   
 Days starchy foods eaten/week  0.03 (-0.50, 0.55) 0.924   
 Days sugared drinks taken/week 0.20 (0.00, 0.41) 0.048   
 Breast development (girls only)b     
  Pre-pubertal (n=178) 64.1 (6.1) Reference  Reference  
  Pubertal (n=97) 67.2 (7.9) 3.07 (1.38, 4.76) <0.001 0.98 (-0.88, 2.84) 0.281 
 Pubic hair developmentb      
  Pre-pubertal (n=441) 64.1 (6.6) Reference  Reference  
  Pubertal (n=170) 66.1 (7.6) 2.04 (0.82, 3.26) 0.001 0.68 (-0.62, 1.99) 0.293 
 Snoring      
  No (n=932) 65.1 (7.2) Reference    
  Yes (n=163) 65.6 (7.8) 0.44 (-0.78, 1.66) 0.477   
 Duration of night sleep      
  < 9 hrs (n=306) 65.8 (7.6) Reference  Reference  
  9 hrs (n=382) 64.8 (7.1) -1.03 (-2.11, 0.06)  -0.92 (-2.02, 0.18)  
  > 9hrs (n=405) 65.2 (7.2) -0.79(-1.86, 0.28) 0.160 -0.67 (-1.76, 0.43) 0.240 
 Smoking in household      
  Non (n=962) 65.2 (7.3) Reference    
  Yes (n=147) 65.0 (6.8) -0.21 (-1.46, 1.06) 0.745   
 Type of school      
  Day (n=117) 65.1 (7.2) Reference  Reference  
  Boarding school (n=719) 66.2 (7.8) 1.13 (-0.26, 2.52) 0.112 -0.24 (-1.67, 1.20) 0.737 
 Physical education at school      
  No (n=385) 65.0 (6.9) Reference    
  Yes (n=719) 65.3 (7.5) 0.32 (-0.58, 1.22) 0.482   
 Infections at BP measurement      
  Asymptomatic malaria      
   Uninfected (n=1067) 65.3 (7.3) Reference    
   Infected (n=22) 64.0 (5.5) -1.31 (-4.36, 1.75) 0.401   
  Schistosomiasis      
   Uninfected (n=964) 65.2 (7.4) Reference    
   Infected (n=112) 65.0 (5.8) -0.19 (-1.62, 1.24) 0.791   
  Hookworm      
   Uninfected (n=1066) 65.2 (7.3) Reference    
   Infected (n=10) 64.0 (5.9) -1.25 (-5.80, 3.30) 0.590   
  Ascaris      
   Uninfected (n=1073) 65.2 (7.3) Reference    
   Infected (n=3) 62.3 (4.3) -2.86 (-11.14, 5.42) 0.498   
  Trichuris      
   Uninfected (n=1036) 65.1 (7.2) Reference    
   Infected (n=40) 66.4 (9.4) 1.23 (-1.07, 3.54) 0.294   
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). 
Factors at the same level were added to the model at the same time and considered confounders for each other and for proximal factors. 
A p-value <0.20 was used for considering factor for inclusion and maintaining factors in the model. 
Adjusted b for which 95% CI exclude 0 are highlighted in bold. 
b; linear regression coefficient: mean difference in blood pressure (BP) measured in mmHg. 
a Not included in the model together but each was adjusted for all other variables in the model. 
b Not included in multivariable model building for other exposures because of large proportion of missing information; but 
each was adjusted for variables in the final model building. 
c Not adjusted for body mass index because body mass index is on the causal pathway. 
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Prevalence of high blood pressure 
Using day-one BP readings, the prevalence of pre-hypertension and high BP was 63 
(10.8%) and 42 (7.2%), respectively among males, and 54 (10.1%) and 52 (9.7%), 
respectively among females. After extra measurements on the second and third visits and 
taking loss to follow-up into account, pre-hypertension prevalence was estimated as 2.2% 
in males and 0.7% in females; high BP prevalence was 0.4% in males and 1.8% in 
females. 
Risk factors for high blood pressure 
Tables 1 and 2 show the relationship between examined characteristics and BP (systolic 
or diastolic) in adolescents. Maternal factors crudely positively associated with 
adolescent systolic BP were gestational BMI and education status; both remained 
associated with systolic BP after adjustment for other maternal factors. The trial 
interventions during pregnancy (albendazole and praziquantel) and early childhood 
(albendazole) had no effect on systolic or diastolic BP. 
Characteristics at the time of BP measurement showing a crude positive association with 
systolic BP were age, BMI, waist circumference, family history of high BP, body 
composition variables, and puberty stage covariates. In multivariable analysis, systolic 
BP increased, on average, by 1.35mmHg, 95% CI (0.32, 2.39) for each one-year increase 
in adolescents’ age; by 0.78mmHg (0.42, 1.14) per unit increase in BMI; and by 
0.21mmHg (0.08, 0.35) per centimetre increase in waist circumference. Family history of 
high BP remained associated with increased SBP, b= 1.84 (0.12, 3.56) after adjustment 
for maternal and childhood factors. Body composition and puberty stage covariates were 
no longer associated with systolic BP on adjusting for adolescents’ age, BMI and waist 
circumference. 
Lifestyle factors crudely associated with systolic BP were increased animal protein 
consumption, and the type of school attended, with some evidence of association for fruit, 
vegetables and sugared drinks consumption. After adjusting for confounders, systolic BP 
reduced, on average, by 1.13mmHg (-2.15, -0.10) among adolescents who consumed 
vegetables for 3-7 days/week (versus 0-2 days/week). 
Current infection with Trichuris was positively associated with systolic BP after adjusting 
for confounders (b=3.48mmHg (0.79, 6.18)). systolic BP dropped by 1.24mmHg (-2.32, 
-0.17) among adolescents who had malaria in childhood compared to those who had not. 
Both clinical and asymptomatic malaria were independently associated with lower BP in 
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multivariable analysis. Weight and height at 10 and 11 years of age were reduced among 
adolescents with childhood clinical and or asymptomatic malaria (Supplementary Table 
1). Compared to those with no asymptomatic malaria, having asymptomatic malaria in 
childhood was associated with, on average, a 3.2 cm reduction in height, 95% CI (-4.5, -
2.0) and a 2.1 kg reduction in weight, 95% CI (-3.0, -1.9). The effect of childhood malaria 
on adolescent BP was weaker on adjusting for adolescent BMI (Supplementary Table 2). 
Genetic data were available for 802 (72%) participants of whom 141 (18%) had sickle-
cell trait (HbAS) and 661 (82%) normal haemoglobin (HbAA). Sickle-cell trait was not 
associated with systolic BP (b=-0.28mmHg (-1.79, 1.23)), even after adjusting for age 
and sex. HbAS was inversely associated with malaria (Supplementary Table 3): in those 
with HbAA, 63% had clinical or asymptomatic malaria up to 5 years compared to 51% 
with HbAS (p-value =0.008). 
Findings for diastolic BP were broadly similar to those for systolic BP, with the 
exceptions that higher fruit rather than vegetable consumption was associated with lower 
diastolic BP, and there was no association with waist circumference or Trichuris 
infection. No associations were observed between adolescent BP and any of the other 
factors considered in this population (Tables 1 and 2). 
Discussion 
      
     
      
     
     
     
        
   
 
         
     
       
       
         
       
      
           
          
          
        
               
           
          
Persistent high BP and pre-hypertension were unusual in early adolescence in this setting.
Maternal gestational BMI and education status at enrolment, participant’s family history
of hypertension, and age and BMI at BP measurement were positively associated with 
both systolic BP and diastolic BP. Malaria parasitaemia in childhood, and 
increased vegetable and fruit consumption were inversely associated with
systolic BP and diastolic BP, respectively. Concurrent Trichuris infection was 
positively associated with systolic BP but not with diastolic BP. There were no effects
of anti-helminth trial interventions (in pregnancy or childhood) on adolescent BP
and no associations between prior helminth infection (in pregnancy or childhood) and 
adolescent BP.
             
             
          
           
              
           
            
            
              
               
   
 
     
     
     
      
       
                
    
  
  
   
            
            
    
      
      
       
 
   
      
      
       
            
            
         
           
        
        
       
Our findings are consistent with several earlier studies [25, 26]. We have shown that 
consuming vegetables and fruits for 3-7 days/week was associated with lower systolic 
BP and diastolic BP, respectively. Our results support findings from a cross-sectional 
study that consuming fruits and vegetables (> 400g per day) lowers systolic BP and 
diastolic BP in adults [26]. We have shown a positive association of BP with 
maternal gestational BMI, and adolescent BMI and waist circumference at the time of
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Malaria parasitaemia in childhood was associated with lower BP in early adolescence, 
consistent with findings from a cross-sectional study among 5-18-year-old Ugandan 
students, which reported that current asymptomatic malaria was associated with lower BP 
[25]. Our study was under-powered to detect the effect of current parasitaemia on BP, 
with only 22 (2.1%) adolescents had parasitaemic at the time of BP measurement. 
Sub-microscopic malaria was most likely misclassified as negative in this population, 
since in malaria-endemic areas, asymptomatic malaria often presents as sub-microscopic 
in individuals with past malaria infection [27]. We found no association between sickle-
cell trait and adolescent BP; contrary to the hypothesis advanced by Etyang, who used 
sickle-cell trait as an instrumental variable in a Mendelian randomisation study [28]. In 
the predominantly adult populations from Kenya, sickle-cell trait (linked with partial 
protection against malaria) was associated with lower BP in Kilifi (currently a low-
moderate but historically a high malaria transmission area) compared to Nairobi (no 
malaria transmission) [29]. The differences in malaria exposure intensity and participant 
age distribution between our study and the Kenyan study could explain our contrasting 
results. 
Similar to earlier studies [30, 31], childhood malaria was associated with reductions in 
both weight and height, and some of the inverse association seen in this study may be 
explained by this mechanism, or by confounding by unmeasured factors. The escalating 
burden of high BP has coincided with the declining malaria burden on the African 
continent [2, 32, 33]. This could be explained by the epidemiological transition process 
on continent, or the effect could be more direct; the mechanisms remain to be elucidated. 
Current but not previous infection with Trichuris (a type of soil transmitted helminth, 
commonly known as whipworm) was associated with increased systolic BP in early 
adolescence. To our knowledge, no study has previously reported such an association. 
This may reflect short-term effects (probably arterial stiffness from inflammatory 
reaction) or it could be a spurious finding due to the many exposures included in the 
analysis. The effect of current Trichuris infection on BP is likely not mediated through 
increasing BMI (weight or height); there was no difference in these measures between 
adolescents with and without current Trichuris infection. 
   
   
                                                          BP measurement, consistent with earlier studies [13].
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Unlike previous studies [34], we found no association between BP and salt intake. The 
lack of evidence for this relationship in our study could be due to measurement error from 
self-report, or the fact that nearly everyone added salt to cooked food. Measuring sodium 
in a 24-hour urine sample or in commonly consumed local foods would provide a more 
accurate reflection of daily intake. Physical activity was not associated with lower BP, 
contrary to earlier literature [35]; sedentary lifestyles are still fairly uncommon in this 
population. 
Previous studies have linked hypertension to socioeconomic determinants 
(socioeconomic status (SES), education, income, urbanisation) [12, 36]. Our study is 
consistent with a Uganda study in adults which showed that BP was not associated with 
urban residence [37] but contrary to studies linking increased BP with low SES [36] and 
urbanisation [12]. We have shown that higher maternal education was associated with 
increased BP in adolescents, whereas other studies, predominantly from high-income 
countries, report an inverse association [36]. Although low SES and education is 
associated with hypertension in the developed world [36], the relationship may be inverse 
in less developed countries [38]. In these settings, offspring from more highly educated 
households are more likely to have sedentary lifestyles and unhealthy dietary practices, 
and to be obese, compared to offspring from less-educated households. 
Strengths of this study included its longitudinal design with prospectively collected data 
reducing recall and reporter bias, the use of robust BP procedures and the measurement 
of BP on up to two extra occasions in those with BP ³95th percentile at the initial visit, to 
avoid overestimation of high BP. It is unlikely that white-coat phenomenon was an issue 
as participants regularly attend this clinic for scheduled and/or illness visits. The use of 
digital machines reduced differences in BP reading between operators which can occur 
with auscultation. 
Study limitations include the possibility of residual confounding by unmeasured factors 
(such as Glomerular filtration rate (GFR). The GFR could not be estimated as creatinine 
was only measured for a subgroup of the participants. The use of digital BP machines 
may overestimate BP; however, digital devices used in this study were calibrated twice 
annually. A large number of statistical tests were undertaken; thus, some findings may be 
due to multiplicity. However, it is reassuring that most findings are consistent with 
previous literature, albeit from different settings. Not inviting all adolescents (those with 
pre-hypertension or normal BP on day-one) for up to two extra BP measurements might 
have resulted in an underestimation in the overall prevalence of pre-hypertension and 
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hypertension. We modelled BP as a continuous outcome, since analysing high or pre-
hypertensive BP versus normal BP as a binary outcome (or outcomes) would be 
underpowered, consequently our findings may not necessarily reflect associations with 
hypertensive disease.  
In summary, routine BP screening which is seldom conducted for adolescents at health 
care visits remains vital in the control and prevention of CVDs later in life. Similar life-
course factors to those observed in high-income settings (such as adiposity and diet) affect 
both systolic BP and diastolic BP among African adolescents. Interventions during 
pregnancy, childhood and early adolescence could be vital in the control and prevention 
of later high BP. Multiple intervention strategies initiated during pregnancy and the early 
postnatal period and continued across a lifetime could be fundamental in the control of 
adulthood hypertension and CVDs. 
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Chapter 7: Genetics of blood pressure among Ugandan adolescents 
7.1 Introduction 
This chapter uses both phenotypic and genotypic data from the EMaBS birth cohort to 
answer thesis objective 5 which investigates genetic polymorphisms associated with BP 
among Ugandan adolescents. 
7.2 Research paper 4: A genome-wide association and replication study of 
blood pressure in Ugandan adolescents 
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A genome-wide association and replication study of blood pressure in 
Ugandan adolescents 
Swaib A. Lule1,2, Alexander J. Mentzer3,4, Benigna Namara2, Allan Muwenzi5, Beatrice Nassanga2, Helen 
Akurut2, Lawrence Lubyayi2, Josephine Tumusiime2, Florence Akello2, Liam Smeeth1, Alison M. 
Elliott1,2, Emily L. Webb1 
1 London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK 
2 MRC/UVRI & LSHTM Uganda Research Unit, P.O. Box 49, Entebbe, Uganda 
3 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom 
4 Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, 
Oxford, UK 
5 University of Cambridge, Cambridge, United Kingdom 
Abstract 
Genetic association studies predominantly in Caucasian and Asian populations have 
identified variants associated with blood pressure (BP). However, in Africa, where high 
genetic diversity and high BP are prevalent, it is not clear if these or other variants are 
associated with BP or whether associations are consistent for different age groups. Using 
data from the Entebbe Mother and Baby Study (EMaBS), we conducted a genome-wide 
association study (GWAS) of BP and a replication study of single nucleotide 
polymorphisms (SNPs) found to be associated in previously published GWAS of BP. 
Systolic and diastolic BP were measured three times among 10- and 11-year olds in the 
EMaBS and the means of the last two measurements used. Whole genome genotype data 
was generated for EMaBS participants using Illumina omni 2.5M arrays and untyped 
genetic variants or selected variants (for the replication analysis) were imputed. GWAS 
was conducted using linear mixed model regression analysis to examine variants 
associated with systolic or diastolic BP. Linear regression analysis was used to assess 
variants previously associated with systolic or diastolic BP (p-value <5.0x10-8) from 
published BP GWASs. 
14 million variants from 815 adolescents were analysed. No variant reached genome-
wide significance (p-value <5.0x10-8) for association with systolic or diastolic BP. The 
most strongly associated variants were rs181430167, p-value =6.8x10-7 and rs12991132, 
p-value =4.0x10-7 for systolic and diastolic BP, respectively. Replication analysis was 
conducted for 330 SNPs previously associated with BP. Respectively, 17 SNPs, 15 SNPs 
and one SNP were associated with systolic BP, diastolic BP and with both traits (p-value 
<0.05). 
 173 
There was no genome-wide evidence of variants influencing BP among Ugandan 
adolescents, but the few variants showing suggestive associations may be worthy of 
future investigation. Replication of a small number of previously identified variants 
suggests that genetic variants associated with BP among African adolescents may overlap 
somewhat with those already established in previous studies, largely based on adults in 
Western settings. 
Keywords: Blood pressure, genetics, single nucleotide polymorphisms, adolescents, 
Africa, Uganda 
Running title: Blood pressure genetics of African adolescents 
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Introduction 
Genome-wide association studies (GWAS) predominantly from Caucasian and Asian 
populations have identified several genetic variants/single nucleotide polymorphisms 
(SNPs) associated with blood pressure (BP) [1-6]. Despite having a high burden of 
hypertension, and opportunities for improved fine-mapping of causative variants 
(including higher genetic diversity and lower linkage disequilibrium (LD) [7-10]), 
African populations are underrepresented in published genetic studies of BP [11]. Among 
38 studies that investigated genetic polymorphisms associated with hypertension in 
Africa-based populations (participant numbers ranging from 65 to 1,939) reviewed in 
[12], all adopted a candidate gene approach rather than conducting a GWAS. It remains 
unclear whether variants associated with BP in non-African populations also influence 
BP among Africans or whether the patterns of genetic susceptibility differ markedly. 
Blood pressure GWAS conducted among populations of African origins in the diaspora 
are rare, and often report different variants associated with BP compared to those reported 
in non-African populations [13-17]. Attempts to replicate genetic findings in independent 
populations have returned mixed results [3, 17-19]. The largest African American GWAS 
of BP included a meta-analysis of 29,378 individuals and identified only one (the SOX6 
locus) of the five loci that were associated with BP in a multi-ethnic (African American, 
European and East Asian) sample of 99,382 individuals [16]. Of the 17 SNPs most 
strongly associated with BP (p-value <1x10-4) in African Americans, three SNPS were 
replicated (p-value <0.05) in a West African sample [15]. Among Ugandan adults, 11 out 
of 27 BP related candidate SNPs (selected because of previous association with BP from 
BP GWASs or admixture mapping analysis) were replicated (p-value <0.05) with eight 
of the 11 SNPs having the same effect direction as in the discovery sample [19]. 
Twin studies report that over 30% of BP variability is heritable [20, 21] but established 
variants associated with BP account for only 2-5% of BP variation [22, 23]. This strongly 
suggests the existence of important undiscovered variants. This “missing heritability” 
could be due to rare or to common SNPs, all conferring small increases or decreases in 
expected BP [24, 25]. There is a need for both GWAS and replication studies to further 
elucidate and improve generalisability of BP genetic findings. 
The role of environmental and of life-style factors for hypertension among Africans is 
well documented as reviewed in [7, 8]. However, the contribution of genetic variants 
remains unknown and understudied [12]. It is not clear whether genetic loci associated 
with hypertension among populations of non-African origin influence susceptibility or 
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protection to hypertension in populations on the African continent. Independent 
confirmation is necessary to validate BP SNPs in different populations. We used data 
from the Entebbe Mother and Baby Study (EMaBS) birth cohort [26] to conduct 1) a 
GWAS of systolic and diastolic BP and 2) a replication study of candidate SNPs identified 
in previously published BP GWAS’s. The GWAS aimed to identify novel BP loci unique 
to this population while candidate gene analysis aimed to identify variants influencing BP 
across different ethnic groups. 
We hypothesised that genetic variants (either unique or not unique to populations in 
Africa) would be associated with BP among Ugandan adolescents. Individuals of African 
origin have different genetic make-up from other ethnic groups [7-10]. Identifying genetic 
variants associated with BP enhances our understanding of BP regulation and might 
highlight potential drug targets for hypertension treatment and prevention. Furthermore, 
the identification of variants associated with hypertension in both adolescence and 
adulthood could offer opportunities for early risk prediction. 
Methods 
The EMaBS [trial registration ISRCTN32849447] in Uganda, was originally designed to 
investigate the influence of worms and their treatment in pregnancy and early childhood 
on vaccine response and on infections in childhood [26]. Briefly, between April 2003 and 
November 2005, 2,507 pregnant women in their second or third trimester were 
randomised in a 2 x 2 factorial design to receive single-dose albendazole (400 mg) or 
matching placebo and single-dose praziquantel (40 mg/kg) or matching placebo. At 15 
months of age, the resulting 2,345 live-born infants were randomised to receive quarterly 
albendazole or matching placebo up to 5 years of age. 
The offspring continued under follow-up after the trial ended in 2011. From 20th May 
2014 to 16th June 2016, cohort participants who were now aged 10-11 years were enrolled 
in a BP sub-study, as part of which additional anthropometric and BP data were collected 
[27]. Adolescents were included in this study if they were aged 10 or 11 years and 
attending their routine annual follow-up during the BP sub-study period (11-year olds 
who had previously enrolled as 10-year olds were not included twice). Where necessary, 
enrolment was postponed until the participant was free of malaria (fever or axillary 
temperature ≥37.5°C and parasitaemia) and other illnesses [27]. BP was measured as 
previously described [27]. Briefly, on the day of enrolment, after five minutes rest period, 
trained nurses measured BP thrice five minutes apart, on the right arm supported at the 
heart level, with the participant seated upright all the way to the back of the chair, with 
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legs uncrossed and feet flat on the floor. Automated Omron (M6, HEM-700) machines 
validated every 6 months by the Uganda National Bureau of Standards, were used. Blood 
pressure phenotypes for this analysis were the mean of the second and third readings for 
systolic and diastolic BP, i.e. systolic and diastolic BP were analysed as two separate 
phenotypes. The second and third BP readings were, on average, lower than the first BP 
reading but similar to each other for both systolic and diastolic BP [27]. 
Early in 2012, whole-genome genotyping of 1391 EMaBS participants was undertaken. 
Genotypic data was generated from red cell pellets that had been separated and stored at 
-80°C until processing. Approximately 2.2 million genetic variants were generated at 
Wellcome Trust Sanger Institute using the Illumina HumanOmni2.5M-8 (‘octo’) 
Beadchip arrays, version 1.1 (Illumina Inc., San Diego, USA). Quality control (using 
standard pipelines) was performed at the University of Oxford using commands in PLINK 
(version 1.7) [28], to remove individuals and variants with high levels of missingness or 
deviations from expected levels of heterozygosity or Hardy-Weinberg equilibrium (p-
value <1x10-8). Untyped genetic variants and the variants identified for replication 
analysis were imputed in the EMaBS sample using a merged panel (1000 Genomes [29], 
African genome variation project [AGVP] [30], and Uganda 2000 Genomes (UG2G), 
genomes of Ugandan individuals of diverse ethnicity from rural Uganda) at the Wellcome 
Trust Centre for Human Genomics. SHAPEIT2 (version 2 790) [31] and IMPUTE2 
(version 2.3.2) [32] were used for imputation using settings as recommended for African 
populations. Only SNPs with an INFO score greater than 0.3 and a minor allele frequency 
greater than 0.01 were taken forward for analysis. 
Ethical approvals for the EMaBS, including the genetic study, were granted by the 
Uganda Virus Research Institute Science and Ethics Committee; the Uganda National 
Council for Science & Technology; and the London School of Hygiene & Tropical 
Medicine. The Oxford Tropical Research Ethics Committee provided additional approval 
for the genetic study. Written informed assent and consent were obtained. 
Association analysis 
The analysis included all adolescents from EMaBS who had both phenotypic and 
genotypic data. The two outcomes (mean systolic BP and mean diastolic BP) were 
analysed separately. GWAS of BP (systolic and diastolic) as quantitative traits was done 
using mixed linear regression methods (allowing for population substructure) assuming 
an additive model and controlling for age and body mass index (BMI) as covariates in 
genome-wide complex trait analysis (GCTA) version 1.22 [33]. A p-value <5x10-8 was 
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considered as the threshold to denote genome-wide significance for SNPs. Results for 
SNPs with p-value <1x10-6 are reported. Manhattan plots and QQ plots were constructed 
to show the distributions of association p-values and the departure of the observed P-
values from the null, respectively. 
For the replication component of the study, SNPs from previously published BP GWASs 
were searched to identify variants reported to be associated with systolic or diastolic BP 
(p-value <5x10-8 in the original GWAS) for the replication study. Replication analysis 
was conducted using linear regression adjusting for age and BMI in Stata version 14 
(College Station, Texas, USA). Variants were tested for association with the phenotype 
they were associated with in the published GWAS, that is variants associated with systolic 
BP in a published GWAS were tested for association with systolic BP but not with 
diastolic BP and vice versa. P-value <0.05 was considered the threshold for statistical 
significance for the replication study although results were also interpreted in light of a 
Bonferroni correction allowing for all tests done in the replication analysis. Base pair 
position is based on the Genome Reference Consortium Human Build 37 (February 
2009). 
Results 
The discovery GWAS analysis used data on 20,074,711 SNPs from 815 adolescents. 
These adolescents had a mean age of 10.4 years, a mean BMI of 16.0 kg/m2, mean systolic 
BP of 106.0 mmHg and mean diastolic BP of 65.3 mmHg. Four hundred and seventeen 
(51%) of the adolescents were male. Detailed characteristics of EMaBS participants 
included and not included in the analysis are described in Table S1. Offspring included 
in the genetic analysis were similar for most characteristics to those not included, except 
that those included were more likely to have been delivered in Entebbe hospital than 
elsewhere and to have been exclusively breastfeeding at six weeks of age. 
The distributions of association p-values (Manhattan plot) for systolic and diastolic BP 
phenotypes are shown in Figure 7.2-1and the QQ plots in Figure 7.2-2. 
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The observed P-values show no departure from the null (Figure 7.2-2), either for systolic 
or diastolic BP, with lambda values of 1.006 and 0.995, respectively. The results show 
adequate control for population substructure in the analysis. 
The SNPs most strongly associated with BP are shown in Table 1. None of the top scoring 
SNPs reached genome-wide levels of significance (p-value <5x10-8) for association with 
adolescent systolic or diastolic BP. Borderline significance (5x10-8 < p-value <1x10-6) for 
association with systolic BP was achieved for 4 index SNPs at 4 separate loci; there were 
4 index SNPs showing borderline significant associations with diastolic BP, at 4 separate 
loci. There was no overlap between the SNPs most strongly associated with systolic BP 
and those most strongly associated with diastolic BP. None of these most strongly 
associated SNPs have been identified as associated with BP in previously published BP 
GWAS. The most strongly associated SNP for systolic BP with p-value 6.8x10-7 was 
rs181430167, located in the intron region of the KLHL29 gene on chromosome 2. The 
lowest p-value (4.0x10-7) for association with diastolic BP was for rs12991132 located 
between ZFP36L2, THADA, LOC1001297261 genes on chromosome 2. 
Of the 389 SNPs [1, 2, 5, 6, 13-18, 34-53] identified for replication, 330 (85%) SNPs 
were included in the replication analysis. Fifty-nine SNPs that were either rare (<0.01) or 
poorly imputed (INFO score <0.3) in the EMaBS sample were not included in the 
replication analysis. Thirty SNPs of the 330 SNPs included in the replication had been 
previously associated with BP in populations of African origins. Forty SNPs had been 
previously associated with both systolic and diastolic BP and were tested for association 
with both. Tables 2 and 3 show results from the replication analysis. Briefly, 33 SNPs (17 
for systolic, 15 for diastolic and one for both systolic and diastolic BP) were associated 
with BP in this population, with the same effect direction as the discovery population for 
14 of the SNPs (5 for systolic BP and 8 for diastolic BP and one for both systolic and 
diastolic BP). 
Of the 30 SNPs previously known to be associated with BP specifically in individuals of 
African origin, three (ATP2B rs2681492, MDM4 rs2169137 and EVX1/HOXA 
rs17428471) were associated with BP in the present study. Only the EVX1/HOXA 
rs17428471 had the same effect direction as in the discovery population. The BAT2/BAT5 
rs805303 variant was associated with systolic BP and diastolic BP of the 40 SNPs tested 
for association with both traits. The G allele of the BAT2/BAT5 rs805303 variant was 
associated with higher systolic and higher diastolic BP among adolescents in this study: 
the same effect direction observed in the discovery population for both traits. 
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There were 370 independent tests (197 for systolic BP, 173 for diastolic BP) conducted, 
thus approximately 19 SNPs (370 x 0.05=18.5) would be expected to be associated with 
BP at p-value <0.05 by chance alone. None of the replicated SNPs met a Bonferroni 
corrected significance threshold (0.05/370=1.35x10-4), although one (rs6712094 
intergenic between FIGN and GRB14) was very close (p-value=2.6x10-4) for association 
with systolic BP. The most strongly associated SNPs for association with diastolic BP 
were rs805303 between BAT2 and BAT5 (p-value=1.0x10-3) and PDLIM5 rs7694000 (p-
value=1.3x10-3). 
Discussion 
To our knowledge, this is the first genetic analysis examining variants associated with BP 
among African adolescents. We hypothesized that common genetic variants (unique or 
not unique to populations in Africa) were associated with systolic and, or diastolic BP in 
Ugandan adolescents and that these associations may overlap with associated variants 
identified in previous studies of Africans. The GWAS revealed no novel or previously 
identified variant associated with systolic or diastolic BP in our study population. Thirty-
three SNPs were associated with BP in the replication analysis, with the direction of effect 
consistent with the discovery population for 14 SNPs. There were no SNPs reaching a 
Bonferroni-adjusted significance level. None of the replicated SNPs were located in genes 
with monogenic effect on hypertension [23]. 
The SNPs most strongly associated with either systolic or diastolic BP were of borderline 
significance and none has been reported as associated with BP in previous BP GWASs. 
It is possible that the most strongly associated SNPs are in LD with the BP causing 
variants. The most strongly associated SNPs were mostly common variants with modest 
effect sizes and might uniquely influence BP in African population. It is important for 
larger genetic studies of African population to investigate the role of these SNPs in BP 
regulation among Africans. These tops SNPs are potential candidates for replication 
analysis in African populations. 
The failure to identify variants strongly associated with BP presumably occurred because 
the study was underpowered to detect effects of rare variants or small effects of common 
variants. Blood pressure is most likely a polygenic trait influenced by the simultaneous 
presence of several gene variants each with a small effect size and contributing in an 
additive manner to BP expression. Thus, the large effect sizes that this study had good 
power to detect, may not be realistic. For example, the present study had 80% power to 
detect a 3.2 mmHg change in mean systolic BP for a minor allele frequency of 20% at 
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genome-wide significance level, p-value <5x10-8. Many of the variants reliably 
associated with BP in adults have an effect size of 0.5mmHg or less [6]. In addition to the 
limitation caused by the relatively small sample size, imputation did not allow inference 
for rare variants not included in the imputation SNP panel. 
Few GWAS “top SNPs” from non-African populations have been replicated in 
populations of African ancestry [15, 16, 19]. Variants associated with BP in populations 
of African origin might be different from variants that influence BP in Caucasian 
populations or not in LD with the BP causing variants. Our replication study was limited 
to variants associated with BP from previous GWAS of BP in other populations. Thirty-
three SNPs identified from previous BP GWAS were replicated, most of these were 
previously identified in populations of non-African origins. Of the identified loci, the 
PAX2 gene is essential in the development of the renal epithelium [54] and plays a critical 
role in kidney development [55]. The kidneys are critical in BP regulation. Two of the 
replicated SNPs are located on the ATP2B1 gene. The ATP2B1 gene is involved in 
calcium homeostasis [56]. The ATP2B1 rs2681492, MDM4 rs2169137, EVX1/HOXA 
rs17428471 SNPs previously associated with BP in trans-ethnic populations (African, 
Caucasian and Asian) were associated with adolescent BP in the present study. These 
genes most likely influence BP across different ethnic groups. 
Replication studies in diverse populations have returned mixed results. This current study 
conducted 370 tests using 330 SNPs, of which 33 SNPs (one SNP for both traits) were 
associated with BP. Failure to replicate most variants associated with BP in other 
populations could be due to differences in minor allele frequencies across populations or 
differences in LD patterns combined with a poor understanding of the causative variants 
or due to spurious initial findings. Blood pressure is likely to be influenced by the 
simultaneous presence of several genetic variants, each conferring a small change in BP. 
Although none of the variants reached Bonferroni levels of significance more associated 
variants were identified than expected under the null suggesting that some of these 
variants found to be associated could be worthy of further follow-up. Fourteen variants 
more than those expected by chance (19 variants) under the null hypothesis were 
associated with BP in this study. 
Of the 40 SNPs tested for association with both traits, only BAT2/BAT5 rs805303 was 
associated with both traits in the adolescents, suggests that not many genetic loci have 
influence on both systolic and diastolic BP. Similar to an earlier replication study among 
adult Ugandans [19], the ATP2B1 rs2681492 was associated with BP in these Ugandan 
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adolescents, but with an opposite effect direction to the discovery population [37] and 
Ugandan adults [19]. The G allele of the ATP2B1 rs2681492 was associated with lower 
systolic BP in Ugandans adults [19] but with higher systolic BP in the present study. 
Some loci may have varying roles in BP regulation across different populations. A 
European study investigated SNPs associated with BP at different age epochs (using 
independent samples for each age group): prepuberty (age 4-7 years), pubertal (8-12 
years) and post-pubertal (13-20 years). The A allele of TGA11 rs1563894 was associated 
with lower systolic BP in prepuberty while the T allele of SMARCA2/VLDLR rs872256 
was associated with higher systolic during puberty [48]. No SNP was associated with BP 
in the post-pubertal period, and no SNP was consistently associated with BP across all 
three age groups. The TGA11 rs1563894 and SMARCA2/VLDLR rs872256 were not 
replicated in this present study. 
The present study has several strengths. This is the first BP GWAS of an African 
population and the first candidate gene analysis among adolescents residing in Africa. 
Participants in this study were similar to non-participants with respect to most baseline 
characteristics. Rigorous quality control procedures were used during the measurement 
of the various variables including BP and genotyping. Data from this study can contribute 
to future BP GWAS meta-analyses. A key limitation of this study was that it was under-
powered to detect effects of rare variants and also to enable testing for effect modification 
by sex and other environmental variables. 
Future work should take advantage of various African cohorts to form consortia that can 
enable the conduct of GWAS meta-analysis well powered to identify rare and low-
frequency variants that may be associated with BP in African populations. Future 
candidate gene analysis using a sample from a different geographical region or ethnic 
background should investigate for interactions between variants, this might help our 
understanding of the aetiology of BP. It is possible that multiple interacting variants (rare 
and common) are influencing BP levels in this population. Although we did not formally 
allow for multiple testing in the replication analysis, the current study had 33 associated 
SNPs 14 more than expected by chance. Polygenic scores analysis of variants associated 
with BP among African populations may explain the missing BP heritability. 
In summary, we conducted the first genetic study of BP phenotypes among Ugandan 
adolescents. Although this study did not identify novel BP variants, replication of some 
previously identified variants suggests that some genetic variants may universally 
influence BP susceptibility. Large scale studies in African populations are required to 
identify novel and evaluate previously reported loci. 
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Table S1: Characteristics of the Entebbe Mother and Baby Study participants included 
and not included in the genetic analysis study (N=2345) 
 
Mothers’ characteristics during 
pregnancy 
Participated  
(n=815) 
Did not participate 
(n=1530) 
Number Percentage/
Mean (SD) 
Number Percentage/
Mean (SD) 
 Age (years)* 815 24.5 (5.6) 1530 23.3 (5.2) 
 Parity (number of children) * 815 3.0 (1.8) 1530 2.7 (1.7) 
 Body mass index* 809 24.0 (3.2) 1509 24.1 (3.2) 
 Household SES index (1 lowest, 6 highest) 806 3.8 (1.2) 1495 3.6 (1.2) 
 Education level     
  None 20 2.5 66  4.3 
  Primary 392 48.2 800 52.4 
  Senior 317 39.0 554 36.3 
  Tertiary 84 10.3 108 7.1 
 Marital status     
  Single 85 10.4 222 14.5 
  Married/cohabiting 709 87.1 1257 82.2 
  Separated/widowed 20 2.5 51  3.3 
 Area of residence     
  Urban 574 71.3 1027 68.1 
  Rural 231 28.7 481 31.9 
 Infections     
  Asymptomatic malaria 75 9.4 173 11.5 
  Schistosomiasis 134 16.5 287 18.8 
  Hookworm 322 39.6 703 46.2 
  Ascaris 21 2.6 33 2.2 
  Trichuris  67 8.2 139 9.1 
  Trichostrongylus 8 1.0 14 0.9 
Participants’ characteristics     
 Birthweight (Kg)* 692 3.2 (0.5) 1204 3.2 (0.5) 
 Sex     
  Male 417 51.1 794 52.0 
 Birth type     
  Singleton 802 98.4 1488 97.3 
  Multiple 13  1.6 42 2.8 
 Feeding at 6 weeks of age     
  Exclusive breastfeeding 579 71.5 893 63.6 
  Mixed feeding 219 27.0 502 35.8 
  Weaned 12 1.8 9 0.6 
 HIV status     
  Unexposed  731 89.7 1334 87.2 
  Exposed not infected 76 9.3 150 9.8 
  Infected 8 1.0 46 3.0 
 Place of birth     
  Entebbe Hospital 611 75.0 1069 70.3 
  Home 85 10.4 179 11.8 
  Others 119 14.6 273 18.0 
 Mode of delivery     
  Normal 731 89.7 1385 91.0 
  Caesarean section 77 9.5 120 7.9 
  Instrumentation 7 0.9 17 1.2 
* Mean value with standard deviation (SD) presented 
Percentages may total to ± 100 due to rounding 
Household socioeconomic status (SES) was a composite variable and could take values 1 (low) to 6 (high) 
Missing data for (a) mother’s characteristics: body mass index 27; household SES 44; education 4; marital 
status 1; place of residence 32; asymptomatic malaria 43; schistosomiasis 9; hookworm 9; ascaris 9; 
trichuris 9; trichostrongylus 9; (b) child’s characteristics: sex 2; birth weight 449; feeding status 131; place 
of delivery 9; mode of delivery 8 
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Chapter 8: Discussion 
8.1 Preface 
This chapter discusses the main findings of the thesis, implications for research and 
policy, strengths and limitations, and generalisability of findings. This PhD comprised of 
a systematic review of literature published on the relationship between birth weight and 
BP among young Africans, and an observational study using prospectively collected data 
from participants born in the EMaBS, a tropical birth cohort of 2,345 live born infants. 
The observational study was designed to investigate the effect of birth weight, postnatal 
growth, pre- and peri-natal and childhood exposures and of genetic polymorphisms on 
adolescents’ BP. Respectively, we hypothesised that birth weight (a proxy for intra-
uterine growth) and change in WAZ (a proxy for postnatal growth) were negatively and 
positively associated with BP in early adolescents. We hypothesised that several 
environmental and genetic factors, including those more common in Africa than in other 
settings would also be associated with BP in adolescents. 
8.2 Main findings 
8.2.1 Systematic review 
As previously reported in chapter 3, Medline, EMBASE, Global Health and Web of 
Science databases were systematically searched for relevant publications up to October 
2016, on the relationship between birth weight and BP among young Africans aged 0 to 
18 years. Reviewed studies varied in size (from 157 to 2,743 participants per study), were 
either cross-sectional or cohort in design and either hospital- or community-based [1]. 
The systematic review showed that the relationship between birth weight and BP among 
young Africans remains under-studied, with only 16 relevant papers (from 13 study 
groups in nine African countries) identified. Evidence from this small number of 
publications (studies) suggested that the relationship between birth weight and BP varied 
with participants’ age; a consistently positive association was seen in neonates (age 0-28 
days), predominantly inverse associations seen in children (age 1-9 years) and inverse or 
no association seen in adolescents (age 10-18 years) [1]. 
A possible explanation for the observed positive association between birth weight and BP 
in neonates is that, the short duration between birth and BP assessment does not allow for 
any impact of subsequent growth trajectory on BP to develop. The effect of the measured 
birth weight may not reflect the effect of birth weight but the effect of current weight on 
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BP in the neonates. Current weight at birth, which in neonates is birth weight, is reported 
to be associated with BP. Thus, in the neonates the impact of growth trajectory is yet to 
be felt. 
The inverse association between birth weight and BP among African children in this 
current review, supports earlier findings in children from Africa and other settings 
reviewed in [2-4]. The findings in children strengthen the fetal origin hypothesis, that low 
birth weight predicts high BP later in life, first published close to three decades ago by 
Barker et al [5]. 
The inconsistent (inverse or no) association between birth weight and BP in adolescents 
reviewed in the present study also supports findings in earlier reviews. Inconsistencies in 
the birth weight-BP relationships observed in adolescents may partly be due to rapid 
pubertal growth due to hormonal changes which start at varied age during adolescence. 
Pubertal growth is associated with greater increases in BP than growth in pre- and post-
pubertal periods [6, 7]. 
The discrepancies in the birth weight-BP relationship in young Africans were less likely 
to be due to differences in study procedures as similar approaches were followed: a rest 
period before and between successive BP measurements; automated devices were used; 
the mean of three or two BP measurements was used for most analyses; and birth weight 
data were prospectively collected nearly in all studies. The small number of studies from 
Africa on the birth weight-BP relationship prohibit definitive conclusions to be made. 
An additional search for manuscripts published after 15th October 2016, identified one 
relevant study on the relationship between birth weight and BP. This study among 528 
rural South Africans aged 5 to 15 years, showed that birth weight was not associated with 
BP [8].  
In summary, the small number of preceding studies from Africa justified the 
observational study using longitudinally collected prospective data from 2,345 mother-
child pairs in the EMaBS birth cohort. 
8.2.2 Observational study 
For the first time in mainland East Africa, we aimed to describe the effect of early-life 
(fetal and postnatal) growth, life-course factors and genetic variants on BP among early 
adolescents aged 10 and 11 years. In the EMaBS, data was collected prenatally from 
2,507 women and their resulting 2,345 live born offspring were followed from birth to 10 
or 11years of age. From 20th May 2014 to 16th June 2016 additional data including BP 
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measurements, anthropometry, physical activity, and diet were obtained from 1,119 
participants. Genetic data from 1,391 participants had been earlier generated using stored 
samples obtained at one year of age. 
8.2.2.1 High blood pressure and pre-hypertension prevalence 
The prevalence of high BP and pre-hypertension was 8% and 11% respectively on day-
one among 10- and 11-year-old adolescents. The prevalence of hypertension after 
measurements taken on three separate occasions was low, estimated at 1%. Only those 
with average systolic and/or diastolic BP ³95th percentile for sex, age and height on the 
first occasion were invited for extra BP measurements on the second and third occasion, 
and this may have biased the estimate. 
Our estimates of high BP and hypertension prevalence were lower than earlier reported 
in 8- to 18-year-old students from the same study area [9]. However, the estimate of high 
BP prevalence was comparable to that among 5- to 16-year-olds from the Seychelles [10] 
and in 10- to 17-year-old Gambians [11], but higher than in 12- to 18-year-old Nigerians 
[12]. 
8.2.2.2 Early growth and adolescent BP 
Birth weight was not associated with BP, although at crude analysis, there was some 
suggestion of a U- or J-shaped relationship between birth weight and BP. The present 
study shows that rapid increases in weight in childhood, especially in the first two years 
of life, predict high BP in adolescents. Chiolero et al showed that increased weight gain 
during any period after birth was associated with high BP in adolescents [13]. Horta et al 
reported that both early and late catch-up growth were associated with increased systolic 
BP in adolescents [14]. These studies together with the present study are consistent 
regarding the influence of rapid weight gain on later BP. The present study further showed 
that the effect on adolescents’ BP was strongest in individuals who were small at birth 
(weight <2,500g) compared to individuals who weighed ³2,500g at birth. 
Although current weight (a mediator rather than a confounder for the effect of birth 
weight on later BP [15]) should not be adjusted for when estimating the effect of birth 
weight on later BP, in this PhD thesis, both results adjusted and not adjusted for the effect 
of current weight were presented. Results adjusted for current weight enabled easier 
comparison with results from earlier studies where the effect of birth weight on later BP 
had been adjusted for. Similar to these earlier studies reviewed in [1, 3, 16], adjusting for 
current weight in this PhD led to a more negative effect of birth weight on later BP in the 
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adolescents. In addition to current weight being a mediator, adjusting for current weight 
makes it complex to interpret the obtained results [3, 15], which could be interpreted as 
the effect of change in weight between birth and a later age on BP rather that the effect 
of fetal growth on later BP [15]. 
Our study suggests that rapid weight gain rather than weight at birth is important in the 
developmental programming of later BP, with fast-growing low birth weight children at 
particularly higher risk compared to children who were heavier at birth. This could be 
due to “a nutritional mismatch” between fetal (the predicted) life and early postnatal 
(realised) life experienced by individuals who were small at birth and rapidly gain weight 
in the early post-natal period. In the EMaBS, weight at any time starting at one year of 
age was a stronger predictor of adolescents’ weight than birth weight. This may reflect a 
resetting of an individual’s growth trajectory in the first year of life [15]. 
8.2.2.3 Blood pressure risk factors in early adolescents 
Maternal gestational BMI and educational status and adolescents’ age, BMI, family 
history of hypertension, waist circumference and current infection with Trichuris were 
positively associated with systolic BP. Childhood (<5 years of age) malaria and higher 
vegetable consumption were associated with reduced systolic BP. Findings for diastolic 
BP were similar to those for systolic BP, except higher fruit consumption rather than 
vegetable consumption was associated with lower diastolic BP and there was no 
association with waist circumference or Trichuris infection for diastolic BP. Trial 
intervention(s) or worm infection(s) in pregnancy or childhood or pre-adolescence had 
no effect on adolescents’ BP. 
Maternal factors (smoking in pregnancy, urban residence and socioeconomic status) and 
adolescent factors (including salt intake, physical activity and sex) associated with high 
BP in other settings [17-25] were not associated with BP in this study. As in other 
developing countries, maternal smoking in pregnancy and sedentary lifestyles were 
uncommon in this population. In this study, nearly all adolescents added salt to cooked 
food, making it hard to detect a differential effect of salt addition on BP. 
Except for maternal education status, other socioeconomic indicators (including 
socioeconomic index and urbanisation) were not associated with BP. Consistent with 
earlier studies from Africa and other LICs, the present study has shown that higher 
maternal education (tertiary or senior) compared to primary was associated with increased 
BP in adolescents [26, 27]. On the contrary, studies from in HICs have showed 
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associations between low education status and increased BP [27, 28]. In many developing 
countries, individuals from more highly educated households are more likely to be obese, 
live sedentary lifestyles and have unhealthy dietary practices compared to those from 
less-educated households, whereas the reverse is in HICs. 
8.2.2.4 Genetic variants associated with BP 
The genetic analysis involved 2,176,694 SNPs from 815 adolescents (with both 
phenotype and genotypic data). The genetic analysis aimed at identifying genetic variants 
associated with systolic and, or diastolic BP among Ugandan adolescents aged 10 and 11 
years of age. We hypothesised that common genetic variants (unique or not unique to 
populations in Africa) were associated with systolic and, or, diastolic BP in the 
adolescents. The BP GWAS revealed no novel variant associated with systolic or diastolic 
BP. None of the SNPs reached genome-wide significance levels (5 x 10-8) for systolic or 
diastolic BP for the GWAS analysis. The most strongly associated variants were: 
rs29356, p-value = 9.6 x 10-7 for systolic BP and rs73861745, p-value = 9.9 x 10-7 for 
diastolic BP. For the replication study, 88 SNPs associated with systolic or diastolic BP 
were identified, of which 74 SNPs had minor allele frequency >0.01; three (4.1%) were 
replicated with p-value <0.05 but none met a Bonferroni corrected significance threshold 
of 6.8x10-4. 
8.3 Selection into the trial and the Blood Pressure Study 
The EMaBS enrolled women who sought antenatal care from Entebbe Hospital. Nearly 
70% of pregnant women in the study area seek antenatal care from Entebbe Hospital [29]. 
Thus, EMaBS did not enroll all of the eligible pregnant women from the study area. A 
community survey by Millard [30] showed that 60% of mothers in the catchment area 
would have been eligible for enrollment into the trial, of these 30% had been enrolled 
into the EMaBS trial. Compared to mothers in the community, those enrolled in the trial 
were of higher socio-economic and, or educational status. 
Twenty seven percent of the pregnant women screened in the EMaBS were eligible for 
enrollment into the trial, of these, 80% were enrolled. Overall, women enrolled in the trial 
were similar to those not enrolled for most characteristics, except that those not enrolled 
were more likely to be primigravida or younger women [31]. Non-enrolment into the 
EMaBS might have introduced a selection bias, as women at risk of having low birth 
weight infants were less likely to be enrolled, for example women thought to have an 
abnormal pregnancy such as those with eclampsia were excluded from the trial. However, 
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among the children born into the birth cohort, those who participated in the BP study at 
10/11 years of age were not different for most characteristics from those who did not 
participate in the BP study, except that those who did not participate in the BP study were 
less likely to be HIV positive, but more likely to be singletons and born to more educated 
or married/cohabiting mothers, who were less likely to have been infected with 
hookworm at enrolment [32]. 
The EMaBS children were more likely to be healthy than the children in community: 
study children were more likely to use footwear or sleep under insecticide-treated bed 
nets than community children [30], although no difference in incidence rates of reported 
common infections was observed between children enrolled in the study and those in the 
community [30]. In addition, EMaBS children received free medical care or their illnesses 
at the study clinic thus they more likely to have better health seeking behaviours than 
their community counterparts. 
In conclusion, EMaBS participants as a whole, and particularly those included in the BP 
study were on average, from higher socio-economic or educated backgrounds and likely 
to be “healthier” than the community they were sampled from. This means that findings 
may not be fully generalizable to the study setting. 
8.4 Interpretation of the study findings 
The findings presented in this thesis support earlier observations of no association 
between intra-uterine growth and adolescent BP [1, 2, 33]; a positive association between 
increased postnatal growth and elevated BP later in life [4, 34-36]; positive associations 
between BP and adiposity (both maternal pregnancy and adolescent) [11, 37, 38], family 
history of hypertension [39] and age [22, 40, 41]; and an inverse association between BP 
and higher fruit or vegetable consumption [9, 42]. 
The relationship between accelerated postnatal weight gain and increased adolescent BP, 
particularly in those small at birth, demonstrates the importance of the ‘nutritional 
mismatch’ (slow uterine growth accompanied by accelerated postnatal growth) in the 
developmental programming of later BP. The strong association in the individuals who 
were small at birth is suggestive of the effect of IUGR rather than of prematurity on later 
BP [43, 44]. 
Findings published in this thesis extend observations to associations between infections 
and adolescent BP: childhood clinical and or asymptomatic malaria was associated with 
reduced BP in adolescents while current Trichuris infection was associated with increased 
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BP. Findings of a protective effect of malaria on BP in the present study are consistent 
with findings in an earlier study among 5- to 18-year-old Ugandans [9]. The protective 
effect of malaria on later BP is partly mediated through reductions in adolescents’ size. 
In the EMaBS, childhood malaria was associated with later reduction in adolescents’ 
weight or height, findings that are consistent with earlier studies from other malaria 
endemic areas [45, 46]. Since the 2000s, age-standardized malaria incidence and death 
rates have declined in most of SSA [47-49], coinciding with the escalating burden of 
hypertension on the African continent [50]. This could be part of the epidemiological 
transition on the continent, or the effect could be more direct; the mechanisms remain to 
be elucidated. However, our findings are contrary to an earlier suggestion from Kenya, 
of an adverse effect of malaria on BP. Despite seeing an association between sickle-cell 
trait and malaria in the adolescents in our study, sickle cell trait was not associated with 
adolescents’ BP. Possible explanations for the contrasting findings could be due to 
differences in study designs and infection intensities. The Kenyan study used sickle cell 
trait as an instrumental variable for malaria transmission. There are differences in the age 
distribution of participant and malaria exposure intensity between our study and the 
Kenyan study. Participants in our study were aged 10 and 11 years and from a malaria 
endemic area [51], while those in the Kenyan study were over 15 years of age and from 
Kilifi (currently a low-moderate but historically a high malaria transmission area) and 
Nairobi (no malaria transmission) [52]. Current infection with Trichuris may also 
contribute to increased BP, but the mechanism is yet to be demonstrated. 
A possible explanation for failure of our study to identify genetic variants associated with 
BP from the GWAS study is that BP is determined by rare variants, each conferring a low 
to moderate effect on BP. Our study was underpowered to detect associations with rare 
or low-frequency variants. BP is most likely a polygenic trait influenced by the 
simultaneous presence of several gene variants each with a small effect size and 
contributing in an additive manner to BP expression. Thus, the large effect sizes that this 
study had good power to detect, may not be realistic. 
Findings from the genetic study emphasise that BP is most likely due to the simultaneous 
presence of several gene variants each with a small effect size. The architecture of BP in 
African adolescents might be different to that in adults, although comparative studies in 
adults and adolescents would need to be done in order to determine this. Larger studies 
are required to investigate the genetic variants on BP. 
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8.5 Study strengths 
A strength of this PhD was the availability of well documented prospectively collected 
data on important covariates (such as birth weight) and potential confounders (such as 
socioeconomic index) determined before the BP study was conceptualized and designed, 
minimising potential recall and reporter bias. 
Participant retention in this cohort was reasonably good, given the challenges of 
maintaining such a cohort. The annual loss to follow-up was lower than anticipated at the 
design stage of the original trial [53]. Overall loss to follow-up was around 50%, less than 
the 60% level considered to introduce bias if data were missing completely at random or 
missing at random [54]. However, the data may not satisfy either of these missingness 
mechanisms. This is a high follow-up for the setting, where address systems are less 
formal, and mobility is relatively high. 
Robust methods were used in defining the main exposure (birth weight), outcomes (BP) 
and potential confounders (such as BMI, or infections such as HIV). For example, weight 
scales were regularly calibrated using a standard ten-kilogram stone made for this 
purpose, while BP monitors were validated and calibrated every six months at the Uganda 
National Bureau of Standards. BP was measured thrice on a single occasion and on up to 
two extra occasions in those with BP ³95th percentile at the initial visit, to avoid 
overestimation of high BP as a result of white-coat phenomenon. 
Although this was the first-time participants in the EMaBS birth cohort had their BP 
measured, white-coat phenomenon was probably less of an issue than it would be for 
participants less familiar with medical and research procedures and settings. Participants 
in the EMaBS regularly attended this clinic for scheduled and/or illness visits and were 
familiar with the clinic setting. In an effort to offset effect of white-coat phenomenon, the 
first BP measurements (higher and different from the second and third readings, see 
supplementary figure 1, page 125.) were not included the estimation of the mean BP 
(systolic or diastolic) used for data analysis. Out of office (ambulatory or home-based) 
BP measurements, would overcome the concerns that arise from white-coat phenomenon 
and masked hypertension (hypertension not detected during office evaluation but only by 
out of office evaluation) that arise from office (clinic) BP measurements. 
Quality control measures were instituted for various laboratory procedures including 
malaria microscopy, stool parasitology analyses and HIV testing. Misclassification of 
these variables was unlikely to be a problem in this cohort. 
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8.6 Study limitations 
The systematic review was based on published studies and hence was prone to publication 
bias as journals are more likely to publish positive findings than inconclusive or negative 
findings. However, inconclusive and negative results seem to have also been published, 
hence if publication bias was an issue, it was not obvious. 
The original trial was not designed specifically for this current study on BP, so data on 
important exposures and potential confounders were missing or not appropriately 
collected, consequently findings are subject to unmeasured or residual confounding. For 
example, birth weight was collected but those with low birth weight could not be 
classified into premature or SGA due to lack of early scan data in this setting. Hence, this 
study was not in a position to determine the independent effect of prematurity or SGA on 
later BP. Also, data were missing for some important exposure variables, for example 
birth weight was missing for 187 (16.7%) of the participants in this current study. Birth 
weight data was likely not missing at random, as those born away from hospital were 
more likely to have missing birth weight data, introducing a selection bias. However, 
EMaBS participants included in the current study were similar in most characteristics to 
those not included in the study. 
Sensitivity analyses assessing the impact of missing values for the main exposures (birth 
weight and change in WAZ) were conducted, as earlier described in chapter 4. Results 
from the sensitivity analyses were similar to those from the main analyses. However, 
simple imputation approaches such as the one used in the thesis are likely to 
underestimate the standard error, and advanced methods for dealing with missing data 
(such as multiple imputation) would have improved these sections of the thesis [55]. An 
imputation approach was used for genetic data but not for the analyses of environmental 
and life-style factors presented in chapters 5 and 6. This was a limitation of the thesis. 
Pregnant women with evidence of helminth-induced pathology or history of adverse 
reaction to anthelminthics or abnormal pregnancy were excluded at enrolment. These 
may have introduced a selection bias in the study population, as those at increased risk of 
having low birth weight neonates were most likely not enrolled in the original trial. 
There are no standardised BP thresholds for young Africans, thus this PhD used the 
American BP thresholds for children and adolescents to estimate the prevalence of pre-
hypertension and hypertension. This permitted comparison of pre-hypertension or 
hypertension prevalence across different studies and populations. A fundamental 
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limitation to the use of these thresholds is, they were defined using and for the American 
population which is different in many ways, with higher average WAZ, WHZ and HAZ 
compared to African populations [56], such as those participants included in the current 
BP study. 
The multivariable analysis in chapter 6 might have been underpowered to detect effects 
of some of the exposures due to the large number of risk factors included in some models. 
This may especially have been the case for the proximal factors (these were added last to 
the model, hence analyses for these factors were based on models with a particularly large 
number of predictor variables, which could have led to overfitting and consequently 
reduced power). In addition, a large number of statistical tests were undertaken; thus, 
some findings may be due to multiplicity. However, it is reassuring that most findings are 
consistent with previous literature, albeit from different settings. 
The use of microscopy for malaria diagnosis might have resulted in differential 
misclassification of malaria. In malaria endemic areas, asymptomatic malaria often 
presents as sub-microscopic in individuals with past malaria infection [57]. Sub-
microscopic malaria was most likely missed and classified as no malaria in individuals 
with past malaria infection(s), thus underreporting the proportion with asymptomatic 
malaria at a given annual study visit. 
Some important exposures and potential confounders (including diet, salt intake, physical 
activity) were self-reported, thus subject to recall bias. 
8.7 Generalisability of findings 
Findings in the present study may apply to the wider Ugandan population. Overall, no 
major differences existed between cohort members enrolled and not enrolled in the BP 
study. The findings may be generalisable to a wider African population where malaria is 
endemic, with moderate prevalence of low birth weight and low prevalence of 
hypertension. 
However, findings in the current study may not apply to other populations. Participants 
in this cohort received free medical care so may have had better health outcomes than the 
general population. In addition, our findings may not be applicable to other settings with 
dissimilar exposure or outcome frequencies such as the prevalence of hypertension, low 
birth weight, worm infections and malaria. For example, Entebbe is a malaria endemic 
region with moderate to high malaria transmission [51, 58], and in the present study 
prevalence of low birth weight and hypertension was low at 7% and 1%, respectively. 
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Findings in this thesis may not apply to non-malaria endemic areas with higher low birth 
weight prevalence or higher prevalence of hypertension compared to the EMaBS study 
area. 
Adolescents with normal or pre-hypertension on the first occasion were not invited for 
extra BP measures, this might have resulted in an under estimation of the overall 
hypertension prevalence in our study. The overall prevalence of hypertension might have 
been higher if all participants had their BP measured on a second and third occasion, 
regardless of the value on the first occasion. 
8.8 Implications for research 
The influence of intra-uterine growth on later BP among young Africans remains 
understudied. There is the need for more studies (with appropriate sample size and 
applying appropriate data analysis methods controlling for potential confounders) from 
Africa investigating the influence of both intra-uterine growth and postnatal growth on 
later BP. 
Findings reported in this thesis should be replicated using further cohort studies or 
alternative study designs. The impact of birth weight, growth, infections (including 
malaria and Trichuris) and genetic variants on BP could be investigated using designs 
such as individual participant data (IPD) meta-analysis or Mendelian randomization 
(MR). Several small African cohorts could contribute data for IPD meta-analyses to 
enable investigation of the suggested U-or J-shaped relationship between birth weight 
and later BP; effect of infections on BP and also improve power for conducting subgroup 
analyses, for example, for variables such as season of conception or birth and prematurity 
or IUGR. 
The MR design can be used to understand the relationship between exposures (such as 
birth weight, malaria) and later BP. MR studies use genetic variant(s) with known 
biological effects as instrumental variables (to represent a known environmental 
exposure) to confirm or refute associations between the environmental exposure and BP. 
MR assumes there are no confounders for the association between the selected 
instrumental variable and the outcome and no pleiotropy (a gene influencing two or more 
unrelated phenotypic traits). The MR design would enable inference where randomised 
trials cannot be conducted due to lack of feasibility or ethical equipoise. 
Low birth weight is either due to prematurity or IUGR, both of which have different 
determinants [59, 60]. Thus, combining prematurity and IUGR together as low birth 
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weight might hinder development of preventive interventions. Birth weight is easily 
measured with good validity and precision; thus, researchers continue to use low birth 
weight instead of prematurity or IUGR in studying their impact on later disease. 
Assessment of prematurity or IUGR involves accurate estimation of gestational age, 
which is often difficult in developing countries. In developing countries (including 
Uganda), IUGR constitutes most of the low birth weight in neonates [61]. In the present 
study, it is not clear if prematurity or IUGR is associated with BP later in life because 
data on prematurity and IUGR was not collected. Future work on the relationship between 
intra-uterine growth and BP should aim to assess the independent effect of prematurity 
or IUGR on later BP. Understanding the possible underlying mechanism through which 
birth weight impacts later BP requires knowing if prematurity or IUGR have similar or 
different associations with BP later in life. 
In Africa where malnutrition is prevalent, the impact of catch-up nutrition in 
malnourished infants or infants born small on BP later in life is understudied. Future 
research should seek to evaluate the impact of catch-up nutritional programmes in 
malnourished infants or infants born small on the programming of later BP. 
Future work should take advantage of various small and large cohorts from Africa to form 
consortia that can enable the conduct of GWAS meta-analysis well powered to identify 
rare and low-frequency variants that may be associated with BP. Polygenic scores capture 
a greater proportion of explained variance in the target phenotype than a single variant. 
The use of polygenic scores could help explain the missing BP heritability. However, this 
requires identification of independent variants from well powered GWAS and use of 
SNPs common to both the discovery and target samples. Future candidate gene analysis 
using a sample from a different geographical region or ethnic background should 
investigate for interactions between variants, this might help our understanding of the 
aetiology of BP. It is possible that multiple interacting genetic variants (rare and common) 
are influencing BP levels in this population. 
8.9 Policy implications and challenges 
Findings in this PhD highlight the importance of optimal growth, weight reduction and a 
healthy diet in high BP prevention. A BP control and high BP prevention policy or 
strategy should adopt a life-course approach, starting in pre-conception or early 
pregnancy, through childhood and adolescence into adulthood. Such a BP control and 
prevention policy would require implementation of multi intervention evidence-based 
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interventions, aiming at increasing physical activity, reducing obesity and promoting a 
healthy diet. A school health programme promoting physical exercise and a healthy diet, 
in addition to educating the next generation of Ugandans might provide a good platform 
for behavioural change aimed at controlling and preventing high BP. However, 
behavioural intervention programmes have historically struggled to create long-lasting 
changes in lifestyle. 
Physical exercise in pregnancy is associated with health benefits both for the mother 
(lower risk for gestational obesity or hypertensive disorders of pregnancy) and their 
resulting offspring (normal birth weight infants) [62, 63]. Despite evidence that exercise 
in pregnancy does not increase the risk of preterm births or reduce the mean gestational 
age at birth [63], implementing a policy advocating for exercise in pregnancy is likely to 
face fears of anticipated pregnancy loss following physical exercise. 
Commercialisation of physical exercise through gym subscriptions, school clubs and 
sports academies, in addition to decreasing public play grounds and facilities is a major 
challenge to implementing a physical exercise policy. In addition, schools are paying 
greater attention to final year results than the physical wellbeing (keeping active) of their 
learners. Physical education lessons are no longer part of the curriculum in most schools 
in Uganda and sport facilities are replaced with class room facilities. Despite 
recommendations by the Uganda ministry of education and sport that schools should have 
play grounds, many schools do not have play grounds or facilities. 
Our study has showed that enhanced weight gain in those small at birth was associated 
with higher BP later in life. However, in a country with a high prevalence of 
undernourished infants, a policy preventing enhanced weight gain may be controversial. 
The short-term impact on mortality from malnutrition (kwashiorkor or marasmus) 
outweighs the longer-term impact of rapid weight gain on increased risk for later higher 
BP. Although a policy change advocating for normal rather than rapid weight gain (catch-
up) growth may have a long-term impact on later BP it would require development of 
clear definitions for slow, normal and rapid weight both for the malnourished children 
and those born with a low birth weight, and even then, may not be considered acceptable 
by parents and clinicians. 
Despite international recommendations for at least one BP measurement every year in 
heathy individuals and at every hospital/clinic visit for those at increased risk of BP, most 
clinicians do not measure BP in children and adolescents. A policy change is needed that 
includes training of medical students to actively screen for BP and accurately make a 
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diagnosis of high BP in children and adolescents. However, if clinicians are to screen and 
accurately diagnose high BP, appropriated sized BP cuffs and simplified BP tables should 
be available, accessible and used. 
The inverse association between fruit or vegetable consumption and BP observed in this 
study strengthens the need for educating children, families and schools on regular 
consumption of fruits and vegetables. A food and diet policy targeting both commercial 
and processing industries should aim to promote heathy dietary practices through 
adequate consumption of fruits and vegetables; reduction in daily salt intake to less than 
6 grams (which could prevent 2.5 million deaths globally per year); reduction of sugar 
and salt in processed food and beverages and adequate labelling of food content for 
processed foods. The growth in fast- and street-food, which are low cost, easily accessible 
and richer in salt and fat (saturated and trans-fatty acid) than traditional foods presents a 
great challenge in promoting a healthy diet in Uganda.  
Socio-economic and cultural beliefs regarding being overweight or obese are a challenge 
to the implementation of BP control and prevention policy. In many African societies, 
parents consider obese children as healthily children with no concerns or problems. Being 
of a large size is a sign of beauty, “good feeding”, prosperity, good health and wellbeing, 
and prestige, whereas small body size is sometimes considered a sign of poverty and poor 
health [64]. 
8.10 Conclusion 
The systematic review showed that the relatively small number of studies with different 
designs prohibited definitive conclusions. The relationship between birth weight and BP 
among young African remains understudied and appears to vary depending on the age of 
the participant. The observational study has demonstrated that i) both low and high birth 
weight might be associated with later BP, ii) rapid early postnatal weight gain especially 
in small individuals at birth plays a key role in the developmental programming of later 
BP; and iii) malaria eradication might escalate the burden of high BP. Multiple 
interventions initiated early in life targeting individuals with family history of 
hypertension, aiming at reducing adiposity (in pregnancy and adolescence) and 
promoting fruit and vegetable consumption could be essential in the control of adulthood 
hypertension and subsequent CVDs. It remains unclear how much of the variation in BP 
among adolescents in SSA can be attributed to genetic factors. 
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 Age, y BP Percentile SBP, mm Hg DBP, mm Hg
Percentile of Height Percentile of Height
5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
1 50th 80 81 83 85 87 88 89 34 35 36 37 38 39 39
90th 94 95 97 99 100 102 103 49 50 51 52 53 53 54
95th 98 99 101 103 104 106 106 54 54 55 56 57 58 58
99th 105 106 108 110 112 113 114 61 62 63 64 65 66 66
2 50th 84 85 87 88 90 92 92 39 40 41 42 43 44 44
90th 97 99 100 102 104 105 106 54 55 56 57 58 58 59
95th 101 102 104 106 108 109 110 59 59 60 61 62 63 63
99th 109 110 111 113 115 117 117 66 67 68 69 70 71 71
3 50th 86 87 89 91 93 94 95 44 44 45 46 47 48 48
90th 100 101 103 105 107 108 109 59 59 60 61 62 63 63
95th 104 105 107 109 110 112 113 63 63 64 65 66 67 67
99th 111 112 114 116 118 119 120 71 71 72 73 74 75 75
4 50th 88 89 91 93 95 96 97 47 48 49 50 51 51 52
90th 102 103 105 107 109 110 111 62 63 64 65 66 66 67
95th 106 107 109 111 112 114 115 66 67 68 69 70 71 71
99th 113 114 116 118 120 121 122 74 75 76 77 78 78 79
5 50th 90 91 93 95 96 98 98 50 51 52 53 54 55 55
90th 104 105 106 108 110 111 112 65 66 67 68 69 69 70
95th 108 109 110 112 114 115 116 69 70 71 72 73 74 74
99th 115 116 118 120 121 123 123 77 78 79 80 81 81 82
6 50th 91 92 94 96 98 99 100 53 53 54 55 56 57 57
90th 105 106 108 110 111 113 113 68 68 69 70 71 72 72
95th 109 110 112 114 115 117 117 72 72 73 74 75 76 76
99th 116 117 119 121 123 124 125 80 80 81 82 83 84 84
7 50th 92 94 95 97 99 100 101 55 55 56 57 58 59 59
90th 106 107 109 111 113 114 115 70 70 71 72 73 74 74
95th 110 111 113 115 117 118 119 74 74 75 76 77 78 78
99th 117 118 120 122 124 125 126 82 82 83 84 85 86 86
8 50th 94 95 97 99 100 102 102 56 57 58 59 60 60 61
90th 107 109 110 112 114 115 116 71 72 72 73 74 75 76
95th 111 112 114 116 118 119 120 75 76 77 78 79 79 80
99th 119 120 122 123 125 127 127 83 84 85 86 87 87 88
9 50th 95 96 98 100 102 103 104 57 58 59 60 61 61 62
90th 109 110 112 114 115 117 118 72 73 74 75 76 76 77
95th 113 114 116 118 119 121 121 76 77 78 79 80 81 81
99th 120 121 123 125 127 128 129 84 85 86 87 88 88 89
10 50th 97 98 100 102 103 105 106 58 59 60 61 61 62 63
90th 111 112 114 115 117 119 119 73 73 74 75 76 77 78
95th 115 116 117 119 121 122 123 77 78 79 80 81 81 82
99th 122 123 125 127 128 130 130 85 86 86 88 88 89 90
11 50th 99 100 102 104 105 107 107 59 59 60 61 62 63 63
90th 113 114 115 117 119 120 121 74 74 75 76 77 78 78
95th 117 118 119 121 123 124 125 78 78 79 80 81 82 82
99th 124 125 127 129 130 132 132 86 86 87 88 89 90 90
12 50th 101 102 104 106 108 109 110 59 60 61 62 63 63 64
90th 115 116 118 120 121 123 123 74 75 75 76 77 78 79
95th 119 120 122 123 125 127 127 78 79 80 81 82 82 83
99th 126 127 129 131 133 134 135 86 87 88 89 90 90 91
13 50th 104 105 106 108 110 111 112 60 60 61 62 63 64 64
90th 117 118 120 122 124 125 126 75 75 76 77 78 79 79
95th 121 122 124 126 128 129 130 79 79 80 81 82 83 83
99th 128 130 131 133 135 136 137 87 87 88 89 90 91 91
14 50th 106 107 109 111 113 114 115 60 61 62 63 64 65 65
90th 120 121 123 125 126 128 128 75 76 77 78 79 79 80
95th 124 125 127 128 130 132 132 80 80 81 82 83 84 84
99th 131 132 134 136 138 139 140 87 88 89 90 91 92 92
15 50th 109 110 112 113 115 117 117 61 62 63 64 65 66 66
90th 122 124 125 127 129 130 131 76 77 78 79 80 80 81
95th 126 127 129 131 133 134 135 81 81 82 83 84 85 85
99th 134 135 136 138 140 142 142 88 89 90 91 92 93 93
16 50th 111 112 114 116 118 119 120 63 63 64 65 66 67 67
90th 125 126 128 130 131 133 134 78 78 79 80 81 82 82
95th 129 130 132 134 135 137 137 82 83 83 84 85 86 87
99th 136 137 139 141 143 144 145 90 90 91 92 93 94 94
17 50th 114 115 116 118 120 121 122 65 66 66 67 68 69 70
90th 127 128 130 132 134 135 136 80 80 81 82 83 84 84
95th 131 132 134 136 138 139 140 84 85 86 87 87 88 89
99th 139 140 141 143 145 146 147 92 93 93 94 95 96 97
The 90th percentile is 1.28 SD, the 95th percentile is 1.645 SD, and the 99th percentile is 2.326 SD over the mean.
For research purposes, the SDs in Table B1 allow one to compute BP Z scores and percentiles for boys with height percentiles given in
Table 3 (ie, the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles). These height percentiles must be converted to height Z scores given
by: 5%  1.645; 10%  1.28; 25%  0.68; 50%  0; 75%  0.68; 90%  1.28; and 95%  1.645, and then computed according to the
methodology in steps 2 through 4 described in Appendix B. For children with height percentiles other than these, follow steps 1 through
4 as described in Appendix B. 
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Appendix 6: Blood pressure level for boys by age and height percentile
Age, y BP Percentile SBP, mm Hg DBP, mm Hg
Percentile of Height Percentile of Height
5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
1 50th 83 84 85 86 88 89 90 38 39 39 40 41 41 42
90th 97 97 98 100 101 102 103 52 53 53 54 55 55 56
95th 100 101 102 104 105 106 107 56 57 57 58 59 59 60
99th 108 108 109 111 112 113 114 64 64 65 65 66 67 67
2 50th 85 85 87 88 89 91 91 43 44 44 45 46 46 47
90th 98 99 100 101 103 104 105 57 58 58 59 60 61 61
95th 102 103 104 105 107 108 109 61 62 62 63 64 65 65
99th 109 110 111 112 114 115 116 69 69 70 70 71 72 72
3 50th 86 87 88 89 91 92 93 47 48 48 49 50 50 51
90th 100 100 102 103 104 106 106 61 62 62 63 64 64 65
95th 104 104 105 107 108 109 110 65 66 66 67 68 68 69
99th 111 111 113 114 115 116 117 73 73 74 74 75 76 76
4 50th 88 88 90 91 92 94 94 50 50 51 52 52 53 54
90th 101 102 103 104 106 107 108 64 64 65 66 67 67 68
95th 105 106 107 108 110 111 112 68 68 69 70 71 71 72
99th 112 113 114 115 117 118 119 76 76 76 77 78 79 79
5 50th 89 90 91 93 94 95 96 52 53 53 54 55 55 56
90th 103 103 105 106 107 109 109 66 67 67 68 69 69 70
95th 107 107 108 110 111 112 113 70 71 71 72 73 73 74
99th 114 114 116 117 118 120 120 78 78 79 79 80 81 81
6 50th 91 92 93 94 96 97 98 54 54 55 56 56 57 58
90th 104 105 106 108 109 110 111 68 68 69 70 70 71 72
95th 108 109 110 111 113 114 115 72 72 73 74 74 75 76
99th 115 116 117 119 120 121 122 80 80 80 81 82 83 83
7 50th 93 93 95 96 97 99 99 55 56 56 57 58 58 59
90th 106 107 108 109 111 112 113 69 70 70 71 72 72 73
95th 110 111 112 113 115 116 116 73 74 74 75 76 76 77
99th 117 118 119 120 122 123 124 81 81 82 82 83 84 84
8 50th 95 95 96 98 99 100 101 57 57 57 58 59 60 60
90th 108 109 110 111 113 114 114 71 71 71 72 73 74 74
95th 112 112 114 115 116 118 118 75 75 75 76 77 78 78
99th 119 120 121 122 123 125 125 82 82 83 83 84 85 86
9 50th 96 97 98 100 101 102 103 58 58 58 59 60 61 61
90th 110 110 112 113 114 116 116 72 72 72 73 74 75 75
95th 114 114 115 117 118 119 120 76 76 76 77 78 79 79
99th 121 121 123 124 125 127 127 83 83 84 84 85 86 87
10 50th 98 99 100 102 103 104 105 59 59 59 60 61 62 62
90th 112 112 114 115 116 118 118 73 73 73 74 75 76 76
95th 116 116 117 119 120 121 122 77 77 77 78 79 80 80
99th 123 123 125 126 127 129 129 84 84 85 86 86 87 88
11 50th 100 101 102 103 105 106 107 60 60 60 61 62 63 63
90th 114 114 116 117 118 119 120 74 74 74 75 76 77 77
95th 118 118 119 121 122 123 124 78 78 78 79 80 81 81
99th 125 125 126 128 129 130 131 85 85 86 87 87 88 89
12 50th 102 103 104 105 107 108 109 61 61 61 62 63 64 64
90th 116 116 117 119 120 121 122 75 75 75 76 77 78 78
95th 119 120 121 123 124 125 126 79 79 79 80 81 82 82
99th 127 127 128 130 131 132 133 86 86 87 88 88 89 90
13 50th 104 105 106 107 109 110 110 62 62 62 63 64 65 65
90th 117 118 119 121 122 123 124 76 76 76 77 78 79 79
95th 121 122 123 124 126 127 128 80 80 80 81 82 83 83
99th 128 129 130 132 133 134 135 87 87 88 89 89 90 91
14 50th 106 106 107 109 110 111 112 63 63 63 64 65 66 66
90th 119 120 121 122 124 125 125 77 77 77 78 79 80 80
95th 123 123 125 126 127 129 129 81 81 81 82 83 84 84
99th 130 131 132 133 135 136 136 88 88 89 90 90 91 92
15 50th 107 108 109 110 111 113 113 64 64 64 65 66 67 67
90th 120 121 122 123 125 126 127 78 78 78 79 80 81 81
95th 124 125 126 127 129 130 131 82 82 82 83 84 85 85
99th 131 132 133 134 136 137 138 89 89 90 91 91 92 93
16 50th 108 108 110 111 112 114 114 64 64 65 66 66 67 68
90th 121 122 123 124 126 127 128 78 78 79 80 81 81 82
95th 125 126 127 128 130 131 132 82 82 83 84 85 85 86
99th 132 133 134 135 137 138 139 90 90 90 91 92 93 93
17 50th 108 109 110 111 113 114 115 64 65 65 66 67 67 68
90th 122 122 123 125 126 127 128 78 79 79 80 81 81 82
95th 125 126 127 129 130 131 132 82 83 83 84 85 85 86
99th 133 133 134 136 137 138 139 90 90 91 91 92 93 93
* The 90th percentile is 1.28 SD, the 95th percentile is 1.645 SD, and the 99th percentile is 2.326 SD over the mean.
For research purposes, the SDs in Table B1 allow one to compute BP Z scores and percentiles for girls with height percentiles given in
Table 4 (ie, the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles). These height percentiles must be converted to height Z scores given
by: 5%  1.645; 10%  1.28; 25%  0.68; 50%  0; 75%  0.68; 90%  1.28; and 95%  1.645 and then computed according to the
methodology in steps 2 through 4 described in Appendix B. For children with height percentiles other than these, follow steps 1 through
4 as described in Appendix B. 
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Appendix 7: Blood pressure level for gir ls by ageand height percentile
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Age (years)
50th
25th
10th
5th
3rd
75th
90th
95th
97th
cm
75
80
85
90
95
100
105
110
115
120
125
130
135
140
145
150
155
160
165
170
175
180
185
190
195
200
cm
76
70
74
66
68
60
62
64
56
58
50
52
54
46
48
44
40
42
34
36
38
30
32
78
in
in
72
76
78
70
74
66
68
60
62
64
56
58
50
52
54
46
48
40
42
34
36
38
30
32
44
in
in
72
SOURCE: Developed by the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion (2000).
Appendix  charts growth Prevention and Control Disease for Centers 8:
Published May 30, 2000.
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2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Age (years)
50th
25th
10th
5th
3rd
75th
90th
95th
97th
70
72
74
76
66
68
60
62
64
56
58
50
52
54
46
48
44
40
42
34
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32
78
75
80
85
90
95
100
105
110
115
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125
130
135
140
145
150
155
160
165
170
175
180
185
190
195
200
cm
cm in
70
72
74
76
66
68
60
62
64
56
58
50
52
54
46
48
44
40
42
34
36
38
30
32
78
in
in
in
SOURCE: Developed by the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion (2000).
Published May 30, 2000.
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            Appendix 9: Blood pressure study questionnaire at 10 and 11 years of age 
 
 
                BPSVISIT, Version 2.0 06/03/15                      Child’s ID number |___|___|___|___|/|___| BIDNO 
BLOOD PRESSURE STUDY VISIT, AT TEN or ELEVEN YEARS OF AGE 
 
Child’s Name: ………………………………….…................................................ 
 NAME 
 
            Date of visit        (dd/mm/201y) 
 
|     |     |/|     |     |/| 2 | 0   | 1 |     | 
 
DATEVB1 
 
1 What is the child’s age on this visit?  |__|__| YEARS               |__|__|   MONTHS 
2 When did the child last have meal (Meal includes food or any drink other than water)  
 Time (in 24hrs) |__|__| . |__|__|  MEALTM 
  
Date       (dd/mm/201y) 
 
|     |     |/|     |     |/| 2 | 0 |1 |     | 
 
MEALDT 
 Time of blood collection   
 Time (in 24hrs) |__|__| . |__|__| BLODTM 
 Date       (dd/mm/201y)      |     |     |/|     |     |/| 2 | 0 |1 |     | BLODT 
Anthropometric Measurements 
3 Weight |__|__|.|__| kg  WEIGHT 
4 Height |__|__|__|.|___| cm    HEIGHT 
5 Height percentile for child’s sex and age |__|__| th HTPER 
Waist circumference and Mid upper arm circumference measurements (cm). 
6 waist circumference |__|__|.|__|  cm WSRT mid upper arm circumference |__|__|.|__|  cm ARM 
 For Girls only    
7 Has the child started having menses? (1=yes, 2=no, 9=don’t know; if there is uncertainty 
use “don’t know”) 
|___| MENS 
Information about the child and the family. 
Interviewer please explain that, although we do have a lot of information about our children, we are taking a special 
interest in factors that may be related to blood pressure at this visit and so will ask some additional questions and may 
repeat some that we have already asked at earlier visits. 
 Child and Family history    
8 Has the child ever had blood pressure measured by a professional health worker? 
(1=yes, 2=no, 9=don’t know; if there is uncertainty use “don’t know”) 
|___| PRES 
9 Has the child ever been told by a doctor or health worker that they have raised blood 
pressure? (1=yes, 2=no, 9=don’t know; if there is uncertainty use “don’t know”) 
|___| HYPC 
10 If yes, Is he/she on treatment for high blood pressures?   (1=yes, 2=no, 9=don’t know; if 
there is uncertainty use “don’t know”)  
|___| HYPT 
11 Does the child have a close relative (father, mother, brother or sister) who has ever been diagnosed by a 
doctor or nurse with any of the following conditions? (1=yes, 2=no, 9=don’t know; if there is uncertainty use 
“don’t know”) 
  High blood pressure |___| HBP 
  Heart attack / angina (chest pain on exertion or walking) |___| HART 
  Stroke  |___| SKRO 
  Diabetes |___| DIAB 
12 Does the child stay in a household in which someone smokes cigarettes in the home?  
(1=yes, 2=no, 9=don’t know; if there is uncertainty use “don’t know”)  
 
|___| SMOK 
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 Sleeping pattern    
13 Does your child have any problems at bedtime or going to bed? (1=yes, 2=no, 9=don’t 
know; if there is uncertainty use “don’t know”)   
|___| BEDT 
14 Does your child have difficulty waking in the morning, seem sleepy during the day 
(1=yes, 2=no, 9=don’t know; if there is uncertainty use “don’t know”)   
|___| NAP 
15 Does your child often take naps during the day? (1=yes, 2=no, 9=don’t know; if there is 
uncertainty use “don’t know”)   
|___| DNAP
S 
16 If yes child has nap, for how long on average is the nap? (enter time in minutes) |___|___|___| NAPT
M 
17 Does your child seem to wake up a lot at night? Any sleep waking or nightmares? 
(Answer 1= yes, 2=No and 9= uncertain) 
|___| WAKE 
18 On average, how many times does your child wake up at night? (Answer 99 if you 
do not know) 
|___|___| WAKE 
19 Do you think this child gets enough sleep? (1=yes, 2=no, 9=don’t know; if there is 
uncertainty use “don’t know”)   
|___| ENOU 
20 On average, for how many hours is the child’s sleep during the night time? (enter 
time in hours) 
|___|___| SLEE
P 
21 Does your child have loud or nightly snoring or any breathing difficulty at night? (1=yes, 
2=no, 9=don’t know; if there is uncertainty use “don’t know”)   
|___| SNOR
E 
22 Does the child have brief spells in which he or she stops breathing during his or her 
sleep? (1=yes, 2=no, 9=don’t know; if there is uncertainty use “don’t know”)   
|___| APNE
A 
         Diet 
23 In the past one month, in a typical week, on how many days does the child eat fruit, such 
as pineapple, mango, jackfruit, apples etc? (enter number of days per week 0-7; enter 9 if 
not sure) 
|___| DIET1 
24 In the past one month, in a typical week, on how many days does the child eat 
vegetables, such cabbage, avocado, greens, carrots, and eggplants etc? (enter number of 
days per week 0-7; enter 9 if not sure) 
|___| DIET2 
25 In the past one month, in a typical week, on how many days does the child drink sugared 
drinks like soda, juices? (enter number of days per week 0-7; enter 9 if not sure) 
|___| DIET3 
26 In the past one month, in a typical week, did the child add salt to your food in addition to 
what has been used when cooking? (1=yes 2=no; enter 9 if not sure) 
|___| DIET4 
27 In the past one month, in a typical week, can you estimate how many (total) 
teaspoons (small spoons) of sugar is normally added to the child’s cup of tea or any 
other drink you take? (enter 99 if not sure) 
|___|___| DIET5 
28 In the past one month, in a typical week, on how many days does the child eat starchy 
staples foods, such as posho, cassava, rice, sweet potatoes, bananas/plantains, etc? 
(enter number of days per week 0-7; enter 9 if not sure) 
|___| DIET
6 
29 In the past one month, in a typical week, on how many days do you eat beef/goat 
meat/pork/mutton, fish, chicken or other animal proteins? (enter number of days per week 
0-7; enter 9 if not sure) 
|___| DIET7 
30 What type of oil or fat is most used for food preparation in your household (answer 
1=vegetable oil (e.g. kimbo, cowboy, sunseed oil, olive oil, fortune oil, roki oil, mukwano oil),   
2=animal oil (e.g Ghee, butter, lard),  3=margarine (e.g. Blue Band), 4= none in particular, 
5 none used, 6=other, 9= I do not know 
 
|___| 
 
OIL 
  If entered 6 (Others) specify the oil or fat type used ……………………………………………. OILTH 
 Breast feeding History   
31 Was this child breastfed during infancy? (Answer 1= yes, 2=No and 9= uncertain) |___| BFED 
32 How old was the children when extra feeds (other than drinking water and breast 
milk) introduced? (in months, answer 99=uncertain) 
|___|___| EFED 
33 How old was the child when breast feeding was stopped? (in months, answer 
99=uncertain) 
|___|___| SBFD 
 Physical Activity   
We are trying to find out about your level of physical activity This includes play, work or dance that make you sweat or 
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make you your legs feel tired, or games that make you breathe hard, like tag, skipping, running, climbing and others. 
 When at school 
34 Do you go to school? (1=yes, 2=no) If answer is no, then move to section when at home |___| SCH 
35 Are you a day scholar or a boarder (1=day, 2=boarder)  |___| SCHTP 
36 For a child who walks to school, how long does it take to get to school? Answer in 
minutes: for boarders enter zero (0) 
|__|__|__| TAK 
37 Does your school have time allocated to physical activity (lessons and sport time 
(including sports or dancing))? (Answer 1=yes, 2=no) If answer is no, then move to 
(question 39) 
|___| PESCH 
38 Do you participate in these physical activity/lessons (including sports and dancing)? 
1=yes, 2=no, 
|___| LKPE 
39 In a typical school week, for how long in total does the physical activity/lesson last 
per week? (including sports and dancing) (Time in minutes)? 
|__|__|__| MNP
E 
40 Do you have break times (at break or lunch periods) from class when you get involved in 
exercise (e.g.  Playing/skipping)? (Answer 1=yes, 2=no) 
|__| BREAK 
41 How much time in total do you spend playing during these beaks (break and lunch) 
per day? (Time in minutes)? 
|__|__|__| BREPL 
42 What do you usually do after school each day? (answer 1=yes, 2=no for each of the following)  
If answer is Yes, for how long? (In minutes). 
 Play |___| PLAY1 |__|__|__| PLAYH1 
 Reading |___| READ1 |__|__|__| READH1 
 Watch Television |___| TV1 |__|__|__| TVH1 
 Fatching water  |___| WAT1 |__|__|__| WATH1 
 Dance |___| DANC1 |__|__|__| DANCH1 
 Digging |___| DIG1 |__|__|__| DIGH1 
 Video game |___| VIG1 |__|__|__| VIGHS1 
 Others 
............................................... 
|___| OTS1 |__|__|__| OTSH1 
 Others 
............................................... 
|___| OTY1 |__|__|__| OTYH1 
 When Home (the days when not going to school) 
43 When at Home (Weekend or Holiday or not going to school), What activities do you usually do and how 
much time per day do you usually spend on that activity (1=Yes, 2=No, 3=Uncertain) 
 Play |___| PLAY2 |__|__|__| PLAYH2 
 Reading |___| READ2 |__|__|__| READH2 
 Watch Television |___| TV2 |__|__|__| TVH2 
 Fatching water  |___| WAT2 |__|__|__| WATH2 
 Dance |___| DANC2 |__|__|__| DANCH2 
 Digging |___| DIG2 |__|__|__| DIGH2 
 Video game |___| VIG2 |__|__|__| VIGHS2 
 Others   .......................................................... |___| OTS2 |__|__|__| OTSH2 
 Others   ....................................................... |___| OTY2 |__|__|__| OTYH2 
 
 Chronic illnesses 
44 Has the child ever been told by a doctor or other health worker that they suffered from any of the following 
chronic diseases? (1=Yes, 2=No, 3=Uncertain)   
  Diabetes |___| DIAT 
  Heart condition |___| HRTD 
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  Cancer |___| CANC 
  Sickle cell disease |___| SCD 
  HIV infection |___| HIV 
  Kidney disease |___| KIDN 
  Thyroid disease |___| TYRO 
 
 Drug use history 
45 Has the child had daily prolonged use of any of the following drugs (indicate 1=yes, 2=no, 9=not sure)   
  Antiretroviral drugs (ARVS) |___| ARVS 
  NSAID (e.g. ibuprofen, naproxen, cyclo0xagenase-2 inhibitors) |___| NSAID 
  Steroids (e.g. methylprednisolone, predislone) |___| STEROIDS 
  Psychiatric drugs (buspirone, carbamezepine, clozapine fluoxetine) |___| PSYCHIA 
  Sympathomimetics (Nasal decongestants, diet pills) |___| SYMPAT 
  Herbals |___| HERBAL 
  Others (mention   ....................................................)                                 |___| MENTION1 
  Others (mention   ....................................................)                                 |___| MENTION2 
  
 Tanner Stage ( use the tanner stage charts) 
   For the male and female participants   
 What is the stage in public hair development? (answer 1=stage 1, 2= stage 11, 3=stage 
111 and 4= stage 1V and 5=stage V)  
|___| STAGPB 
     
  For the Females (girls) participants only   
 What is the stage for the breast development? (answer 1=stage 1, 2= stage 11, 3=stage 
111 and 4= stage 1V and 5=stage V) 
|___| STAGBR 
 
  
Blood pressure and pulse: systolic/diastolic blood pressure (mmHg) and pulse (beats/minute) 
Take 3 reading, waiting 5 minutes between each reading 
 1st Systolic BP |__|__|__| SBP1 1ST Diastolic |__|__|__| DBP1 1st Pulse rate |__|__|__| PRA1 
 2nd Systolic BP |__|__|__| SBP2 2nd Diastolic |__|__|__| DBP1 2nd Pulse rate |__|__|__| PRA2 
 3rd Systolic BP |__|__|__| SBP3 3rd Diastolic |__|__|__| DBP1 3rd Pulse rate |__|__|__| PRA3 
Mean blood pressure readings and blood pressure percentile  
 Mean Systolic   |__|__|__|    MSBP1     Systolic percentile    |__|__|th SCENTL1 
 Mean Diastolic |__|__|__|    MDBP1      Diastolic percentile   |__|__|th DCENTL1 
Classification of Blood pressure (according the BPS Classification code) 
Classification of BP (answer 1=Normal (<90th BP percentile), 2 = Prehypertension (90th to <95th BP 
percentile), 3= Stage 1 hypertension (95th percentile to the 99th percentile plus 5 mmHg) and 4 =Stage 2 
hypertension (> 99th percentile plus 5 mmHg) 
 
 
|___| 
 
 
CLAS1 
NOTE If answer is 3, invite the child for day two for further BP measurement in two weeks’ time. 
If answer is 4, invite the child for day two for further BP measurement in one weeks’ time. 
 Is the child eligible for second day BP measurement? (Answer 1=yes, 2=no) |___| APOI2 
 
Date of second day appointment  
 
|     |     |/|     |     |/| 2 | 0   | 1  |     | 
 
DATEAP2 
 
Investigator’s 
 
......................................................................... 
 
................................................................ 
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 Name    Signature 
 
DAY TWO 
 
Date of visit (dd/mm/201y) 
 
|     |     |/|     |     |/| 2 | 0 |1 |     | 
 
DATEVB2 
First blood pressure reading 
Take 3 reading, waiting 5 minutes between each reading 
 1st Systolic BP |__|__|__| 
SBP21 
1ST Diastolic |__|__|__| DBP21 1st Pulse rate |__|__|__| PRA21 
 2nd Systolic BP |__|__|__| 
SBP22 
2nd Diastolic |__|__|__| DBP22 2nd Pulse rate |__|__|__| PRA22 
 3rd Systolic BP |__|__|__| 
SBP23 
3rd Diastolic |__|__|__| DBP23 3rd Pulse rate |__|__|__| PRA32 
Mean blood pressure readings and Blood pressure percentile 
 Mean Systolic   |__|__|__|    MSBP21    Systolic percentile    |__|__|th SCENTL21 
 Mean Diastolic |__|__|__|    MDBP22    Diastolic percentile   |__|__|th DCENTL22 
Classification of Blood pressure (according the BPS Classification code) 
Classification of BP (answer 1=Normal (<90th BP percentile), 2 = Prehypertension (90th to <95th 
BP percentile), 3= Stage 1 hypertension (95th percentile to the 99th percentile plus 5 mmHg) 
and 4 =Stage 2 hypertension (> 99th percentile plus 5 mmHg) 
|___| CLAS2 
NOTE If answer is 3, invite the child for day two for further BP measurement in two weeks’ time. 
If answer is 4, invite the child for day two for further BP measurement in one weeks’ time. 
 
Is this child eligible for third day BP measurement? (Answer 1=yes, 2=no) |___| APOI3 
 
Date of third day appointment 
 
|     |     |/|     |     |/| 2 | 0   | 1 |     | 
 
DATEAP3 
 
Investigator’s 
 
........................................................................ 
 
.................................................................... 
                              Name Signature 
DAY THREE 
 
Date of Visit       (dd/mm/201y) 
 
|     |     |/|     |     |/| 2 | 0 |1 |     | 
 
DATEVB3 
First blood pressure and pulse rate reading 
Take 3 reading, waiting 5 minutes between each reading 
 1st Systolic BP |__|__|__| SBP31 1ST Diastolic |__|__|__| DBP31 1st Pulse rate |__|__|__| PRA31 
 2nd Systolic BP |__|__|__| SBP32 2nd Diastolic |__|__|__| DBP32 2nd Pulse rate |__|__|__| PRA32 
 3rd Systolic BP |__|__|__| SBP33 3rd Diastolic |__|__|__| DBP33 3rd Pulse rate |__|__|__| PRA33 
Mean blood pressure readings and Blood pressure percentile 
 Mean Systolic   |__|__|__|    MSBP3     Systolic percentile    |__|__|th SCENTL3 
 Mean Diastolic |__|__|__|    MDBP3    Diastolic percentile   |__|__|th DCENTL3 
If the mean systolic BP and/or diastolic BP is > 95th centile on day three, then the child has hypertension and BP 
should be staged 
Classification of Blood pressure (according the BPS Classification code) 
Classification of BP (answer 1=Normal (<90th BP percentile), 2 = Prehypertension (90th to 
<95th BP percentile), 3= Stage 1 hypertension (95th percentile to the 99th percentile plus 5 
mmHg) and 4 =Stage 2 hypertension (>99th percentile plus 5 mmHg) 
|___| CLAS3 
NOTE  
If answer is 3 or 4, investigate and refer for further management within one week. 
 
Investigator’s 
 
......................................................................... 
 
.................................................................... 
          Name    Signature 
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ABSTRACT 
Background: There is limited data from Africa on the effect of pre- and post-natal growth 
and infant feeding on later body composition. 
Objective: To investigate the effect of birth weight, exclusive breastfeeding and infant 
growth on adolescent body composition, using data from a Ugandan birth cohort. 
Methods: Data was collected prenatally from pregnant women and prospectively from their 
resulting live offspring. Data on body composition parameters (fat mass index [FMI]and fat 
free mass index [FFMI]) was collected from 10- and 11-year olds in this cohort. Linear 
regression analysis was used to assess the effect of birth weight, exclusive breastfeeding and 
infant growth on FMI and FFMI, adjusting for confounders. 
Results: 177 adolescents with a median age of 10.1 years were included in this analysis, with 
mean FMI 2.9 kg/m2 (standard deviation (SD) 1.2), mean FFMI 12.8 kg/m2 (SD 1.4) and 
mean birth weight 3.2 kg (SD 0.5). Ninety (50.9%) were male and 110 (63.2%) were 
exclusively breastfeeding at six weeks of age. In multivariable analysis, birth weight was 
associated with FMI (regression coefficient β= 0.66 per kg increase in birth weight, 95% 
confidence interval (CI) (0.04, 1.29), P=0.02), while exclusive breastfeeding (β= -0.43, 95% 
CI(-1.06, 0.19), P=0.12), growth 0-6 months (β= 0.24 95% CI(-0.43, 0.92), P=0.48) and 
growth 6-12 months (β= 0.61, 95% CI(-0.23, 1.46), P=0.11) were not associated with FMI 
among adolescents. Birth weight (β= 0.91, 95% CI (0.17, 1.65), P=0.01) was also associated 
with FFMI. Exclusive breastfeeding (β= 0.17, 95% CI (-0.60, 0.94), P=0.62), growth 0-6 
months (β= 0.56, 95% CI (-0.20, 1.33), P= 0.10), and growth 6-12 months (β= -0.02, 95% 
CI (-1.02, 0.99), P=0.97) were not associated with FFMI. 
Conclusions: Birth weight predicted body composition parameters in Ugandan early 
adolescents. However, exclusive breastfeeding at six weeks of age and growth in infancy 
were not associated with body composition at adolescence 
Keywords: Birth weight, exclusive breastfeeding, infant growth, fat mass, fat free mass, 
adolescents, Uganda 
Subject: Nutrition and Disease  
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Introduction 
Previously neglected due to high burdens of infectious disease morbidity, attention paid to 
NCDs in Africa has recently increased. Studies suggest that high blood pressure (BP) (1,2) 
and other cardiovascular diseases (CVDs) (3) have escalated on the African continent over 
recent decades, disproportionately affecting populations at younger ages than in more 
affluent countries (4). The rising burden of non-communicable diseases (NCDs) in low and 
middle income countries is of public health and economic significance (5) given the fragile 
health care systems and associated cost implications. In Africa, deaths due to NCDs are rising 
faster than anywhere else in the world (4). An understanding of the pathways for development 
of NCDs in this setting is essential for informing interventions for prevention of NCDs. 
Body composition, specifically increased adiposity, is associated with risk of NCDs later in 
life (6) and early-life factors, such as pre- and post-natal growth and infant feeding, have 
been reported to program and alter body composition (7). Sub-optimal nutrition in the fetal 
or infant periods triggers cellular and epigenetic changes that may affect later body 
composition (8). Rapid growth especially in infancy may result in metabolic changes which 
can manifest as increased adiposity and result in later NCDs (9,10). Thus, body composition 
change represents a mechanism through which early-life exposures may influence 
susceptibility to NCDs in adulthood. 
Evidence, predominantly from high-income countries, has shown that compared to normal 
birth weight infants, both low and high birth weight infants may bear an increased risk of 
adulthood obesity (11). Rapid weight gain and lack of exclusive breastfeeding in infancy 
have been associated with increased adiposity in adulthood (12). Exclusive breastfeeding has 
also been reported to be associated with a reduction in fat mass (FM; a proxy for adiposity 
(13,14). However, results are inconsistent, with some studies finding no evidence for 
association between birth weight (low or high) and FM (7,11,15,16) in late adolescence or 
adulthood, or for an impact of these early-life factors on risk of NCDs later in life (17,18). 
Results (19) also suggest mixed evidence for an association between birth weight and fat free 
mass (FFM; a proxy for lean muscle mass (20)) in late adolescence or adulthood. 
Few studies from Africa have investigated the relationship between birth weight, exclusive 
breastfeeding and growth in infancy, and body composition later in life, with tools for 
measuring body composition not widely available. Studies from South Africa (21) and 
  
 
258 
Cameroon (22) found that  birth weight and linear growth were positively associated with 
both FM and FFM. However, the impact of early-life factors on later body composition 
remains under studied among populations from Africa.  
Methods 
The current study used prospectively collected data from the Entebbe Mother and Baby Study 
(EMaBS) birth cohort. The EMaBS started life as a randomised controlled trial of 
anthelminthic treatment interventions. It was conducted in Wakiso district, on the northern 
shores of Lake Victoria in Uganda. Between 2003 and 2005, pregnant women attending 
antenatal care at Entebbe Hospital and residing in Entebbe Municipality or Katabi sub-county 
were enrolled into a double-blind randomised placebo-controlled trial designed to evaluate 
the effect of deworming treatment in pregnancy and childhood on response to childhood 
vaccines and infections. A detailed description of the trial design has been given elsewhere 
(23). 
We analysed prospectively collected data from the EMaBS, to investigate if birth weight, 
exclusive breastfeeding and growth in infancy were associated with body composition (fat 
mass index [FMI] and fat free mass indices [FFMI]) in early adolescence. Birth weight was 
measured and recorded to the nearest 0.1 kg for infants delivered in Entebbe hospital using 
weight scales (Fazzini SRL, Vimodrone, Italy), and captured as recorded on child health 
cards for infants delivered elsewhere. Further details have been reported previously 
(24).Weight was measured at six months and then annually starting at one year of age using 
weighing scales (Seca GmbH & Co. KG, Hamburg, Germany). Height was measured at six 
months and then annually to the nearest 0.1cm using stadiometers (Seca213 GmbH & Co. 
KG, Hamburg, Germany). Information on feeding practices was obtained at six weeks of age. 
The trial was completed in 2011 when all children had turned five years of age. After the trial 
completion, the offspring continued under follow up, being seen at annual routine visits and 
when sick. 
Between 20th May 2014 and 16th June 2016, 10- and 11-year olds in the EMaBS attending the 
study clinic for their annual visit were enrolled into the EMaBS blood pressure study (BPS). 
The primary aim of the EMaBS BPS was to investigate whether birth weight and pre- and 
peri-natal exposures, and genetic polymorphisms are important in programming BP in 
Ugandan adolescents; further details are described elsewhere (25). From 21st January 2015 
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to 23rd December 2015, additional data on body composition (FM and FFM) was collected 
from EMaBS participants enrolled into the BPS; outside this period the body composition 
analyser machine was not available. Briefly, adolescents stood barefoot on the posterior 
electrode base while holding strongly the two anterior electrodes handles of the segmental 
body composition analyser machine (TANITA BC-418, TANITA Corporation, Tokyo 
Japan). To avoid ambiguities from using body composition percentages (26,27), height 
normalized indices (FMI in kg/m2 and FFMI in kg/m2) were computed and used for analysis. 
FMI is considered as a measure of adiposity and FFMI as a measure of lean muscle mass. 
Statistical methods 
Study exposures were birth weight, breastfeeding status at six weeks, early infant growth (0-
6 months) and late infant growth (6-12 months), while the study outcomes were FMI and 
FFMI at 10 or 11 years of age. Birth weight was considered for analysis as both a continuous 
variable and as a categorical variable (low birth weight <2.5kg, normal weight 2.5-3.5kg and 
high birth weight >3.5kg). The 2006 World Health Organisation(WHO) growth standards 
(28) were used to compute weight for age standardised Z-scores at birth, and at six and 12 
months of age. For each participant, growth for the periods 0-6 months and 6-12 months was 
calculated as the change in Z-score during that period. Growth in each time period (0-6 
months, 6-12 months) was categorised as either increased or normal growth using the cut-off 
of a 0.67 increase in z-score (10,29) 
Characteristics of study participants were compared with those of cohort members who did 
not participate using t-test and chi-squared tests. Descriptive statistics were calculated as 
frequencies, means and standard deviations. Spearman’s correlation was used to assess 
correlations of body composition indices with each other and with birth weight. Linear 
regression models were fitted separately for FMI and FFMI, adjusting for confounders. 
Potential confounders considered were maternal age, body Mass Index (BMI), education, 
area of residence and HIV status; household socio-economic status at enrolment; and 
offspring’s place of delivery, sex, age at body composition analysis, family history of 
hypertension, type of school attended, days/week animal-proteins were eaten, days/week 
fruits were eaten, days/week vegetables were eaten, days/week starchy food were eaten, 
days/week sugared drinks were taken. Factors associated with the outcome, or with the 
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exposure of interest were added to the model concurrently and likelihood ratio tests were 
used to assess adjusted associations between each variable and the outcome. 
Current BMI, which can be partitioned into FMI plus FFMI, was considered to be on the 
causal pathway between birth weight and FMI or FFMI, thus was not considered as a 
potential confounder for inclusion in regression models. Assumptions underlying the linear 
regression model analysis (linear relationship between the dependent and predictor variables, 
homoscedasticity, normally distributed residuals) were investigated using a combination of 
scatter plots, plots of residuals against fitted values, and normal probability plots. The 
possibility of multicollinearity due to inclusion of correlated predictor variables was assessed 
using the change in standard error method. 
For each of the main exposures, factors associated with that exposure or with the outcome at 
a 5% level of significance were included in the final model for that exposure. Three a priori 
confounders, household socio-economic status, age and sex were included in the final model 
regardless of whether associated with the exposure or outcome or not. The test for trend was 
used to investigate the shape of the relationship between birth weight and the outcomes. 
Likelihood ratio test p-values were calculated. STATA version 14.2 (College Station, Texas, 
USA) was used for data analysis. Interaction terms were fitted to assess whether birth weight 
might modify the effect of breastfeeding or increased growth on the outcomes (FMI or 
FFMI). 
The EMaBS was granted ethical approval by the Uganda Virus Research Institute Science 
and Ethics Committee, the Ethics committee of the London School of Hygiene and Tropical 
Medicine, and the Uganda National Council of Science and Technology. 
Results  
Of the 2,345 live born EMaBS offspring, 1,119 (47.7%) enrolled into the BP study (25) at 
10 or 11 years of age and 177 (7.6%) had data on body composition taken and were included 
in the analysis. Of the 177 participants included, 80 (50.9%) were male; 175 (98.9%) were 
singleton births; and 161 (91.0%) were not exposed to maternal HIV in pregnancy, see table 
1. Regarding the key exposures, the mean birth weight was 3.2 kg (standard deviation (SD) 
0.5); 13 (9.4%) had low birth weight, 92 (66.2%) normal birth weight and 34 (24.5%) high 
birth weight with 38 participants of unknown birth weight. One hundred and ten (63.2%) 
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were exclusively breastfed at six weeks of age; with three participants missing data on this 
exposure. One hundred and eight (61%) and 123 (69%) participants had information on 
growth between 0 and 6 months, and between 6 and 12 months, respectively (the remaining 
were missing anthropometry for at least one of the time points and thus the change in z-score 
could not be calculated); 35 (32.4%) had increased growth in the first 6 months of life and 
15 (12.2%) had increased growth between 6 and 12 months of age. 
Adolescents who had body composition measured were similar to original EMaBS cohort 
members who did not participate for most characteristics, except participants were more 
likely to be born to separated/divorced/widowed mothers (P-value=0.037) and were less 
likely to be born to mothers with hookworm infections in pregnancy (P-value=0.036). 
At participation, offspring had a median age of 10.1 years (IQR: 10.0 to 10.7), mean BMI 
15.8 kg/m2 (SD 1.9), mean FMI 2.9 kg/m2 (SD 1.2) and mean FFMI 12.8 kg/m2 (SD 1.4). 
Among males, the mean FMI was 2.7 kg/m2 (SD 1.3) and mean FFMI was 13.3 kg/m2 (SD 
1.1), while in females the mean FMI was 3.1 kg/m2 (SD 0.9) and mean FFMI was 12.4 kg/m2 
(SD 1.5), see Figure 1. Birth weight was positively correlated with both FMI (r=0.35, p-
value<0.001) and FFMI (r=0.34, p-value<0.001). There was strong correlation between FMI 
and FFMI with r=0.517, p-value <0.001. 
The relationships between the main exposures, and FMI and FFMI are shown in table 2. 
Unadjusted estimates show that FMI increased by 0.73 kg/m2 per unit kilogram increase in 
birth weight, 95% confidence interval (CI):0.33-1.13. When birth weight was treated as a 
categorical variable, it showed a dose-response relationship with FMI (P-trend=0.007). 
Further investigation of this dose-response relationship showed no departure from linearity 
(P=0.92). Exclusive breastfeeding at six weeks (β= -0.19, 95% CI: -0.55, 0.17), increased 
growth between birth and 6 months of age (β= 0.15, 95% CI: -0.42, 0.71) and increased 
growth between 6 and 12 months (β= 0.62, 95% CI: -0.10, 1.33) were not associated with 
FMI in unadjusted analysis. In multivariable analysis birth weight (β= 0.66, 95% CI: 0.04, 
1.29) remained associated with FMI; exclusive breastfeeding at six weeks (β= -0.43, 95% 
CI: -1.06, 0.19), increased growth between birth and 6 months of age (β= 0.24 95% CI: -0.43, 
0.92) and increased growth between 6 and 12 months (β= 0.61, 95% CI: -0.23, 1.46) were 
not associated with FMI. 
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Figure 1: Distribution of fat mass index and fat free mass index by sex 
Birth weight was positively associated with FFMI in unadjusted analysis (β= 0.68, 95% CI: 
0.21, 1.16), while exclusive breastfeeding at six weeks (β= 0.14 95% CI: -0.30, 0.57), 
increased growth between birth and 6 months of age (β= 0.36, 95% CI; -0.29, 1.00) and 
increased growth between 6 and 12 months (β= -0.51, 95% CI: -1.33, 0.32) were not 
associated with FFMI. When birth weight was analysed as a categorical variable, findings 
were consistent with a linear relationship with FFMI (P-trend=0.009, p-value for departure 
from trend 0.93). In multivariable analysis, birth weight (β= 0.91, 95% CI: 0.17, 1.65) 
remained associated with FFMI; there remained no evidence of association for the other 
exposures. There was no evidence that the effect of breastfeeding or growth rate on FMI or 
FFMI differed by sex or birth weight: for example, for FMI, p-values were 0.97, 0.47 and 
0.60 for interaction between birth weight and breastfeeding, growth 0-6 months and growth 
6-12 months, respectively. The corresponding interaction p-values for FFMI were 0.12, 0.13 
and 0.16, respectively. For all analyses, assessment of the assumptions underlying the linear 
regression analysis indicated that these were met, and there was no suggestion of 
multicollinearity.
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Table 1 Participant characteristics (N=177) 
Characteristics  Frequency/ Mean (sd) Percentage 
 Maternal at enrolment   
  Age, years  24.7 (6.1)  
  Household economic status (1 lowest, 6 highest) (n=176) 3.8 (1.1)  
  Body mass index (kg/m2) 24.5 (3.3)  
  Area of residence (n=176)   
   Urban 114 64.8 
   Rural 62 35.2 
  Education   
   None 4 2.3 
   Primary 77 43.5 
   Secondary 76 42.9 
   Tertiary  20 11.3 
  HIV status   
   Negative 161 91.0 
   Positive 16 9.0 
 Offspring   
  Age, years 10.4(0.5)  
  Birth weight, kg (n=139) 3.2 (0.5)  
  Fat mass index 2.9 (1.2)  
  Fat free mass index 12.8 (1.4)  
  Sex   
   Male 90 50.9 
   Female 87 49.2 
  Exclusively breastfed at 6 weeks (n=174)   
   No 64 36.9 
   Yes 110 63.2 
  Place of birth   
   Entebbe Hospital  127 71.8 
   Home 20 11.3 
   Other places 30 17.0 
  HIV status   
   Unexposed 161 91.0 
   Exposed not infected 14 7.9 
   Infected 2 1.1 
  Public hair development (n=174)   
   Pre-pubertal 128 73.6 
   Pubertal 46 26.4 
  Breast development (girls only) (n=83)   
   Pre-pubertal 66 79.5 
   Pubertal 17 20.5 
  Days fruit eaten/week (n=174)   
   None 13 7.5 
   1-3 113 64.9 
   4-7 48 27.6 
  Days vegetables eaten/week (n=176)   
   None 15 8.5 
   1-3 101 57.4 
   4-7 60 34.1 
  Days animal-protein eaten/week (n=176)   
   None 14 8.0 
   1-3 133 75.6 
   4-7 29 16.5 
  Days starchy food eaten/week   
   1-3 4 2.3 
   4-7 173 97.7 
  Days sugared drinks taken/week   
   None 63 36.2 
   1-3 82 46.3 
   4-7 31 17.5 
  Type of school (n=176)   
   Boarding 27 15.3 
   Day  149 84.7 
Percentages may be ± 100 due rounding. 
SD; standard deviation. 
Missing data: area of residence 1; birth weight 38; pubic hair development 3; breast development 4; days fruit eaten/week 3; days 
vegetables eaten/week 1; days proteins eaten/week 1; type of school 1. 
 
263
  
 
 
Ta
bl
e 2
 
U
na
dj
us
te
d 
an
d 
ad
ju
st
ed
 a
ss
oc
ia
tio
ns
 b
et
w
ee
n 
bi
rt
h 
w
ei
gh
t, 
ex
cl
us
iv
e 
br
ea
st
fe
ed
in
g 
an
d 
gr
ow
th
 i
n 
in
fa
nc
y,
 a
nd
 b
od
y 
co
m
po
sit
io
n 
ou
tc
om
es
 (N
=1
77
) 
Ex
po
su
re
s 
U
na
dj
us
te
d 
A
dj
us
te
d 
β 
(9
5 
%
 C
I)
 
p-
va
lu
e 
β 
(9
5 
%
 C
I)
 
p-
va
lu
e*
 
Fa
t m
as
s i
nd
ex
 
 
 
 
 
 
 
Bi
rth
 w
ei
gh
t (
co
nt
in
uo
us
) (
n=
13
9)
 
0.
73
 (0
.3
3,
 1
.1
3)
 
<0
.0
01
 
0.
66
 (0
.0
4,
 1
.2
9)
 
0.
01
9 
 
 
Bi
rth
 w
ei
gh
t (
ca
te
go
ric
al
)  
 
 
 
 
 
 
 
<2
.5
 k
g 
(n
=1
3)
 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
2.
5 
to
 3
.5
 (n
=9
2)
 
0.
54
 (-
0.
18
, 1
.2
6)
 
 
0.
87
 (-
0.
06
, 1
.8
0)
 
 
 
 
 
> 
3.
5 
kg
 (n
=3
4)
 
1.
03
 (0
.2
4,
 1
.8
2)
 
0.
00
7 
[tr
en
d]
 
1.
09
 (-
0.
04
, 2
.2
3)
 
0.
05
1 
[tr
en
d]
 
 
 
Ex
cl
us
iv
el
y 
br
ea
stf
ed
 a
t 6
 w
ee
ks
  
 
 
 
 
 
 
 
N
o 
(n
=6
4)
 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
Y
es
 (n
=1
10
) 
-0
.1
9 
(-0
.5
5,
 0
.1
7)
 
0.
53
8 
-0
.4
3 
(-1
.0
6,
 0
.1
9)
 
0.
12
2 
 
 
G
ro
w
th
 b
et
w
ee
n 
0 
to
 6
 m
on
th
s 
 
 
 
 
 
 
 
N
or
m
al
 (n
=7
3)
 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
In
cr
ea
se
d 
(n
=3
5)
 
0.
15
 (-
0.
42
, 0
.7
1)
 
0.
60
0 
0.
24
 (-
0.
43
, 0
.9
2)
 
0.
48
0 
 
 
G
ro
w
th
 b
et
w
ee
n 
6 
to
 1
2 
m
on
th
s  
 
 
 
 
 
 
 
N
or
m
al
 (n
=1
08
) 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
In
cr
ea
se
d 
(n
=1
5)
 
0.
62
 (-
0.
10
, 1
.3
3)
 
0.
08
9 
0.
61
 (-
0.
23
, 1
.4
6)
 
0.
10
7 
Fa
t f
re
e m
as
s i
nd
ex
 
 
 
Bi
rth
 w
ei
gh
t (
co
nt
in
uo
us
) (
n=
13
9)
 
0.
68
 (0
.2
1,
 1
.1
6)
 
0.
00
5 
0.
91
 (0
.1
7,
 1
.6
5)
 
0.
00
7 
 
 
Bi
rth
 w
ei
gh
t (
ca
te
go
ric
al
)  
 
 
 
 
 
 
 
> 
2.
5 
kg
 (n
=1
3)
 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
2.
5 
to
 3
.5
 (n
=9
2)
 
0.
61
 (-
0.
24
, 1
.4
5)
 
 
1.
11
 (0
.0
1,
 2
.2
1)
 
 
 
 
 
> 
3.
5 
kg
 (n
=3
4)
 
1.
16
 (0
.2
3,
 2
.0
9)
 
0.
00
9 
[tr
en
d]
 
1.
53
 (0
.1
9,
 2
.8
7)
 
0.
02
0 
[tr
en
d]
 
 
 
Ex
cl
us
iv
el
y 
br
ea
stf
ed
 a
t 6
 w
ee
ks
 
 
 
 
 
 
 
 
N
o 
(n
=6
4)
 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
Y
es
 (n
=1
10
) 
0.
14
 (-
0.
30
, 0
.5
7)
 
0.
53
8 
0.
17
 (-
0.
60
, 0
.9
4)
 
0.
61
9 
 
 
G
ro
w
th
 b
et
w
ee
n 
0 
to
 6
 m
on
th
s 
 
 
 
 
 
 
 
N
or
m
al
 (n
=7
3)
 
Re
fe
re
nc
e 
 
re
fe
re
nc
e 
 
 
 
 
In
cr
ea
se
d 
(n
=3
5)
 
0.
36
 (-
0.
29
, 1
.0
0)
 
0.
27
2 
0.
56
 (-
0.
20
, 1
.3
3)
 
0.
10
0 
 
 
G
ro
w
th
 b
et
w
ee
n 
6 
to
 1
2 
m
on
th
s 
 
 
 
 
 
 
 
N
or
m
al
 (n
=1
08
) 
Re
fe
re
nc
e 
 
Re
fe
re
nc
e 
 
 
 
 
In
cr
ea
se
d 
(n
=1
5)
 
-0
.5
1 
(-1
.3
3,
 0
.3
2)
 
0.
22
4 
-0
.0
2 
(-1
.0
2,
 0
.9
9)
 
0.
97
1 
In
 m
ul
tiv
ar
ia
bl
e 
an
al
ys
is,
 a
ll 
fa
ct
or
s s
ho
w
n 
in
 th
e 
ta
bl
e 
w
er
e 
ad
de
d 
to
 th
e 
m
od
el
 to
ge
th
er
. A
dj
us
te
d 
as
so
ci
at
io
ns
 w
er
e 
ad
ju
ste
d 
fo
r m
at
er
na
l 
ch
ar
ac
te
ris
tic
s a
t e
nr
ol
m
en
t (
ho
us
eh
ol
d 
so
ci
o-
ec
on
om
ic
 st
at
us
, a
ge
, b
od
y 
m
as
s i
nd
ex
, H
IV
 st
at
us
) a
nd
 a
do
le
sc
en
ts’
 c
ha
ra
ct
er
ist
ic
s (
pl
ac
e 
of
 
de
liv
er
y,
 a
ge
, s
ex
, d
ay
s a
ni
m
al
-p
ro
te
in
 e
at
en
/w
ee
k,
 d
ay
s f
ru
its
 e
at
en
/w
ee
k)
 
* 
lik
el
ih
oo
d 
ra
tio
 te
st 
p-
va
lu
e 
264
  
 
265 
Discussion 
We hypothesised that birth weight, exclusive breastfeeding and rate of growth were each 
associated with body composition indices among Ugandan adolescents aged 10-11 years. 
This study showed that birth weight was associated with both adolescent FMI and adolescent 
FFMI but there was no association between exclusive breastfeeding in the first six weeks or 
growth rate in infancy and FMI or FFMI among early adolescents. 
Our findings of a positive association between birth weight and both FMI and FFMI are 
consistent with results from across-sectional study among 557 Cameroonian children aged 
5-12 years (22) and from a birth cohort study among South Africans, with body composition 
assessed at ages10 and 22 years (21,30). 
We did not find evidence for an effect of exclusive breastfeeding in the first six weeks on 
FMI or FFMI. This was contrary to results reported  in a meta-analysis (31) that showed that 
on average, each additional month of exclusive breastfeeding reduced adiposity by 4%.The 
lack of association between exclusive breastfeeding in the first six weeks with adiposity or 
lean muscle mass development in this study supports results among 18 year old Brazilians 
enrolled in a population based birth cohort (32). In our study, only 63% of mothers reported 
exclusive breastfeeding at six weeks but nearly all mothers [172 (97.2%)] were giving some 
breast milk and only 2 (1.1%) had weaned, thus a differential effect of breast milk may be 
hard to detect in this population. The relationship between exclusive breastfeeding in the first 
six months of life and adolescents’ body composition was not examined because data on 
feeding status at six months was not collected. 
There was no association between increased rate of growth in the first six months of life or 
from 6 to 12 months and FMI or FFMI. These findings do not support earlier studies 
predominantly from European counties reviewed in (18,33) and results from a later study 
among 909 Dutch term infants (33) which reported positive associations between growth rate 
and body composition. Our study was likely underpowered to detect true associations: of the 
177 adolescents for whom body composition data were available, data on growth were only 
available for around two thirds, thus reducing the sample size for this analysis. Among 
participants in the larger EMaBS BPS (1,119 participants, of which the 177 participants with 
body composition data were a subset), growth in the first two years of life was positively 
associated with BP in early adolescence (25). 
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Many studies have used body mass index (BMI) as a surrogate outcome measure for body 
adiposity.  However, evidence to date shows that BMI creates ambiguities since it cannot 
specifically differentiate between FM and FFM (34). We therefore used direct measurement 
of body composition and the height normalised indices for FM and FFM which are reported 
to be more precise measures of adiposity and lean muscle, respectively (26). The strong 
correlation between FMI and FFMI suggests that, for the Uganda adolescents participating 
in our study, FMI and FFMI both increase proportionally with an increase in BMI. This is 
reflected by the fact that birth weight was positively associated with both increased adiposity 
and increased lean muscle mass in early adolescence. 
We used a bio-electrical impendence body composition analyser machine to measure 
segmental body composition among the study adolescents. Bio-electrical impendence has 
been reported to have good correlation with other methods such as dual energy 
absorptiometry (35) and, importantly in this setting, provided a relatively inexpensive field 
method of body composition analysis. 
To our knowledge, this was the first study in East Africa to investigate the impact of early-
life factors on the body composition parameters FMI and FFMI. Strengths of the study are 
its cohort design and the robust methods used for measuring body composition parameters. 
Data on the exposures of interest and potential confounders were collected prospectively, 
minimizing recall and reporter bias. Exposures and confounders were determined before the 
BP study was conceptualized and designed. However, the possibility of residual confounding 
due to unmeasured variables cannot be ruled out. Some exposure information such as 
exclusive breastfeeding at six weeks was not available for all of the adolescents. In this study 
we were unable to differentiate the effects of low birth weight due to growth restriction in 
utero from effects due to pre-term birth because accurate data on gestational age was not 
available in this population. 
Whereas we have investigated the effect of two postnatal factors (rate of growth and 
exclusive breastfeeding) on later disease risk, further studies should investigate the effect of 
other factors such as current diet, age at menarche, sleep patterns/ duration and the effect of 
an obesogenic environment on body composition. In conclusion, exclusive breastfeeding, 
and infant growth were not associated with body composition among early adolescents from 
a tropical setting. However, birth weight is a good predictor of both adiposity and lean muscle 
mass later in life in this setting. 
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Supplementary tables 
Table S1 Unadjusted associations of maternal, childhood and adolescence characteristics with 
birth weight and exclusive breastfeeding  
Characteristics Birth weight Exclusive breast feeding 
 Maternal at enrolment b (95 % CI)  p-value b (95 % CI)  p-value 
  Age  0.02 (0.01, 0.03) 0.003 -0.01 (-0.02, 0.00) 0.059 
  Household economic status  0.06 (-0.01, 0.13) 0.086 -0.08 (-0.14, -0.02) 0.014 
  Body mass index 0.03 (0.01, 0.06) 0.007 -0.00 (-0.03, 0.02) 0.657 
  Area of residence     
   Urban Reference  Reference  
   real -0.12 (-0.20, 0.17) 0.869 -0.06 (-0.21, 0.10) 0.473 
  Education     
   None -0.43 (-1.44, 0.58)  0.21 (-0.28, 0.70)  
   Primary Reference  Reference  
   Senior 0.00 (-0.18, 0.19)  0.15 (-0.01, 0.30)  
   Tertiary  0.19 (-0.07, 0.45) 0.377 0.21 (-0.03, 0.45) 0.154 
  HIV status     
   Negative Reference  Reference  
   Positive 0.01 (-0.29, 0.32) 0.941 -0.33 (-0.58, -0.07) 0.012 
 Childhood     
  Birth weight -  0.03 (-0.13, 0.19) 0.716 
  Sex     
   Male Reference  Reference  
   Female -0.02 (-0.19, 0.15) 0.825 0.08 (-0.7, 0.22) 0.307 
  Exclusively breastfed by 6 weeks     
   No Reference    
   Yes 0.03 (-0.15, 0.21) 0.716 -  
  Place of birth     
   Entebbe Hospital  Reference  Reference  
   Home -0.68 (-1.18, -0.18)  -0.11 (-0.34, 0.12)  
   Other places -0.07 (-0.38, 0.24) 0.029 -0.25 (-0.45, -0.06) 0.030 
  HIV status     
   Unexposed Reference  Reference  
   Exposed not infected 0.04 (-0.29, 0.374)  -0.30 (-0.57, -0.04)  
   Infected -0.15 (-0.87, 0.57) 0.885 -0.66 (-1.60, 0.28) 0.033 
 Adolescence     
  Age 0.23 (0.07, 0.39) 0.005 -0.14 (-0.27, -0.01) 0.040 
  Body mass index 0.10 (0.06, 0.14) <0.001 -0.01 (-0.05, 0.03) 0.551 
  Public hair development     
   Pre-pubertal Reference  Reference  
   Pubertal -0.08 (-0.28, 0.12) 0.406 -0.07 (-0.24, 0.09) 0.386 
  Breast development (girls only)     
   Pre-pubertal Reference  Reference  
   Pubertal 0.00 (-0.28, 0.29) 0.980 -0.19 (-0.46, 0.07) 0.151 
  Days a fruit is eaten/week     
   None Reference  Reference  
   1-3 0.04 (-0.28, 0.36)  -0.14 (-0.42, 0.14)  
   4-7 0.26 (-0.08, 0.60) 0.066 -0.13 (-0.43, 0.17) 0.617 
  Days vegetables is eaten/week     
   None Reference  Reference  
   1-3 -0.05 (-0.37, 0.28)  -0.05 (-0.32, 0.21)  
   4-7 0.01 (-0.33, 0.35) 0.807 -0.01 (-0.28, 0.27) 0.826 
  Days animal-protein eaten/week     
   None Reference  Reference  
   1-3 -0.10 (-0.41, 0.21)  -0.03 (-0.30, 0.24)  
   4-7 0.21 (-0.15, 0.57) 0.034 0.08 (-0.23, 0.39) 0.521 
  Days starchy food eaten/week     
   1-3 Reference  Reference  
   4-7 0.10 (-0.48, 0.69) 0.730 -0.12 (-0.60, 0.36) 0.623 
  Days sugared drinks taken/week     
   None Reference  Reference  
268
   1-3 -0.04 (-0.23, 0.15)  0.01 (-0.15, 0.17)  
   4-7 -0.07 (-0.31, 0.18) 0.849 0.18 (-0.03, 0.39) 0.196 
  Type of school     
   boarding Reference  Reference  
   Day  -0.20 (-0.43, 0.04) 0.098 0.00 (-0.20, 0.20) 0.996 
  Family history of hypertension     
   No Reference  Reference  
   Yes -0.10 (-0.38, 0.18) 0.479 -0.00 (-0.26, 0.25) 0.980 
Percentages may be ± 100 due rounding. 
Missing data: area of residence 1; birth weight 38; pubic hair development 1; breast development 4; days a fruit is 
eaten/week 3; days vegetables are eaten/week 1; days proteins are eaten/week 1; type of school 1. 
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Table S2 Unadjusted associations of maternal, childhood and adolescence characteristics with 
increased growth for given periods 
Characteristics 0-6 months of age 6-12 months of age 
 Maternal at enrolment b (95 % CI) p-value b (95 % CI) p-value 
  Age  0.00 (-0.01, 0.02) 0.731 0.00 (-0.01, 0.01) 0.532 
  Household economic status  0.01 (-0.07, 0.85) 0.827 0.03(-0.02, 0.08) 0.245 
  Body mass index -0.00 (-0.03, 0.03) 0.972 0.03 (0.01, 0.05) 0.001 
  Area of residence     
   Urban Reference  Reference  
   real 0.07 (-0.13, 0.27) 0.495 -0.01 (-0.13, 0.12) 0.906 
  Education     
   None -0.30 (-1.26, 0.65)  -0.17 (-0.64, 0.29)  
   Primary Reference  Reference  
   Senior 0.03 (-0.17, 0.23)  -0.06 (-0.19, 0.06)  
   Tertiary  0.07 (-0.20, 0.34) 0.862 -0.17 (-0.37, 0.02) 0.324 
  HIV status     
   Negative Reference  Reference  
   Positive -0.19 (-0.56, 0.17) 0.294 -0.13 (-0.37, 0.11) 0.277 
 Childhood     
  Birth weight -0.31 (-0.48, -0.15) <0.001 -0.04 (-0.18, 0.09) 0.508 
  Sex     
   Male Reference  Reference  
   Female -0.05 (-0.23, 0.13) 0.549 -0.00 (-0.12, 0.12) 0.996 
  Exclusively breastfed by 6 weeks     
   No Reference  Reference  
   Yes 0.07 (-0.13, 0.27) 0.483 -0.14 (-0.27, -0.01) 0.033 
  Place of birth     
   Entebbe Hospital  Reference  Reference  
   Home -0.31 (-0.96, 0.35)  0.04 (-0.16, 0.25)  
   Other places 0.32 (-0.02, 0.66) 0.112 -0.14 (-0.31, 0.04) 0.255 
  HIV status     
   Unexposed Reference  Reference  
   Exposed not infected -0.19 (-0.56, 0.17)  -0.13 (-0.37, 0.11)  
   Infected - 0.294 - 0.277 
 Adolescence     
  Age -0.10 (-0.27, 0.06) 0.229 0.09 (-0.02, 0.20) 0.097 
  Body mass index 0.02 (-0.93, 0.06) 0.447 0.01 (-0.02, 0.04) 0.446 
  Public hair development     
   Pre-pubertal Reference  Reference  
   Pubertal 0.05 (-0.16, 0.25) 0.663 -0.12 (-0.26, 0.02) 0.089 
  Breast development (girls only)     
   Pre-pubertal Reference  Reference  
   Pubertal 0.08 (-0.23, 0.40) 0.592 0.09 (-0.15, 0.33) 0.472 
  Days a fruit is eaten/week     
   None Reference  Reference  
   1-3 -0.03 (-0.34, 0.28)  0.04 (-0.17, 0.26)  
   4-7 -0.21 (-0.55, 0.14) 0.242 -0.06 (-0.30, 0.17) 0.299 
  Days vegetables is eaten/week     
   None Reference  Reference  
   1-3 0.27 (-0.06, 0.60)  0.00 (-0.23, 0.23)  
   4-7 0.17 (-0.17, 0.52) 0.227 0.01 (-0.22, 0.25) 0.976 
  Days animal-protein eaten/week     
   None Reference  Reference  
   1-3 0.08 (-0.25, 0.40)  0.14 (-0.06, 0.34)  
   4-7 0.36 (-0.05, 0.77) 0.115 -0.14 (-0.11, 0.40) 0.399 
  Days starchy food eaten/week     
   1-3 Reference  Reference  
   4-7 0.33 (-0.34, 1.00) 0.328 0.16 (-0.26, 0.51) 0.515 
  Days sugared drinks taken/week     
   None Reference  Reference  
   1-3 -0.00 (-0.20, 0.20)  0.111 (-0.02, 0.24)  
   4-7 0.19 (-0.07, 0.44) 0.258 -0.-3 (-0.20, 0.14) 0.114 
  Type of school     
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   boarding Reference  Reference  
   Day  0.07 (-0.16, 0.31) 0.536 -0.02 (-0.18, 0.13) 0.763 
  Family history of hypertension     
   No Reference  Reference  
   Yes 0.19 (-0.09, 0.48) 0.179 0.06 (-0.14, 0.27)  
Percentages may be ± 100 due rounding. 
Missing data: area of residence 1; birth weight 38; pubic hair development 1; breast development 4; days a fruit is 
eaten/week 3; days vegetables are eaten/week 1; days proteins are eaten/week 1; type of school 1. 
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Table S3 Unadjusted associations of maternal, childhood and adolescence characteristics with fat 
mass index and fat free mass index 
Characteristics Fat mass index Fat free mass index 
 Maternal at enrolment b (95 % CI) p-value b (95 % CI) p-value 
  Age  0.02 (-0.01, 0.05) 0.117 -0.00 (-0.04, 0.03) 0.810 
  Household economic status  0.12 (-0.03, 0.27) 0.123 0.08 (-0.10, 0.26) 0.369 
  Body mass index 0.12 (0.07, 0.17) <0.001 0.06 (-0.00, 0.12) 0.056 
  Area of residence     
   Urban Reference  Reference  
   real 0.05 (-0.32, 0.41) 0.794 -0.17 (-0.60, 0.26) 0.444 
  Education     
   None -0.22 (-1.36, 0.92)  -.026 (-1.65, 1.12)  
   Primary Reference  Reference  
   Senior 0.10 (-0.26, 46)  0.02 (-0.41, 0.46)  
   Tertiary  1.01 (0.45, 1.57) 0.004 0.75 (0.07, 1.43) 0.149 
  HIV status     
   Negative Reference  Reference  
   Positive -0.12 (-0.72, 0.48) 0.688 -0.03 (-0.74, 0.68) 0.925 
 Childhood     
  Birth weight 0.73 (0.33, 1.13) <0.001 0.68 (0.21, 1.16) 0.005 
  Sex     
   Male Reference  Reference  
   Female 0.44 (0.10, 0.77) 0.012 -0.87 (-1.26, -0.46) <0.001 
  Exclusively breastfed at 6 weeks     
   No Reference  Reference  
   Yes -0.19 (-0.55, 0.17) 0.299 0.14 (-0.30, 0.57) 0.538 
  Place of birth     
   Entebbe Hospital  Reference  Reference  
   Home -0.50 (-1.05, 0.05)  -0.29 (-0.94, 0.37)  
   Other  0.07 (-0.39, 0.53) 0.167 0.32 (-0.23, 0.87) 0.300 
  HIV status     
   Unexposed Reference  Reference  
   Exposed not infected -0.10 (-0.74, 0.55)  -0.09 (-0.86, 0.67)  
   Infected -0.31 (-1.94, 1.33) 0.897 0.38 (-1.56, 2.33) 0.878 
 Adolescence     
  Age 0.18 (-0.13, 0.50) 0.256 0.23 (-0.14, 0.61) 0.224 
  Body mass index 0.49 (0.44, 0.54) <0.001 0.52 (0.44, 0.59) <0.001 
  Public hair development     
   Pre-pubertal Reference  Reference  
   Pubertal -0.01 (-0.30, 0.29) 0.963 0.30 (-0.14, 0.74) 0.177 
  Breast development (girls only)     
   Pre-pubertal Reference  Reference  
   Pubertal 0.46 (-0.03, 0.95) 0.066 1.27 (0.51, 2.02) 0.001 
  Days a fruit eaten/week     
   None Reference  Reference  
   1-3 0.34 (-0.33, 1.02)  0.32 (-0.47, 1.10)  
   4-7 0.62 (-0.09, 1.34) 0.171 0.92 (0.08, 1.76) 0.018 
  Days vegetables eaten/week     
   None Reference  Reference  
   1-3 0.53 (-0.10, 1.16)  0.36 (-0.40, 1.12)  
   4-7 0.23 (-0.43, 0.89) 0.118 0.35 (-0.44, 1.14) 0.634 
  Days animal-protein eaten/week     
   None Reference  Reference  
   1-3 0.23 (-0.42, 0.87)  -0.09 (-0.86, 0.68)  
   4-7 0.46 (-0.29, 1.21) 0.451 -0.31 (-1.20, 0.58) 0.697 
  Days starchy food eaten/week     
   1-3 Reference  Reference  
   4-7 0.04 (-1.12, 1.21) 0.941 -0.61 (-1.99, 0.77) 0.384 
  Days sugared drinks taken/week     
   None Reference  Reference  
   1-3 0.26 (-0.12, 0.65)  -0.13 (-0.58, 0.33)  
   4-7 0.07 (-0.43, 0.57) 0.378 0.18 (-0.41, 0.78) 0.559 
  Type of school     
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   boarding Reference  Reference  
   Day  -0.72 (-1.19, -0.25) 0.003 0.06 (-0.51, 0.63) 0.832 
  Family history of hypertension     
   No Reference  Reference  
   Yes 0.51 (-0.09, 1.11) 0.093 -0.01 (-0.73, 7.0) 0.970 
Percentages may be ± 100 due rounding. 
Missing data: area of residence 1; birth weight 38; pubic hair development 1; breast development 4; days a fruit is 
eaten/week 3; days vegetables are eaten/week 1; days proteins are eaten/week 1; type of school 1. 
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Abstract  
Background: The relationship between blood pressure (BP) and early-life factors such as birth 
weight, life-course factors such as obesity, and genetic variants among Africans are unknown. 
This PhD aimed to systematically review literature on the relationship between birth weight 
and BP among young Africans and to use data from the Entebbe Mother and Baby Study 
(EMaBS), a Ugandan birth cohort, to investigate the impact of early-life, life-course and 
genetic factors on adolescents’ BP. 
Methods: Four databases were systematically searched for relevant publications. In the 
EMaBS, data were collected prenatally from pregnant women and prospectively from the 
resulting offspring, with BP measured in adolescence. Linear regression was used to relate 
birth weight, early-growth and other characteristics to BP. Genetic analyses were conducted to 
investigate genetic variants associated with adolescents’ BP. 
Results: The systematic review showed that among the few published studies from Africa, the 
relationship between birth weight and BP varied by participants’ age. Findings from the 
EMaBS indicated strong evidence of association between postnatal weight gain and later BP, 
with fast-growing low birth weight individuals particularly affected. Maternal factors 
positively associated with higher adolescent BP were gestational body mass index (BMI) and 
higher education status. Adolescent factors positively associated with higher BP were age, 
waist circumference, BMI, family history of hypertension and current Trichuris infection. 
Previous malaria infection in childhood and higher vegetable or fruit consumption were 
associated with lower BP in adolescence. No genetic variant reached genome-wide significance 
for association with BP. Thirty-three of 330 variants previously identified as associated with 
BP were replicated in this study, but none were significant after accounting for multiple testing. 
Conclusions: Postnatal weight gain rather than birth weight is associated with later BP, with 
fast-growing low birth weight individuals at particular risk. Larger studies are required to 
characterise BP genetics in African adolescents. 
